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Abstract
The innate immune system forms the first line of defense against intruding pathogens. A
core element of this response is the formation of the inflammasome, a multiprotein com-
plex. This results in the activation of caspase-1 that leads to gasdermin-D-dependent
pyroptosis, a pro-inflammatory form of cell death, and the maturation and release of
the cytokines IL (interleukin)-1β and IL-18. Inflammasome formation is initiated by the
activation of cytosolic pattern recognition receptors in response to various pathogen-
derived stimuli. Most inflammasome-forming receptors contain a PYD (Pyrin domain)
through which they recruit an adaptor protein called ASC (apoptosis associated speck
like protein containing a CARD). ASC consist of an N-terminal PYD and a C-terminal
CARD (caspase recruitment and activation domain) through which it recruits caspase-1.
A hallmark of inflammasome activation is the formation of the ASC speck, a micrometer-
sized complex formed by ASC. It has been shown that isolated PYDs of human ASC
spontaneously form a three-stranded helical filament in which the individual subunits
interact with each other via six asymmetric interaction interfaces. Yet, the necessity of
oligomeric ASC assemblies for its function has not been shown.
By using a combined solid-state NMR and cryo-electron microscopy approach, we
show that also murine ASCPYD filaments display the same three-stranded helical ar-
rangement as human ASCPYD filaments. This indicates that the assembly mechanism
of inflammasomes is conserved amongst different species. Furthermore, we provide
evidence that, within an ASC speck, filaments of ASCPYD are further condensed via
ASCCARD/ASCCARD interactions. Mutations within the ASCCARD that disrupt this inter-
action lead to the formation of filaments instead of specks. Mutated ASCCARDs are
dominant and prevent formation of dense wild type ASC specks in a dose dependent
manner when expressed ectopically.
To unravel the biological role of ASC speck formation we used a structure-guided mu-
tagenesis approach targeting all six interaction interfaces based on the murine ASCPYD
filament structure. The results suggest that the ASC speck is required for efficient cy-
tokine maturation but dispensable for pyroptosis. Specifically, the mutations E80R and
3
Y59A in the ASCPYD either completely abrogate or reduce the speed of ASCPYD fila-
ment formation in vitro and prevent ASC speck formation in cells. These mutants still
interact with PYD-containing receptors and are therefore able to support induction of
pyroptosis. However, only a small amount of caspase-1 is activated which is not suf-
ficient for efficient cytokine processing. Therefore, we conclude that the ASC speck
serves as signal amplification step for inflammasome-dependent cytokine maturation.
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1 Introduction
Pathogens are a constant threat to single- and multi-cellular organisms, which over the
course of evolution gave rise to the development of different forms of immunity. Even
the simplest forms of life, bacteria, have immune system like CRISPR (clustered regu-
larly interspaced palindromic repeats) or restriction enzymes that protect from bacterio-
phage infections1. Immunity is more complex in multicellular organisms like vertebrates
which evolved the elaborate adaptive immune system. The adaptive immune system
allows the formation of an immunological memory after the first contact with a pathogen
enabling a very swift elimination of the same pathogen in case of a second infection2–4.
The first line of defense is, however, constituted by the innate immune system. The
innate immune system is evolutionary more basal as it is already present in nematodes
and insects5–9. It relies on a set of germ-line encoded receptors, PRRs (pattern recog-
nition receptors), that specifically detect conserved molecules of microbial origin, so
called PAMPs (pathogen-associated molecular patterns), also referred to as MAMPs
(microbe-associated molecular patterns)9–12. The PAMPs are essential molecules of
pathogens which cannot evolve easily due to their very specific tasks and interactions
and are very similar amongst a variety of different pathogens13. The prototypic PAMP
is LPS (lipopolysaccharide) from the outer membrane of gram negative bacteria. Other
examples of PAMPs include peptidoglycan and lipoteichoic acids from gram positive
bacteria or double stranded RNA (ribonucleic acid) from viruses13. This allows a sin-
gle PRR to detect multiple different pathogens. Nonetheless, mutations in PAMPs that
render them invisible for PRRs occur constantly necessitating the continuous adaption
of the innate immune system to changing environments and pathogens14. A second
class of ligands of PRRs are the so called DAMPs (damage-associated molecular pat-
terns). DAMPs are endogenous molecules but they are sensed in places where they
are normally not present. For example, detection of intracellular components on the out-
side of the plasma membrane signifies that non-homeostatic processes are proceeding
alerting a cell of impending danger15,16. Multiple different classes of PRRs were de-
scribed. Examples for PRR-families are the TLRs (Toll-like receptors), the RLRs (RIG-I
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[retinoic acid inducible I]-like receptors ), ALRs (AIM2 [absent in melanoma 2]-like re-
ceptors) and NLRs (NOD [nucleotide-binding and oligomerization domain]-like recep-
tors)17–22. These PRRs differ in their localization, the stimuli leading to their activation
but also the responses they elicit. These responses are tailored to the stimulus sensed
by the receptor and often result in upregulation of antimicrobial and pro-inflammatory
genes17–19. However, also non-transcriptional responses are known. One example of a
non-transcriptional response is the formation of inflammasomes by certain PRRs23,24.
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1.1 Inflammasomes
Figure 1.1: Overview of inflammasome activation. Adapted from Petr Broz.
Inflammasome receptors are cytosolic soluble PRRs belonging either to the NLRs,
ALRs or Pyrin23,24. Upon activation, inflammasome receptors oligomerize and recruit
the adaptor protein ASC (apoptosis associated speck like protein containing a CARD)
(Fig. 1.1). Interestingly, usually only one large macromolecular inflammasome com-
plex can be detected per cell. This complex is usually referred to as ASC speck, named
after its main constituent25,26. Apart from the receptor and ASC, also the downstream
effector pro-caspase-1 is part of the inflammasome23,24. Recruitment of pro-caspase-1
into the inflammasome complex leads to proximity induced auto-proteolytic cleavage
and thereby activation of caspase-127,28. Active caspase-1 cleaves gasdermin-D which
induces a pro-inflammatory cell death called pyroptosis29–31. Additionally, caspase-1 is
able to cleave the pro-inflammatory cytokines IL-1β and IL-18. Mature IL-1β and IL-18
are then released from the cell and can influence the immune system where they act
as major drivers of fever and inducers of cytokines32 (Fig. 1.1).
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1.2 IL-1β/IL-18
Both, IL (interleukin)-1β and IL-18 are cytokines belonging to the interleukin-1 family.
IL-1 was initially described in 197733 while IL-18 was only identified in 199534. The
IL-1 family now consists of 11 members and is closely linked to inflammation35. Most
family members are produced as biologically active proteins, but IL-1β and IL-18 are
expressed in an inactive pro-form36. While pro-IL-18 is constitutively expressed, pro-
IL-1β expression requires a signal often referred to as priming. TLR signaling from the
cell envelope leads to a NF-κB (nuclear factor kappa-light-chain-enhancer of activated
B cells) dependent upregulation of many pro-inflammatory genes, amongst them pro-
IL-1β. This priming step thereby alerts a cell of impending danger37. After expression,
both pro-IL-1β and pro-IL-18 need to undergo a proteolytic maturation step. This cleav-
age step separates the N-terminal pro-domain from the protein and renders it signaling
competent by allowing it to bind to its receptor35. The main activation pathway is via
cleavage of pro-IL-1β/-18 by the inflammasome-dependent caspase-1 (see below)32.
However, alternative pathways exist and most of them are linked to neutrophils. It has
been shown that elastase, matrix metalloprotease 9 and granzyme A are able to cleave
IL-1β extracellularly into the biologically active form35. Interestingly, also the apoptotic
caspase-8 has been suggested to cleave pro-IL-1β/-18 in an inflammasome dependent
manner further expanding the possbilities for pro-IL-1β/-18 maturation38.
After processing, IL-1β and IL-18 need to be released from the cell. As the cytokines
lack a classical secretion signal sequence, the export mechanism remained enigmatic
and was called unconventional secretion36. Recently, it has been shown that cleavage
of gasdermin-D is required for IL-1β/-18 release but whether the release is unspecific
via pyroptosis or via a specific pore is still unknown (see below)30,31. After release,
IL-1β and IL-18 bind to their cognate receptors, IL-1R1 (IL-1 receptor 1) and IL-18Rα
(IL-18 receptor α), respectively. Receptor binding leads to heterodimerization of IL-
1R1 with IL-1RAcP (IL-1R accessory protein) and IL-18Rα with IL-18Rβ. Both recep-
tors contain TIR (Toll/interleukin-1 receptor) homology domains that enable signaling
through MyD88 (Myeloid differentiation primary response gene 88) to activate NF-κB
and MAPK (mitogen-activated protein kinases) signaling39. In general, IL-1β signals
the immune system that a threat has been recognized via induction of fever and neu-
trophil influx39. IL-18 on the other hand does not induce fever but is best known for
its ability to induce IFNγ (interferon-γ), another pro-inflammatory cytokine important for
innate and adaptive immunity35.
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As IL-1β and IL-18 are such powerful cytokines, not only their maturation and release
but also the signaling is tightly regulated. For example, IL-1Ra (IL-1R antagonist) com-
petes with IL-1β for binding of the IL-1R thereby blocking IL-1R signaling. IL-1R2 on
the other hand acts as decoy receptor binding IL-1β but, in contrast to IL-1R, does not
induce the downstream signaling cascade. IL-18BP (IL-18 binding protein) does, as the
name suggests, bind to IL-18 with high affinity thereby preventing its interaction with the
IL-18 receptor32.
Consequently, elevated IL-1β/-18 signaling, either through absence of negative regula-
tors or through overproduction of the cytokines themselves, leads to massive systemic
inflammation. If the underlying cause is a genetic mutation, the disease is classified
as an autoinflammatory disease35. Hyperactivation of caspase-1 by inflammasome
receptors harboring gain-of-function mutations (see below) are often the cause of ele-
vated IL-1β and IL-18 levels35. Therefore, blocking IL-1β by drugs has proven efficient
to ameliorate many autoinflammatory diseases. For example, anakinra (brand name
Kineret R©, an IL-1R antagonist), rilonacept (brand name Arcalyst R©, an IL-1 decoy re-
ceptor) or canakinumab (brand name Ilaris R©, an anti-IL-1β antibody) have been used
to treat autoinflammatory diseases40. A major drawback of these therapies is the high
price in the range of 20’000-250’000 US$ per patient per year41–43. Thus, the need to
develop alternative therapies that target IL-1β maturation or signaling persists.
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1.3 Pyroptosis
Besides the maturation of IL-1β and IL-18, activation of caspase-1 triggers a cell death
pathway called pyroptosis. Pyroptosis is a form of programmed cell death but in con-
trast to apoptosis, and similar to necroptosis, displays a pro-inflammatory rather than an
anti-inflammatory phenotype29. Pyroptosis was discovered in Salmonella and Shigella
infected cells but initially described as apoptosis44. The term pyroptosis was coined in
2001 when it became clear that the cell death induced by intracellular Salmonella was
neither apoptosis nor necrosis45. Since then, the differences between apoptosis and
pyroptosis have been elucidated further46.
Even though both types of cell death depend on caspases, apoptotic or inflammatory,
and their catalytic activity (see below), the cell fate is fundamentally different. Apoptosis
is characterized by nuclear fragmentation and the segmentation of the cell into apoptotic
bodies which are then phagocytosed by other cells. Importantly, the integrity of the cell
membrane is not compromised and the whole process is inflammatory silent47. Pyrop-
tosis on the other hand is characterized by permeabilization of the plasma membrane
followed by cell swelling and release of cytosolic contents characterizing pyroptosis as a
profoundly pro-inflammatory type of cell death47. Pyroptotic cells were described to dis-
play multiple bubble-like protrusions similar in size to apoptotic bodies therefore named
pyroptotic bodies. Furthermore, it was shown that pyroptotic cells undergo cytoplasmic
flattening making them morphologically distinct from necroptotic cells which display cell
swelling resulting in an ”explosion” of the cell body48.
Two functions have been attributed to pyroptosis. The first is to expel intracellular bac-
teria so they are deprived of their replicative niche49. This exposes the bacteria like
Salmonella to phagocytosis and killing by other immune cells, e.g. neutrophils50. For
some bacterial pathogens like Salmonella enterica serovar Typhimurium, Legionella
pneumophila or Burkholderia thailandensis it was even shown that clearance occurred
independently of IL-1β or IL-18 suggesting that pyroptosis is the main innate immune
mechanism against these bacteria50.
The second role of pyroptosis is to release further DAMPs, such as ATP (adenosine
triphosphate), DNA (deoxyribonucleic acid) or RNA (ribonucleic acid), and alarmins
like HMGB1 (high mobility group box 1, also known as amphoterin) or IL-1α49. The
DAMPs can elicit strong pro-inflammatory responses when detected extracellularly by
recruiting inflammatory cells and stimulating cytokine secretion50. The probably best
studied alarmin in the context of pyroptosis is HMGB151. HMGB1 is released from
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dying cells and can signal through TLR4 (Toll-like receptor 4) to induce TNF (tumor
necrosis factor) release and NF-κB signaling in neighboring cells, thereby further in-
creasing the pro-inflammatory state of the host52. Another important group of alarmins
are the eicosanoids. These signaling lipids induce vascular leakage and recruitment of
immune cells to the inflammatory site49. Control of pyroptosis is important as systemic
pyroptosis has been linked to the severe outcome of sepsis. If the infection cannot be
cleared, prolonged and sustained pyroptosis leads to an often lethal shock due to the
massive release of DAMPs47. Another case where pyroptosis appears to be detrimental
is AIDS (acquired immune deficiency syndrome). One of the hallmarks of developing
AIDS is the gradual loss of CD4+ T-cells. It was recently shown that the vast majority of
CD4+ T-cells do not die by apoptosis but rather caspase-1 dependent pyroptosis. Es-
pecially cells undergoing an abortive HIV (human immunodeficiency virus) infection die
by pyroptosis suggesting caspase-1 as a new target for AIDS medication53.
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1.4 Caspase-1
Mammalian genomes encode two groups of caspases (cysteine-dependent aspartate-
directed proteases), the apoptotic caspases including caspase-3, caspase-7, caspase-
8 and caspase-9, and the inflammatory caspases caspase-1, caspase-12 and caspase-
4 and caspase-5 in humans or caspase-11 in rodents54. The inflammatory caspases
are all present in a single genomic locus. This localization suggests a close evolution-
ary relationship and possibly the emergence of the different inflammatory caspases by
gene duplication55,56.
Caspase-1 was the first inflammatory caspase to be described. It was discovered
as protease processing pro-IL-1β into the mature form and received the name ICE
(interleukin-1 converting enzyme)27,57–59. Caspase-1 itself is synthesized as an inac-
tive zymogen called pro-caspase-127. Pro-caspase-1 is recruited to the inflammasome
where it undergoes proximity-induced autocatalytic processing yielding active caspase-
128. While pro-caspase-1 is composed of a N-terminal CARD followed by the catalytic
p20 and p10 subunits, all separated by linkers, the active caspase-1 consists of a het-
erotetramer of two p20 and two p10 subunits27. The active site of caspase-1, cysteine
284 in mice or cysteine 285 in humans, is located in the p20 domain but the p10 is
equally essential for the proteolytic activity. Caspase-1 shows a relatively narrow sub-
strate specificity exemplified by the fact that most mutations in the target peptide abro-
gate its cleavage by caspase-160. Interestingly, the three-dimensional structure of the
caspase-1 target seems not to be important as caspase-1 cleaves native and denatured
IL-1β with nearly the same kinetics60. Despite the substrate-specificity, many additional
caspase-1 substrates have been identified in vitro55,61. One of the best substrates
of caspase-1 besides IL-1β and IL-18 is gasdermin-D (see below)30,31. An additional
caspase-1 substrate is GAPDH (glyceraldehyde 3-phosphate dehydrogenase) involved
in glycolysis, an essential pathway for the generation of ATP. However, the relevance
of many of the additional caspase-1 substrates in vivo is still unknown, since for exam-
ple GAPDH cleavage requires a 50 times higher caspase-1 concentration than IL-1β
cleavage. Nonetheless, GAPDH-cleavage has been observed after inflammasome ac-
tivation62.
Clearly, the main functions of caspase-1 are induction of pyroptosis by cleavage of
gasdermin-D, and possibly additional yet unknown targets (see below)30,31, and the
cleavage and maturation of the pro-inflammatory cytokines pro-IL-1β and pro-IL-18
(see above)55,56,63. While the catalytic activity of caspase-1 is required for both, py-
14
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roptosis and IL-1β/-18 secretion, autoproteolytic maturation is not required for pyropto-
sis. Mutating the various auto-cleavage sites within caspase-1 (D103, D122, D296,
D308, D313, D314 in murine caspase-1) rendered cells incapable of IL-1β secre-
tion after inflammasome activation but pyroptosis was still observed64. Additionally,
inflammasome-dependent caspase-1 maturation required the adaptor protein ASC. Yet,
if the receptor contained a CARD instead of a PYD, absence of ASC did not impair cell
death because CARD-containing receptors are able to directly interact with caspase-
1(see below)64,65. Thus, the level of autoprocessing of caspase-1 controls the down-
stream signaling pathways, although the exact mechanism has remained unclear. Pro-
posed mechanisms include differential substrate specificity or differential levels of ac-
tivity. Consistent with its role in cell culture, Casp1 deficient mice display a higher bac-
terial burden after infection with S. Typhimurium, Francisella tularensis or Legionella
pneumophila, reinforcing the importance of the inflammasome during infections66–68.
15
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1.5 ASC (apoptosis-associated speck-like protein containing
a CARD)
The inflammasome adaptor protein ASC is a small protein of 195 amino acids in hu-
mans and 193 amino acids in mice and has an approximate molecular weight of 22
kDa25,69. It is expressed in various tissues like skeletal muscle, colon, kidney, ton-
sil, testis, lung and liver and many cell types, especially in immune cells25,69,70. Most
structural and functional work on ASC was done using human ASC, but the mouse or-
thologue shows 73% identity and there are no functional differences between the two
orthologues known so far (Fig. 1.2)69.
Figure 1.2: Alignment of murine (Uniprot: Q9EPB4) and human (Uniprot: Q9ULZ3)
ASC. Alignment done using the EMBOSS needle (protein alignment)
tool71–73.
ASC consists of two protein-protein interaction domains, an N-terminal PYD (pyrin do-
main) and a C-terminal CARD (caspase recruitment and activation domain)25. It is
characterized as adaptor protein in inflammasome signaling where it bridges from in-
flammasome receptors to the effector pro-caspase-1 and leads to proximity induced
caspase-1 autoprocessing23,24.
1.5.1 Structure of ASC
Both domains of ASC, the PYD and the CARD, belong to the death-fold superfamily.
This family of protein-protein interaction domains is characterized by a globular fold
and consists of six amphipathic alpha-helices (H1-H6) in an antiparallel arrangement.
Despite the very similar fold, the death-fold superfamily shows a high degree of se-
quence variance74. The name of the death-fold superfamily derives from the fact that
16
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the death-fold containing proteins are involved in signaling pathways for programmed
cell death like apoptosis and pyroptosis. The different subfamilies, DD (death domain),
DED (death effector domain), PYD and CARD, all display some specifics distinguish-
ing them from each other. DDs have a more exposed H3, DEDs have an additional
hydrophobic patch and a RxDL-motif in the H5-H6 loop, PYDs have a short H3 and
an extended H2/H3 loop while CARDs have a bent and broken H1 (split into H1a and
H1b)74. All the death-fold domains are evolutionarily related and the differences are
thought to have arisen due to the necessity for binding specificity74.
The PYD is the newest member of the death-fold superfamily75 and the PYD of hu-
man ASC (ASCPYD) was one of the first PYD structures to be solved76 (Fig. 1.3). The
ASCPYD is able to interact with itself as exemplified by the appearance of filamentous
structures if the ASCPYD is overexpressed in cells and the aggregation of ASCPYD at
neutral pH in vitro. At acidic pH, ASCPYD is soluble providing the basis for NMR stud-
ies of the domain76. Importantly, the structure of monomeric ASCPYD seems to be the
same at acidic and neutral pH76,77.
Figure 1.3: Structure of ASC. Ribbon representation of the solution structure of
monomeric full-lenght human ASC (PDB 2KN677). CARD colored in dark
blue (front) and light blue (back) and PYD colored in red (front) and orange
(back). N denotes the N-terminus, C the C-terminus, H1-H6 represent the
six characteristic helices of death-fold domains.
As the ASCPYD, the CARD of ASC (ASCCARD) is also able to form filamentous struc-
tures in cells77,78. The structure of the ASCCARD shows some peculiarities: While H1 in
CARDs is usually fragmented into H1a and H1b, the ASCCARD lacks the H1a fragment
and H2 and H3 are in an unusual orientation implying further adaptations towards bind-
ing specificity (Fig. 1.3)77.
17
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ASCPYD and ASCCARD are connected by a relatively long linker of 23 amino acids in hu-
mans and 22 amino acids in mice. It displays some residual structure in NMR spectra
but overall it is in an extended conformation. This linker flexibility is thought to increase
the space being available to be scanned by either domain in order to enhance the
chance of protein-protein interactions (Fig. 1.3)77.
As both domains are involved in protein-protein interactions, extensive mutational anal-
yses of surface exposed residues were conducted. Surface exposed residues of the
ASCPYD were mutated to alanine or charge reversals were introduced and the effect on
PYD oligomerization was analyzed in vitro or in cellular overexpression systems (Tab.
1.1). In general, PYD-PYD interactions rely heavily on the opposing charges of two
large surfaces. The positively charged surface formed by H2 and H3 interacts with the
negatively charged surface formed by H1 and H4 as well as the loop between H3 and
H4, referred to as type I interaction79,80. The same interaction interfaces were shown
to be important for interactions of ASCPYD with the PYDs of Pyrin, NLRP3 (NLR-family
PYD-containing protein 3) and AIM2 (absent in melanoma 2)80–83. Other death-fold do-
mains do not only rely on type I interactions but also employ type II interactions (H4 and
loop between H4 and H5 interacting with the H5-H6 loop) and type III interactions (H3
interacting with H1-H2 loop and H3-H4 loop)84. Consistently, type II and III interactions
were later shown to be involved in ASCPYD oligomerization and interactions with other
PYDs81,85.
Table 1.1: Previously mutated residues in the ASCPYD and their effect on oligomer-
ization. ”Residue” denotes the residues mutated in human ASCPYD while ”in
mice” denotes the corresponding residues in murine ASC. ”Mutation” is the
amino acid that was introduced while ”effect”’describes whether the mutation
abrogated (–), diminished (+/–) or did not change (+) interactions of ASCPYD
with itself (readout depending on the original study).
residue mutation effect in mice residue mutation effect in mice
R3 A +/–81;+79,80 R3
R41
Q –79
R41R5 A +79 R5 K +79
D6 A +79 D6 W –79
I8 A –79 I8 L44 A +79 L44
18
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Table 1.1: Previously mutated residues in the ASCPYD.
residue mutation effect in mice residue mutation effect in mice
D10 A +79,80 D10
L45
A –79
L45
L12 A –79 L12 I +79
E13
A –85;+/–80;+79
E13
E +79
R –81 Q +79
L15 A –79 L15
M47
A –79
M47
E18 A +79,80 E18 L +79
E19
A –79,85
E19
I +79
Q +79 V +79
L20 A –79 L20 Q –79
K21
A –79,80,85
K21
N –79
Q –79,81
D48
A –79,80,85
D48
R +79 N –79,81
E –79 E –79
K22 A +79 K22 R –79,81
F23
A –79
F23
L50 A +/–81;+79 I50
L +79
D51
A –79,80,85
D51
K24 A +79 K24 N –79
L25
A –79,85
L25
E +79
M +79 R –81
I +79 K –79
V +79 L52 A –79 L52
F +79 D54 A +79,80 D54
G –79 K55 A +79 K55
Q –79 L56 A –79 L56
N –79 V57 A +79 V57
K –79 F59 A –81;+79 Y59
E –79 L61 A +79 L61
K26
A –79,85
K26
E62
A –79;+85
E62
E –81 Q +79
Q –79 T63 A +80 S63
R +79
E67
A –79;+80,85
E67
L27 A –79 L27 Q +79
L28 A +79 L28 L68 A –79,85 L68
V30 A +79 V30 V72 A –79 V72
P31 A +79 Q31 L73 A –85;+79 L73
L32 A +79 L32 R74 A +79,80 R74
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Table 1.1: Previously mutated residues in the ASCPYD.
residue mutation effect in mice residue mutation effect in mice
R33 A +79 R33 D75 A +79 D75
E34 A +79,80 E34 M76 A –79 M76
Y36 A +/–81 Y36 L78 A +79 L78
R38 A +79,80 R38
E80
A –79;+80
E80
I39 A +79 I39 R +/–81
R40 A –79 P40 M81 A +79 L81
R41
A –79,80,85
R41
Q84 A –80 Q84
E –81 L85 A +79 L85
A similar mutational approach for surface exposed residues was taken for ASCCARD
probing their involvement in interactions with itself and the CARD of caspase-1 (caspase-
1CARD, Tab. 1.2)85,86. Again, type I interactions have proven to be crucial for both,
ASCCARD oligomerization and its interaction with caspase-1CARD86.
Regarding oligomeric ASC, the structure of the filament formed by human ASCPYD was
solved using cryo-electron microscopy81. The ASCPYD filament is a 3 start helix with
an inner diameter of 20 A˚ and outer diameter of 90 A˚ displaying a 53◦ right-handed
rotation and 14.0 A˚ axial rise per subunit81. In this filament, the extensive (880 A˚2) type
I interactions connect the subunits of a strand while the less extensive type II (540 A˚2)
and type III (360 A˚2) interactions connect the different strands. There are some differ-
ences between the structure of the soluble ASCPYD and the ASCPYD in the filament,
especially in the long H2-H3 loop and the short H3, but overall the two structures over-
lap quite well81.
In accordance with the function of ASC as inflammasome adaptor (see below), ASCPYD
filament formation can be nucleated by the PYDs of AIM2 and NLRP3 which is shown
by an enhanced oligomerization speed of ASCPYD in presence of either AIM2PYD or
NLRP3PYD in vitro. Additionally, substoichiometric amounts of AIM2PYD and NLRP3PYD
are located at one end of ASCPYD filaments81. Furthermore, it has been shown that
the ASCPYD has prion like properties. After filament nucleation, the ASCPYD undergoes
a slight structural rearrangement which is then propagated to further ASCPYD subunits
during filament formation. This suggests that ASCPYD filament formation is an all-or-
nothing, irreversible process87,88.
No similar oligomeric structure is known for the ASCCARD so far but the oligomeric state
of full length ASC, the ASC speck, has been investigated using high-resolution fluo-
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rescence microscopy and electron microscopy. The analysis revealed that ASC speck
has an irregular, filamentous structure with a denser core88,89 but in-depth structural
analyses of the ASC speck are missing.
Table 1.2: Previously mutated residues in the ASCCARD and their effect on
oligomerization. ”Residue” denotes the residues mutated in human
ASCCARD while ”in mice” denotes the corresponding residues in murine ASC.
”Mutation” is the amino acid that was introduced while ”effect” describes
whether the mutation abrogated (–), diminished (+/–) or did not change (+)
interactions of ASCCARD with itself85 or caspase-186 (readout depending on
the original study).
residue mutation effect in mice
R125 D –86 R123
E130 R –86 D128
D134 R –86 D132
Y137 E –86 H135
D143 A +86 E141
E144 R –86 G142
Q145 A +86 Q143
Y146 E +86 Y144
R150 E +86 R148
M159 A –85 M157
R160
E –86
R158
A –85
D191 R –86 D189
1.5.2 Function of ASC
ASC was initially identified in cancer cell lines where it aggregated into speck-like,
macromolecular complexes in the cellular periphery of apoptotic cells. Furthermore,
its expression correlated with increased sensitivity to apoptotic stimuli25. Apart from
being involved in apoptosis, ASC was initially implied in NF-κB signaling. Conflicting
reports emerged whether ASC enhances or impairs NF-κB signaling, but later studies
suggested that ASC is not involved in NF-κB signaling at all90–93.
Besides, it was described that the promoter of ASC is a target of hyper-methylation
thereby silencing ASC expression. This was observed in various cancer cell lines and
primary isolates of breast cancers leading to the alternative name TMS-1 (target of
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methylation-induced gene silencing). Mechanistically, loss of ASC expression was pro-
posed to provide cancer cells with the ability to escape cell death thereby enhancing
proliferation92,94. Methylation-induced silencing of ASC has since also been associated
with additional types of cancers like prostate and colorectal cancer95–97.
With the emergence of the inflammasome as important step in caspase-1 activation,
the role of ASC became better defined28. After activation (and oligomerization) of PYD-
containing inflammasome receptors (see below), ASC is recruited via PYD-PYD inter-
actions. This interaction serves as nucleation point for ASC oligomerization and speck
formation. The ASC speck is the large, macromolecular form of the inflammasome
with a size of approximately 1-2 µm25,98. Aggregation of the ASC speck was reported
to be a quick process with all soluble ASC incorporated into the speck in less than
three minutes98,99. The ASC speck is largely insoluble and its formation is indepen-
dent of caspase-1, although pro-caspase-1 is recruited to it64,98. ASC specks can be
released by pyroptosis and might be taken up by phagocytic cells where they initiate
further pro-inflammatory signaling events. Moreover, ASC specks were detected in ex-
tracellular fluids of patients with CAPS (cryopyrin associated periodic syndrome), an
auto-inflammatory disease characterized by constitutive inflammasome activation due
to mutations in NLRP3 (see below)88,89.
It was proposed that after recruitment to the ASC speck, caspase-1 forms filaments
on its own via its CARD81,100. However, the physiological role of caspase-1CARD fila-
ments was not determined yet. Nonetheless, recruitment of pro-caspase-1 leads to it
activation by proximity-induced auto-processing into the active caspase-1 p10/p20 het-
erotetramer. Active caspase-1 in turn cleaves the pro-inflammatory cytokines pro-IL-1β
and pro-IL-18 into their bioactive forms which are then released (see above)27,81.
Consistent with its role as adaptor, ASC deficient cells fail to induce pyroptosis and
cytokine secretion after stimulation of PYD-containing receptors like NLRP3, AIM2 or
Pyrin23,24. Furthermore, ASC also plays an important role in vivo. Asc knock-out mice,
similarly to Casp1 knock-out mice, have a significantly higher bacterial burden and mor-
tality after infection with Francisella tularensis compared with wild type68.
In the case of the NLRC4 (NLR-family CARD-containing protein 4) inflammasome (see
below), the role of ASC is different. NLRC4 has a CARD instead of a PYD and is able
to directly interact with the caspase-1CARD, thereby seemingly bypassing the require-
ment of ASC65. Consistently, cell death after NLRC4 activation in cells is independent
of ASC. Nonetheless, if present, ASC forms a speck after NLRC4 activation and the
amount of secreted cytokines is markedly enhanced64,67,91,101. In an in vivo model of
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S. Typhimurium infection, a potent activator of NLRC4, ASC has only a limited effect.
Even though cytokine levels were markedly reduced in Asc deficient mice, the disease
outcome was similar to wild type mice indicating that pyroptosis is the main innate im-
mune response against S. Typhimurium102.
Collectively, ASC plays an important role in innate immunity as an adaptor for inflam-
masomes. Despite the fact that ASC speck formation is observed after activation of all
known inflammasome receptors, it was not directly shown that the ASC speck or ASC
filaments are indeed required for inflammasome signaling103. Furthermore, it is not
clear how CARD-containing receptors like NLRC4 recruit ASC to form the ASC speck.
1.5.3 Regulation of inflammasomes on the level of ASC
As inflammasomes are important and potent signaling complexes, they need to be
tightly regulated. The most studied regulation step is the activation of the different re-
ceptors, which will be discussed below for the different receptors individually. But also
ASC itself and its oligomerization are regulated in multiple ways. The first mechanism
is to control the expression of ASC. Hypermethylation of the CpG-island in the ASC
promoter leads to transcriptional repression and thereby blocks the expression of ASC,
as observed in many cancer cells, thereby efficiently blocking pyroptosis94.
But also the localization of ASC is crucial for inflammasome activation and signaling.
While in resting cells ASC is primarily localized in the nucleus, ASC needs to relocate
into the cytosol for inflammasome assembly. This happens during the priming phase of
the cells and retaining ASC in the nucleus by using a fusion protein with a nuclear local-
ization sequence prevents IL-1β release after NLRP3 stimulation104. It was proposed
that ASC is associated with IKKα (IκB kinase α) in the nucleus in resting cells. The
priming signal then enables translocation of the ASC/IKKα complex out of the nucleus
which requires the kinase activity of IKKi (IKK related kinase). Once in the cytoplasm,
the second signal leads to the dissociation of the ASC/IKKα complex enabling interac-
tion of ASC with the receptor and the formation of the speck105.
Post translational modifications were shown to be involved in multiple innate immune
signaling pathways and also in inflammasome signaling106. Phosphorylation of human
ASC on residues Y146 and Y187 (or the corresponding murine ASC residue Y144) lo-
cated in the ASCCARD in a Syk (spleen tyrosine kinase) and / or JNK (c-Jun N-terminal
kinase) dependent way was reported. In absence of ASC phosphorylation the forma-
tion of ASC specks is reduced and less IL-1β is secreted after NLRP3 and AIM2 but
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not NLRC4 activation107,108. These findings are, however, complicated by the fact that
Syk is a negative regulator of pro-IL-1β and NLRP3 expression after TLR stimulation by
extracellular PAMPs108. Recently, it was shown that, downstream of Syk, Pyk2 (proline-
rich tyrosine kinase 2) directly interacts with ASC after NLRP3 activation and phospho-
rylates the human ASCCARD on residue Y146. This phosphorylation enables the for-
mation of ASC specks. On the other hand, ASC speck formation after AIM2 activation
is not dependent on Pyk2 but another kinase called FAK (focal adhesion kinase)109.
A kinase related to Syk called BTK (Bruton’s tyrosine kinase) was also proposed to
modulate ASC activity. BTK associates with ASC and possibly phosphorylates human
ASC on Y146 and helps to form the interaction with NLRP3 but BTK is not involved
in the AIM2 inflammasome110. Why different kinases are required for ASCCARD phos-
phorylation after AIM2 and NLRP3 activation and why ASCCARD phosphroylation is not
involved in NLRC4 signaling111, even though all inflammasome receptors initiate ASC
speck formation, is not clear yet. Furthermore, why multiple kinases that phosphorylate
the same residues in the ASCCARD exist and how exactly they regulate inflammasome
assembly remains to be addressed experimentally.
An additional form of post-translational modification of ASC to regulate inflammasome
activity is ubiquitination. It was reported that the linear ubiquitin assembly complex
(LUBAC), consisting of HOIL-1L (heme-oxidized IRP2 [iron regulated protein 2] ubiqui-
tin ligase 1L), HOIP (HOIL-1L interacting protein) and SHARPIN (Shank-associated RH
[regulator of G-protein signaling homology] domain-interacting protein), directly ubiquiti-
nates ASC in vitro. Furthermore, macrophages deficient in HOIL-1L failed to release IL-
1β after NLRP3 stimulation and displayed reduced IL-1β release after AIM2 activation.
Therefore, linear ubiquitination of ASC seems to promote inflammasome function112.
Conversely, ASC was shown to display K63-linked ubiquitination after AIM2 activation
directing it to autophagy dependent degradation and decreasing inflammasome signal-
ing113. Furthermore, viral infections were shown to cause K63-linked ubiquitination of
ASC on residue K174 by TRAF3 (TNFR [tumor necrosis factor receptor]-associated
factor 3). This K63-linked ubiquitination seemed to enhance NLRP3 inflammasome
activation114. However, how these contradictory reports of the role of ubiquitination of
ASC can be reconciled and why no involvement of ubiquitination was observed after
NLRC4 activation112,114 remains to be determined.
Furthermore, a set of proteins only consisting of a CARD or a PYD, termed COPs
(CARD only proteins) and POPs (Pyrin only proteins), respectively, thought to be in-
volveld in inflammasome regulation exists in humans and related primates but not in
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rodents. Additionally, some viruses encode viral POPs (vPOPs)115,116. Humans ex-
press 3 COPs called CARD16 (COP/Pseudo-ICE), CARD17 (INCA, inhibitory CARD)
and CARD18 (ICEBERG). They are all encoded in the same gene cluster as the pro-
inflammatory caspases-1, -4, -5, and -12 and are thought to have arisen from gene
duplications of caspase-1, with which they share the highest homology. Nonetheless,
different functions were attributed the COPs115,116. CARD16 has the highest homology
to caspase-1CARD and exists in two isoforms, a long and a short one. While nothing is
known about the long isoform, the short isoform was initially described to interact with
the caspase-1CARD and to block IL-1β release117,118. A more recent study found that
CARD16 not only interacts with caspase-1 but also with ASC and thereby promotes the
formation of caspase-1CARD filaments and subsequently enhances IL-1β release119.
But the mechanism of this enhanced caspase-1 oligomerization is yet unknown. Also
CARD17 was first described to interact with caspase-1CARD120. Conflicting reports exist
concerning the interaction between CARD17 and ASCCARD, but the possible interaction
between CARD17 and ASCCARD seems not have any consequences on ASC oligomer-
ization or speck formation100,119. Yet, CARD17 blocks the oligomerization of caspase-1
by capping growing caspase-1CARD filaments in vitro and efficiently blocks caspase-1
activation and cytokine release100. CARD18 was described as yet another inhibitor
of IL-1β production by binding to caspase-1CARD117,121. It has since been suggested
that CARD18 associates with caspase-1CARD filaments but its overexpression does not
change IL-1β levels therefore questioning the role as caspase-1 inhibitor100.
In contrast to the COPs, that all arose from caspase-1 gene duplications, the three
POPs arose from different gene duplications. The most interesting POP regarding ASC
is POP1 that originated from a duplication of exon 1 of ASC coding for the ASCPYD
and displays 64% identity to the ASCPYD115,116. POP1 can interact with ASCPYD and
as the structure of POP1 is highly similar to ASCPYD, ASCPYD/POP1 interactions are
very similar to ASCPYD/ASCPYD interactions122,123. The effect of this ASCPYD/POP1
interaction was first reported to promote IL-1β release122, but further analysis showed
an opposite phenotype124. Stable knock-down of POP1 increases IL-1β release while
overexpression decreases IL-1β release in the human monocytic cell line THP-1. Fur-
thermore, transgenic mice expressing human POP1 in the macrophage / dendritic cell
lineage have lower levels of IL-1β after systemic NLRP3 challenge124. Mechanisti-
cally, POP1 binds to ASCPYD and thereby blocks the interaction of ASC with a PYD-
containing receptor123,125. The exact effect of POP1 on inflammasome signaling via
CARD-containing receptors warrants further investigation, although experimental evi-
25
Introduction
dence suggest a similar function than for PYD-containing receptors124.
POP2 shows the highest similarity to the PYD of NLRP2 (69% amino acid similarity) and
it is able to interact with ASC, NLRP1, NLRP3 and NLRP12. Consequently, it blocks
IL-1β release after activation of NLRP1 and NLRP3 inflammasomes. The mechanism
is suggested to be either binding to ASCPYD and preventing interaction with the receptor
or binding to the PYD of the receptor and thereby blocking recruitment of ASC115,116,126.
POP3 seems to have arisen from a partial gene duplication of AIM2, with whose PYD
(AIM2PYD) it shares 61% sequence identity. POP3 does not interact with ASCPYD but
only with AIM2PYD, thereby blocking ASC recruitment and blocking inflammasome sig-
naling after AIM2 activation127.
Interestingly, some poxviruses have acquired vPOPs via horizontal gene transfer and
employ them in their immune evasion strategies. Myxoma and Shope Fibroma virus
encode a POP1/ASCPYD homologue each, called ML013L and gp013L, respectively.
Both proteins co-localize with the ASC speck and interact with ASC. Moreover they in-
hibit IL-1β release thereby facilitating the host colonization by the virus128,129.
Figure 1.4: ASC isoforms. P, PYD; C, CARD. Adapted from Bryan et al.130
Lastly, alternative splicing variant of ASC were discovered in both humans and mice
(Fig. 1.4). ASC-b consists of the ASCPYD and the ASCCARD without the flexible linker,
ASC-c lacks H3-H6 of ASCPYD but retains the linker and the ASCCARD and ASC-d con-
sists of ASCPYD H1 and H2 and a novel 69-amino acid peptide without homology to
any known domain. While ASC and ASC-b are able to interact and co-localize with
NLRP3, ASC-c and ASC-d do not. On the other hand, co-localization with caspase-
1 was observed for ASC, ASC-b and ASC-d, all containing a complete CARD130,131.
Functionally, some discrepancies were reported. While one group reported that inflam-
masome reconstitution with ASC-b leads to higher IL-1β levels than reconstitution with
ASC131, the second group reported that co-expression of ASC-b with ASC reduces IL-
1β levels below the level of ASC expression alone130. ASC-c inhibits IL-1β secretion
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and as it mainly consists of a CARD it might be regarded as another COP while ASC-d
does not have any influence on IL-1β secretion130.
Collectively, many regulatory mechanisms were described controlling inflammasomes
on the level of ASC but vastly diverging outcomes were reported for some mecha-
nisms. This might be due to the experimental settings as most studies were done
in overexpression systems or in vitro calling for better characterization in more realis-
tic conditions, for example by generation of knock-out cell lines and the expression of
physiological levels of the different proteins.
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1.6 Receptors
All known inflammasome receptors belong either to the ALR (AIM2 like receptors) fam-
ily, to the NLR (Nod-like receptor) family, or Pyrin. However, not all of the receptors
directly bind to a ligand but some rather act as adaptor molecules.
1.6.1 NLRP3
In 2004, NLRP3 (NLR-family PYD-containing protein 3, also called Cryopyrin or Nalp3)
was for the first time described to be able to initiate inflammasome formation132. Even
though NLRP3 is the most extensively studied inflammasome receptor so far, the exact
mechanisms and signals leading to its activation are still unclear and its physiological
role is debated133. Interestingly, basal expression of NLRP3 is not sufficient for in-
flammasome activation which therefore relies on a two-step activation mechanism. A
first priming step upregulates NLRP3 expression in a NF-κB dependent manner down-
stream of TLR signaling, a pathway also leading to pro-IL-1β expression134,135. Further-
more, also post-translational modifications like deubiquitination of NLRP3 by BRCC3
(BRAC1/BRAC2-containing complex) are part of the priming process136–138. A sec-
ond activation step is then required to initiate inflammasome formation. This second
signal can be one of a large group of chemically different substances including crys-
talline and particulate matters (monosodium urate [MSU] crystals, silica, asbestos and
alum), pore-forming toxins and ionophores, extracellular ATP and several substances
of pathogenic origin (viral, bacterial, fungal and protozoan)37. As these stimuli are
chemically diverse they probably do not directly bind to NLRP3 but rather converge
on a common signal139. Multiple mechanisms have been proposed to take over this
function: The production of ROS (reactive oxygen species), mitochondrial damage and
lysosomal rupture140. The best candidate as a common trigger for NLRP3 activation is,
however, the efflux of K+ and a concomitant drop of intracellular K+ concentrations141.
While depletion of intracellular K+ is sufficient to trigger NLRP3 inflammasome activa-
tion acting either on or upstream of NLRP3, the exact mechanisms of NLRP3 activation
are still unknown141. On the other hand, mitochondrial perturbation and ROS produc-
tion were not required for NLRP3 activation, although both is frequently observed with
stimuli activating NLRP3141.
The main groups of NLRP3 activators are K+ ionophores, extracellular ATP and crys-
talline / particulate substrates142. The discovery that extracellular ATP leads to secre-
tion of mature IL-1β and that it leads to a drop in intracellular K+ concentration predates
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the discovery of inflammasomes by nearly a decade28,143. Millimolar concentrations of
extracellular ATP activate NLRP3 by inducing K+ efflux via P2X7R (P2X7 receptor)144.
P2X7R is an ion channel which opens after ATP binding and facilitates the exchange
of intracellular K+ for extracellular Na+ and Ca2+ efficiently decreasing intracellular K+
concentrations145. Also nigericin was known as IL-1β trigger before the discovery of the
inflammasome28,143. Nigericin is one of the most commonly used triggers for NLRP3
activation144. It can either exist in a free, membrane-impermeant anionic form or as
neutral, membrane-permeant form when bound to either K+ or H+. In one cycle, pro-
tonated, extracellular nigericin enters the cells where the proton is released and ex-
changed with a potassium ion. The potassium-bound nigericin then crosses the plasma
membrane once more thereby dissipating the K+ gradient without changing the charge
of the cell146. There are also other ionophores that are able to induce NLRP3 activation
like gramicidin147. Gramicidin is a peptide inserting into the plasma membrane and fa-
cilitates K+ efflux balanced by Na+ influx leading to NLRP3 activation148.
The mechanism of NLRP3 activation by crystalline and particulate stimuli is less clear.
These stimuli including monosodium urate crystals (MSU)149, which is associated with
gout, and alum150,151, an adjuvant approved for use in humans, are taken up by phago-
cytes. However, at one point along the phagocytosis pathway, lysosomal rupture is
observed leading to K+ efflux in an unknown fashion resulting in NLRP3 activation142.
Recently, a new mechanism was proposed to detect intracellular gram-positive bacteria.
N-acetylglucosamine originating from the gram-positive cell wall binds to the glycolytic
enzyme hexokinase. This leads to the inactivation of hexokinase and its dissociation
from its usual binding partner VDAC (voltage-dependent anion channel) in the mito-
chondrial outer membrane. This results in NLRP3 activation in a yet unresolved man-
ner. Interestingly, while NLRP3 dependent IL-1β release was observed, the cells did
not display any signs of pyroptosis. Furthermore, the process is seemingly indepen-
dent of K+ efflux, questioning the role of K+ efflux as general NLRP3 activation mecha-
nism152. Furthermore, another K+-independent pathway of NLRP3 activation has been
reported153. The authors found that imiquimod and the related molecule CL097 inhib-
ited the quinone oxidoreductases NQO2 (NAD(P)H [nicotinamide adenine dinucleotide
phosphate] quinone dehydrogenase 2) and the mitochondrial complex I, thus inducing
a burst of mitochondrial ROS production and thiol oxidation that led to NLRP3 activa-
tion153.
As with all inflammasome components, NLRP3 needs to be tightly regulated. To achieve
this, several regulatory mechanisms were proposed to control NLRP3 inflammasome
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activation. The most important steps are the above mentioned priming step upregulat-
ing NLRP3 expression and the activation of NLRP3134,135. But multiple other, modula-
tory, mechanisms were described. Recently, NEK7 (NIMA [never in mitosis A] related
kinase 7) was discovered by three groups independently to be a new, essential com-
ponent of the NLRP3 inflammasome. NEK7 associates with NLRP3 using its kinase
domain but independently of its kinase activity. The NEK7-NLRP3 association is down-
stream of K+ efflux as high extracellular K+ levels efficiently blocked the interaction.
Interestingly, NEK7 is also involved in mitosis and therefore it was postulated that dur-
ing mitosis NEK7 is not sufficiently available to interact with NLRP3 thereby blocking
simultaneous activation of inflammasomes and mitosis154–156.
But also multiple post-translational mechanisms are acting on NLRP3106. For exam-
ple, multiple kinases were shown to enhance NLRP3 signaling including Syk (speen
tyrosine kinase), DAPK (death associated protein kinase), TAK1 (transforming growth
factor beta-activated kinase 1), ERK (extracellular signal-regulated kinase) and BTK
(Bruton’s tyrosine kinase)110,111,157–162. Additionally, ubiquitination of NLRP3 by ubiqui-
tin ligases FBXL2 (F-box/LRR-repeat protein 2) and MARCH7 (membrane associated
ring-CH-type finger 7) was shown to downregulate NLRP3 activation163,164. Conversely,
deubiquitination of the LRR of NLRP3 by murine BRCC3 or human BRCC36 leads to
enhanced NLRP3 activation137,138. Furthermore, S-nitrosylation and ADP-ribosylation
were also implicated in NLRP3 regulation165–169. But also proteinaceous components
are known to regulate NLRP3 directly. An example is the orphan receptor SHP (small
heterodimer partner) that directly binds to and inhibits NLRP3170. Lastly, also an NLRP3
intrinsic regulatory mechanism was described. The central NOD (nucleotide binding
and oligomerization domain) of NLRP3 is able to bind and hydrolyze ATP. Mutations in
the NOD abrogating ATP binding also blocked NLRP3 oligomerization and ASC recruit-
ment indicating that ATP binding is required for NLRP3 signaling171.
The importance of NLRP3 regulation is corroborated by the involvement of faulty NLRP3
activation in autoinflammatory diseases172,173. A variety of gain-of-function mutations
were discovered in the NOD of NLRP3 leading to enhanced inflammasome activation.
These mutations result in autoinflammatory diseases which are collectively referred to
as CAPS (cryopyrin-associated periodic syndromes). Depending on the exact mutation
as well as additional factors the disease severity varies from FCAS (familial cold autoin-
flammatory syndrome), as the mildest form, to MWS (Muckle-Wells syndrome) and the
most debilitating form, NOMID (neonatal-onset multisystem inflammatory disease) also
called CINCA (chronic infantile neurological, cutaneous and articular syndrome)174–178.
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The typical symptoms of FCAS are rash, fever and joint pain after cold exposure, while
MWS presents with recurrent rashes, hearing loss and amyloidosis. NOMID/CINCA is
characterized by the above mentioned symptoms accompanied by mental retardation,
meningitis and bone deformities172,178. Treatment of these diseases using IL-1β block-
ing agents was shown to be effective in several studies where either the recombinant
IL-1 receptor antagonist anakinra, the IL-1 trap rilonacept or the anti-IL-1β antibody
cankinumab were used179–181. Consequently, these drugs were approved for use in
CAPS patients by authorities172.
Besides the mutations of NLRP3 and the resulting autoinflammatory diseases, NLRP3
was also shown to be involved in the pathogenesis of other diseases in mostly age-
related conditions. During aging, a progressive, low-grade but chronic inflammatory
state is developing. NLRP3 is associated with many chronic inflammatory diseases as
it can be triggered by many of the metabolic byproducts. These include MSU crys-
tals in gout, β-amyloid plaques in Alzheimer’s disease, free fatty acids and islet amy-
loid polypeptide in type 2 diabetes and cholesterol crystals in atherosclerosis149,182–184.
Also in these diseases, preliminary studies targeting IL-1β downstream of NLRP3 show-
ed promising results185.
1.6.2 AIM2
AIM2 (absent in melanoma 2) was initially discovered as a tumor-suppression gene186.
Further studies then correlated AIM2 expression with cancer outcome, i.e. patients
without AIM2 expression in cancers cells have a worse prognosis. It is thought that
AIM2 has an inhibitory role in cell proliferation thereby reducing cancer growth. Inter-
estingly, the anti-cancer effects of AIM2 are independent of inflammasomes187.
Only later, a inflammasome complex sensing double stranded DNA (dsDNA) in the cy-
tosol was discovered188 and the receptor for this complex was identified as AIM2189–192.
AIM2 consists of two domains, a PYD (AIM2PYD) required for interaction with ASCPYD
and a HIN-200 (hematopoietic interferon-inducible nuclear proteins with a 200-amino-
acid repeat) domain required for dsDNA binding. AIM2 seems to recognize any dsDNA,
either of bacterial, viral, synthetic origin or even host-derived dsDNA, provided it resides
in the cytosol and has a length of at least 80 bases193. Structurally, a concave, positive
surface of the HIN-200 domain binds the sugar-phosphate backbone of dsDNA creating
an interaction surface of 1’000-1’200 A˚2 resulting in a high binding affinity of the HIN-
200 domain to dsDNA193. The interaction between AIM2 and dsDNA is highly flexible
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allowing multiple AIM2 monomers to closely bind to a stretch of dsDNA which serves as
oligomerization hub, a function that is taken over by the NOD (nucleotide binding and
oligomerization domain) in NLRs (Fig. 1.5)193.
Figure 1.5: Model of the AIM2 inflammasome. Adapted from Lu and colleagues194.
In the resting state, the AIM2PYD binds to the HIN-200 domain thereby keeping it inac-
tive. Similar to the binding of dsDNA, the AIM2PYD binds to the concave, positive surface
of the HIN-200 domain. Only dsDNA recognition relieves this auto-inhibition and allows
signaling195. Multiple AIM2 monomers wrap around a stretch of dsDNA in a filament-
like fashion bringing their PYDs into close proximity. The relatively long linker between
the HIN-200 and the PYD of approximately 50 amino acids stretching a distance of
up to 19 nm enables even relatively distant AIM2PYDs to interact. The AIM2PYDs then
form short helical arrangements which serve as nucleation platforms for the ASCPYD
filaments (Fig. 1.5)194. Consistently, activation of AIM2 in macrophages can be either
achieved by sterile delivery (transfection, electroporation) of dsDNA or synthetic dsDNA
analogues like poly(dA:dT) (poly [deoxyadenylic-deoxythymidylic] acid). But also infec-
tions with certain bacteria like Francisella tularensis subspecies novicida196–201, My-
cobacterium tuberculosis202,203, Listeria monotcytogenes204–206 or Brucella abortus207
activate AIM2 and in absence of AIM2 reduced caspase-1 activation and IL-1β release
can be observed. While most bacteria also engage other inflammasome receptors,
Francisella is the only known bacterium that solely activates AIM2. Mice deficient in
Aim2 are generally more susceptible to infections with reduced cytokine serum levels
and increased bacterial burdens after Francisella197–199, M. tuberculosis208, B. abor-
tus207 but also Staphylococcus aureus challenge209.
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Additionally, cell culture experiments also established a role for AIM2 in recognition of
certain viruses like MCMV (mouse cytomegalovirus), Vaccinia virus, Human papillo-
maviruses or Hepatitis B virus. But apart from MCMV, where Aim2 deficiency lead to
increased viral titers after infection, the significance of the AIM2 inflammasome during
viral infections in vivo is unknown199,201,210,211.
Furthermore, the AIM2 inflammasome does not only participate in host defense but
aberrant AIM2 activation by host DNA is responsible for elevated IL-1β levels in pa-
tients with acute or chronic skin conditions like psoriasis or arthritis187. However, mech-
anisms are in place to prevent auto-activation. Among these are, in humans and other
primates, the POPs. Especially POP3, binding to the AIM2PYD thereby blocking ASC
recruitment127, and POP1, binding to the ASCPYD thereby modulating IL-1β release,
are relevant in the context of the AIM2 inflammasome (see above)123–125. Another
modulatory protein of the AIM2 inflammasome is p202. p202 contains tandem HIN-200
domains and is also able to bind to dsDNA in a similar fashion as AIM2. Expression of
p202 blocks ASC recruitment to AIM2 as it leads to a separation of AIM2 on the dsDNA
placing the AIM2PYDs to far apart to be able to initiate ASCPYD oligomerization. This
efficiently blocks inflammasome assembly192,212,213.
1.6.3 Pyrin
Pyrin is encoded by the gene MEFV (Mediterranean fever). It was identified to harbor
point mutations associated with the autoinflammatory disease FMF (familial Mediter-
ranean fever)214,215. The severity of FMF is varying from patient to patient but it is gen-
erally characterized by recurrent episodes of fever and polyserositis172. The disease
is, as the name suggests, mainly confined to the Mediterranean. In some populations
up to one third of the people are heterozygous carriers of a mutation suggesting a se-
lective advantage conferred by some mutations. But the selective pressure and why it
is confined to the Mediterranean is not known216. Most of the known FMF-associated
mutations of Pyrin map to the C-terminal B30.2 domain216. B30.2 domains were de-
scribed to be involved in protein-protein interactions217 and specifically the Pyrin B30.2
was described to interact with caspase-1218. The effect of this interaction is, however,
not fully clear and conflicting reports regarding its effect on IL-1β secretion exist219–221.
Interestingly, murine Pyrin lacks the C-terminal B30.2 domain. Knock-ins of human
Pyrin B30.2 mutants associated with FMF lead to an FMF-like phenotype in mice. Fur-
thermore, high levels of IL-1β can be detected in these mice independent of NLRP3
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but dependent on ASC suggesting that the FMF-associated mutations lead to the con-
stitutive formation of a Pyrin inflammasome222. This is consistent with the fact that
Pyrin harbors an N-terminal PYD and interacts with ASCPYD83,221. However, the signal
leading to Pyrin inflammasome formation, in absence of FMF-associated mutations,
was only described recently to be inactivation of Rho (Ras homology gene family)
GTPases, specifically RhoA, but not Cdc42 (cell division control protein 42 homolog)
and Rac1 (Ras-related C3 botulinum toxin substrate 1)223. Rho GTPases are crucial
for cell homeostasis and cytoskeleton function224. They are therefore often targeted
and inactivated by pathogens to control host cell behavior. Examples for this are the
glucosylation of RhoA by the Clostridium difficle toxin B (TcdB), the adenylylation by
Histophilus somni effector protein IbpA and Vibrio parahaemolyticus effector protein
VopS, the ADP-ribosylation by Clostrididum difficile C3 toxin or the deamination by
Burkholderia cenocepacia in a type VI secretion system dependent manner223,225. Ad-
ditionally, Pyrin must be dephosphorylated to be activated226 and this can be exploited
by pathogens. For example Yersinia prevents Pyrin activation by induction of Pyrin
phosphorylation therefore keeping it in an inactive state despite modifications of Rho
GTPases227. Thus, Pyrin is activated by disturbances of cell homeostasis during infec-
tions and not by sensing the pathogens themselves223.
So far, however, the relevance for the Pyrin inflammasome in fighting bacterial infec-
tions has only been shown for B. cenocepacia223. Furthermore, the role of Pyrin might
be even more complex. It was recently suggested that Pyrin directs NLRP3 but also
NLRP1 and pro-caspase-1 to autophagy-dependent degradation thereby decreasing
inflammasome activation and that this function is affected by FMF-associated muta-
tions228. Collectively, additional work needs to be conducted to elucidate the physiolog-
ical role of Pyrin, especially in vivo, and to address the exact mechanisms by which the
FMF-associated Pyrin mutations cause disease in order to specifically treat patients.
The standard treatment for FMF is a daily dose of colchicine229–232, an inhibitor of mi-
crotubule polymerization which is toxic at higher doses233. Recently, targeting IL-1β
with anakinra or canakinumab showed promising results in some patients172. However,
the need for safe and less expensive drugs still persists.
1.6.4 NLRC4
The NLRC4 (NLR-family CARD-containing protein 4) inflammasome was shown to be
activated in response to bacteria in the cytosol by detecting T3SS (type III secretion sys-
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tem) components and flagella91,234–236. A group of other NLR proteins, known as NAIPs
(NLR family, apoptosis-inhibitory protein), act as co-receptors for NLRC4 by directly
binding these ligands and initiating NLRC4 oligomerization. NAIPs have a tri-partite do-
main organization containing an N-terminal BIR-domain (Baculovirus inhibitor of apop-
tosis protein repeat), a central NOD (nucleotide binding and oligomerization domain)
and C-terminal LLRs (leucine rich repeats). While the human genome only encodes a
single NAIP, the murine genome encodes seven NAIPs probably originating from gene
duplications237,238. Using the central NOD, the NAIPs bind to different components
from T3SS or flagella. Specifically, murine NAIP1 binds to the T3SS needle subunit,
murine NAIP2 to the T3SS rod subunit and murine NAIP5 or NAIP6 to flagellin239. As
humans only encode a single NAIP, it is assumed that different splice variants show dif-
ferent binding specificities and take over the roles of the different mouse orthologues240.
Once bound to their ligand, NAIPs are relieved from their auto-inhibited state and are
able to recruit NLRC4. NLRC4 is another member of the NLR-family consisting of C-
terminal LRRs, a central NOD and an N-terminal CARD. Also NLRC4 is present in an
auto-inhibited state where the LRRs prevent protein-protein interactions via the CARD
of NLRC4241. Ligand-activated NAIPs interact with inactive NLRC4 and induce struc-
tural rearrangements in NLRC4 that relieve its auto-inhibitory state and exposing a so-
called ”activating” surface. This then enables sequential recruitment of further NLRC4
monomers, concomitantly relieving auto-inhibition. Finally, one active NAIP recruits 9-
11 NLRC4 monomers into a wheel-like structure. This wheel-like structure then recruits
ASC and caspase-1 leading to caspase-1 activation and finally cytokine secretion and
pyroptosis242–245. Therefore, minute amounts of cytosolic, bacterial PAMPs can lead
to a massive immune response. However, how the CARD-containing NLRC4 recruits
ASC is not known.
To control and prevent aberrant NLRC4 activation, it was suggested that NLRC4 activa-
tion requires phosphorylation of S533 by PKCγ (protein kinase C delta type). Absence
of S533 phosphorylation correlated with decreased IL-1β levels after NLRC4 activa-
tion246,247.
As NLRC4 contains a CARD, it was shown that it is able to directly interact with caspase-
1 in absence of ASC65,248. This interaction leads to an active form of caspase-1 and
results in pyroptosis. However, caspase-1 is not auto-processed and no IL-1β release
can be observed in absence of ASC. As only pyroptosis can be observed, this pu-
tative, small complex consisting of NAIP, NLRC4 and caspase-1 was termed ”death
complex”64.
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Functionally, the NLRC4 inflammasome is best studied in the case of S. Typhimurium
infections. But also other T3SS expressing bacteria like Pseudomonas aeruginosa and
flagellated bacteria like Legionella pneumophila are potent activators of the NLRC4 in-
flammasome. Therefore, NLRC4 deficient macrophages fail to induce pyroptosis and
cytokine secretion upon challenge with these bacteria66,91,234–236. Consistently, NLRC4
deficient mice succumb faster and display higher bacterial burdens than wild type con-
trols after infection with gram-negative bacteria like S. Typhimurium, Legionella pneu-
mophila or Klebsiella pneumoniae234,249–252.
Similar to NLRP3, gain-of-function mutations were found in human NLRC4. These sin-
gle amino acid substitutions (T337S, V341A, and H443P) map to the central NOD and
result in the release of the auto-inhibitory state and thereby constitutive NLRC4 inflam-
masome activation. This is accompanied by a general, systemic inflammatory state
characterized by elevated cytokine levels and recurrent MAS (macrophage activation
syndrome). Pathologically, patients with the NLRC4 gain-of-function mutations display
episodes of fever, often cold induced, and rashes. Similar phenotypes could be reca-
pitulated in murine models and treatment with an IL-1 receptor antagonist (anakinra)
clearly improved the conditions253–255.
1.6.5 Other inflammasome receptors
Apart from the widely studied and well understood inflammasome receptors NLRP3,
AIM2, Pyrin and NLRC4 also other inflammasome receptors were proposed. However,
the degree of study and how well they are established varies24.
NLRP1
NLRP1 was the first inflammasome receptor to be described28. NLRP1 belongs to the
NLR-family but has a more complicated domain architecture than for example NLRP3
or NLRC4. Human NLRP1 has an C-terminal PYD, followed by an NOD, LRRs, a FIIND
(function-to-find domain) and a C-terminal CARD256,257. Interestingly, rodents have 3
paralogs called NLRP1A, NLRP1B and NLRP1C but all of them lack the PYD258. Func-
tionally, NLRP1B was shown to be cleaved and activated by lethal toxin of Bacillus an-
thracis259. Lethal toxin is an A/B toxin consisting of the lethal factor and the protective
antigen binding to the cell260. Yet, several murine Nlrp1b alleles exist with some being
lethal toxin responsive and some unresponsive. Surprisingly, both responsive and non-
responsive NLRP1B variants are cleaved by lethal toxin suggesting that NLRP1 inflam-
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masome activation is a multistep process261. Consistently, a processing event within
the FIIND was observed to be required for activation in lethal toxin responsive NLRP1B
variants262. Thus, the current model suggests that NLRP1B acts as a decoy target for
lethal toxin during B. anthracis infection thereby protecting the host24. Gain-of-function
mutations in human NLRP1 have recently been identified, showing that human NLRP1
also signals through its CARD, while the PYD serves a regulatory function. However
the endogenous ligand that activates NLRP1 in humans is unknown so far263.
NLRP6
NLRP6 is mainly expressed in the intestines264. Deficiency in Nlrp6 leads to increased
susceptibility to chemically induced colitis and colitis induced tumors in mice and corre-
lates with a decrease in IL-18 secretion. This observation and the described interaction
of NLRP6 with ASC suggest the existence of an NLRP6 inflammasome264,265. It was
further shown that NLRP6 also regulates the microbiota as Nlrp6 deficient mice show
a dysbiotic microbiota266,267. Furthermore, NLRP6 was also implicated in intestinal an-
tiviral immunity268. However, the signals recognized by NLRP6 and whether NLRP6 is
a bona fide inflammasome receptor remain unknown24,269.
NLRP7
NLRP7 is only present in humans but not mice. Initial structure determinations of the
PYD of NLRP7 suggested that it will not be able to interact with the ASCPYD270. Yet,
it was later shown that NLRP7 can assemble an ASC-dependent inflammasome in re-
sponse to microbial acylated lipoproteins from Mycoplasma sp. in human macrophages271.
Furthermore, also Mycobacteria are able to activate NLRP7272. Similar to NLRP3,
NLRP7 requires ATP binding by its NOD to initiate signaling273. However, the extent
and relevance of the NLRP7 inflammasome remains to be shown.
NLRP12
NLRP12 was discovered to be recruited to ASC in an overexpression system274. Sub-
sequently, NLRP12 was postulated as a negative regulator of NF-κB signaling275, a
function which requires ATP binding to its central NOD276. Additionally, NLRP12 is also
implicated in controlling migration of dendritic cells and neutrophils277. Furthermore,
NLRP12 was suggested to initiate inflammasome formation in response to Yersinia
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pestis and Plasmodium infections278,279. Moreover, rare gain-of-function mutations in
NLRP12 exist leading to an autoinflammatory disease characterized by recurrent fever
and cold sensitivity. The identified mutations result in increased speck formation and
elevated IL-1β levels280–282. Thus, an initial study using the IL-1 receptor antagonist
anakinra to treat patients with Nlrp12 mutations showed a positive effect on disease
manifestation283.
IFI16
Human IFI16 and the murine orthologue IFI204 are DNA sensors regulating interferon
production during viral and bacterial infections284,285. However, IFI16 interacts with
ASC in the nucleus upon infection with Kaposi’s sarcoma-associated herpesvirus and
initiates an inflammasome complex286. Furthermore, IFI16 is associated with inflam-
masome activation upon HIV infections53,287. IFI16 recognizes dsDNA and binds to it in
a sequence-independent manner similarly to AIM2 (see above)288. But for both, IFI16
and IFI204, the physiological relevance as inflammasome receptor remains unknown.
1.6.6 Non-canonical inflammasome: Murine caspase-11 and human
caspases-4 and -5
Initial studies with Casp1 and Casp11 deficient mice suggested that the two inflamma-
tory caspases have redundant roles regarding septic shock289,290. However, it was dis-
covered that Casp1 knock-out mice were also deficient for Casp11291. While Casp1–/–/
Casp11+/+ mice were susceptible to lethal sepsis, Casp11–/–/Casp1+/+ mice were re-
sistant showing that caspase-1 and caspase-11 have non-redundant roles and that
caspase-11 is responsible for the severe outcome of sepsis291.
Caspase-11 is a cytosolic protein that requires an activation step290,292. Activation of
caspase-11 leads to pyroptotic cell death. Caspase-11 dependent pyroptosis is mor-
phologically indistinguishable from caspase-1 dependent pyroptosis and it is also de-
pendent on cleavage of gasdermin-D30,31 (see below). Additionally, release of IL-1β
and IL-18 can be observed after caspase-11 activation, hence the name non-canonical
inflammasome as opposed to the canonical caspase-1 inflammasome. However, mat-
uration of IL-1β/-18 requires the formation of a canonical NLRP3 inflammasome291,293.
NLRP3 activation after non-canonical inflammasome activation is a cell intrinsic pro-
cess and requires the efflux of K+294.
Consistent with its role in sepsis, it was shown that caspase-11 is activated in response
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to cytosolic LPS295, specifically the lipid A moiety of LPS. Caspase-11 activation re-
quires hexa-acylated LPS, and bacteria that feature modified versions of LPS do not
activate this pathway, such as Francisella novicida that has a tetra-acylated LPS293,295.
Surprisingly, LPS binds directly to the CARD of caspase-11 and activates it without
the requirement of any further receptors. Also the CARDs of human caspase-4 and
caspase-5 can directly bind to LPS296. Consistently, bacteria like Burkholderia that re-
side in the cytosol are potent triggers of caspase-11297. But also S. Typhimurium or
L. monocytogenes mutants (sifA and sdhA, respectively), that lead to a cytosolic lo-
calization of these usually vacuolar bacteria, activate caspase-11297. Furthermore, in
absence of caspase-1, also wild type S. Typhimurium can activate caspase-11298.
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1.7 Caspase-12
Murine caspase-12 is an additional inflammatory caspase displaying high homology to
murine caspase-1 (39% identity), murine caspase-11 (38% identity), human caspase-4
(48% identity) and human caspase-5 (45% identity) placing it in the group of the pro-
inflammatory caspases299,300. While the Casp12 gene is intact in rodents as well as
non-human primates, two different alleles exist in the human population. The short
form CASP12S, which is fixed in the Caucasian population as well as most other non-
African populations, contains a premature stop codon at position 125 instead of an
arginine301. The CASP12S allele therefore only consists of the CARD of caspase-12.
The CASP12L allele on the other hand can nearly exclusively be found in populations
of sub-Saharan African descent and contains the full open reading frame. While also
in these populations many people are homozygous for the CASP12S allele, a large
fraction of the people are heterozygous and some even homozygous for the CASP12L
allele. In sub-Saharan African populations the average frequency of CASP12L allele
was estimated to be approximately 28%302,303. As the CASP12S alleles seem to have
a common origin, it has been suggested that the pseudogenization of CASP12L to
CASP12S predates the out-of-Africa migration of Homo sapiens (approximately 40’000-
60’000 years ago)303,304. This quick fixation of the CASP12S allele in the Caucasian
and other non-African populations is a clear indication of a positive selection pressure
on the CASP12S allele. Indeed, the selective advantage was estimated to be approxi-
mately 0.5-1% and started 60’000-100’000 years ago303,304. However, the origin of this
selective pressure is not known so far.
Initially, the CASP12L allele has been described to protect patients from severe sepsis
in a small cohort of African-Americans301. However, this has since been questioned
by a larger study with Malian volunteers that found no difference in secretion of pro-
inflammatory cytokines in whole blood after challenge with LPS or different Yersinia
strains (Y. pestis, Y. pseudotuberculosis, Y. enterocolitica) in people carrying both Casp-
12 alleles compared to homozygous carrier of the CASP12S allele302. Furthermore,
another study could not find any correlation between the presence of the CASP12L al-
lele and spontaneous clearance of hepatitis C virus, which happens in a small fraction
of people whereas most develop a chronic infection305.
There has also been some considerable effort to elucidate the function of the rodent
caspase-12 homologue. So far, no caspase-12 targets besides itself are known and the
catalytic activity of caspase-12 is the lowest amongst the characterized caspases306.
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Additionally, caspase-12 is only able to cleave itself (in cis and trans) between the large
(p20) and small (p10) subunits but not between the pro-domain (CARD) and the large
subunit which further differentiates caspase-12 from other caspases306. Nonetheless,
caspase-12 has been linked to the ER (endoplasmic reticulum) stress response where
it has been shown to be upregulated307. Furthermore, it has been proposed to be es-
sential for ER stress-dependent apoptosis but not for the extrinsic or intrinsic apoptosis
pathways300. Even though additional factors like TRAF2 (TNF [tumor necrosis factor]
receptor-associated factor 2) have been implicated as well307 the exact mechanism how
caspase-12 should be involved in apoptosis is unclear and its role in ER stress has also
been contested308.
On the other hand, it was reported that in mice caspase-12 should act as dominant neg-
ative regulator of caspase-1308. With the aid of Casp12 knock-out mice, it was reported
that caspase-12 deficient cells display increased caspase-1 activity and therefore re-
lease more IL-1β and IL-18 but also interferon-γ308. Furthermore, caspase-12 was re-
ported to dampen the immune response to Plasmodium infection thereby amelioration
the outcome of cerebral malaria in an inflammasome independent but NF-κB dependent
manner309 and it was reported that caspase-12 modulates NOD (nucleotide-binding
and oligomerization domain-containing protein) signaling by interacting with RIP2 (re-
ceptor interacting serine/threonine kinase 2)310. Finally, caspase-12 was described
to restrict West Nile virus infections in a caspase-1 and RIG-I dependent manner311.
However, the original Casp12 knock-out mice created by Saleh and colleagues308 are
also deficient for Casp11312,313 therefore questioning which of the observed pheno-
types could be assigned to caspase-11 and which to caspase-12. Recently, however
Casp11 proficient Casp12 knock-out mice were generated312,313 and the results show
that caspase-12 inhibits diet induced obesity and insulin resistance312. Importantly
however, no effect of caspase-12 on canonical and non-canonical inflammasome sig-
naling could be detected in vivo after LPS injection or Listeria monocytogenes infection
or ex vivo in BMDMs incubated with ATP or nigericin, infected with E. coli, Citrobacter
rodentium or S. Typhimurium or transfected with dsDNA313 thereby further questioning
the physiological role of caspase-12.
41
Introduction
1.8 Gasdermin-D
Recently, two independent approaches identified gasdermin-D as an important exe-
cutioner of pyroptotic cell death. The first group employed an forward genetic screen
using ENU (N-ethyl-N-nitrosourea) induced mutagenesis in mice for mediators of non-
canonical inflammasome signaling (LPS injection)30 while the second group used a
CRISPR-Cas9 genome wide knock-out screen for both caspase-11 and NAIP/NLRC4
mediated pyroptosis31. A third report later announced the identification of gasdermin-D
in the NLRP3 complex by a mass spectrometry approach314. Gasdermin-D is part of the
gasdermin family of proteins consisting of gasdermin-A, -B, -C, DFNA5 and DFNB59
in humans and gasdermin-A1–A3, -C1–C4, DFNA5 and DFNB59 in mice315. Gasder-
mins were identified to be expressed in the gastrointestinal tract as well as the skin and
derive their name thereof316. Importantly, all gasdermins, except DFNB59, display a
conserved two-domain architecture317.
Upon inflammasome activation, gasdermin-D is cleaved into an N-terminal (p30) and
a C-terminal (p20) fragment whereby the N-terminal fragment is sufficient to induce
pyroptosis31. The C-terminal domain of gasdermin-D functions as auto-inhibitory do-
main as well as solubility tag and after cleavage of gasdermin-D the C-terminal frag-
ment stays soluble while the N-terminal fragment precipitates in vitro318. In cells,
the released N-terminal gasdermin-D fragment associates with the plasma membrane
and can bind to phosphatidylinositol (4)-phosphate, (4,5)-bisphosphate and (3,4,5)-
triphosphate48,319. This is supported by the fact that a reduction of phosphatidylinositol
phosphate concentrations in the plasma membrane by chemical means is able to block
pyroptosis48. After membrane association, the N-terminal fragment of gasdermin-D can
insert into the membrane and form a pore. It was estimated that 16-24 monomers of
the gasdermin-D N-terminal domain participate in one pore317,320. The size of the pore
has an inner diameter of approximately 15 nm and an outer diameter of approximately
23 nm317–319. This pore size would theoretically be large enough to let pass both IL-
1β/-18 (4.5 nm diameter) as well as caspase-1 (7.5 nm diameter)317. However, it was
not shown so far whether IL-1β and IL-18 are indeed released through the gasdermin-D
pore.
Interestingly, after caspase-11 activation gasdermin-D is essential for both, pyroptosis
and NLRP3 dependent caspase-1 and IL-1β maturation and secretion. On the other
hand, gasdermin-D is not required for canonical caspase-1 and IL-1β processing and
at later time points even pyroptosis is independent of gasdermin-D30. This difference
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between the absolute requirement for caspase-11 mediated pyroptosis and relative re-
quirement for caspase-1 mediated pyroptosis is mirrored in their evolutionary relation-
ships. While all vertebrates display caspase-1 dependent cell death, only mammalians
express caspase-11 and gasdermin-D indicating a possible co-evolution of caspase-11
and gasdermin-D30.
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1.9 Aim of the thesis
The ability of ASC to form speck-like aggregates, so-called ASC specks, was known
even before the inflammasome emerged as important pathway in innate immunity. Yet,
the structure and the organization of these ASC specks has remained enigmatic, al-
though it had been observed that ASC has the ability to oligomerize into filaments by
its death-fold domains, namely the ASCPYD or ASCCARD. The aim of the first part of
my thesis was to aid in elucidation of the structure of the murine ASCPYD filament by
a novel combined NMR and electron microscopy approach. The aim of the main part
of my thesis was to clarify the roles of the two domains of ASC in speck formation,
determine how CARD-containing receptors initiate speck formation and clarify whether
the ASC speck has indeed a role in inflammasome signaling.
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2.1 Research article I
Structure and assembly of the mouse ASC inflam-
masome by combined NMR spectroscopy and cryo-
electron microscopy
L. Sborgi*, F. Ravotti*, V. P. Dandey*, M. S. Dick, A. Mazur, S. Reckel, M. Chami,
S. Scherer, M. Huber, A. Bo¨ckmann, E. H. Egelman, H. Stahlberg, P. Broz, B. H. Meier
and S. Hiller.
* denotes equal contribution.
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Statement of contribution
I performed all experiments in cells, i.e. generated the cell lines and performed inflam-
masome activation, cell death and IL-1β release measurements as well as the fluores-
cence microscopy and speck quantification. These data were included in Fig. 1b, Fig.
5 and Fig. S6. Additionally, I performed some of the ASCFL and ASCPYD purifications
for electron microscopy and was involved in writing of the manuscript.
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Inflammasomes are multiprotein complexes that control the in-
nate immune response by activating caspase-1, thus promoting
the secretion of cytokines in response to invading pathogens and
endogenous triggers. Assembly of inflammasomes is induced by
activation of a receptor protein. Many inflammasome receptors
require the adapter protein ASC [apoptosis-associated speck-like
protein containing a caspase-recruitment domain (CARD)], which
consists of two domains, the N-terminal pyrin domain (PYD) and
the C-terminal CARD. Upon activation, ASC forms large oligomeric
filaments, which facilitate procaspase-1 recruitment. Here, we
characterize the structure and filament formation of mouse ASC
in vitro at atomic resolution. Information from cryo-electron micros-
copy and solid-state NMR spectroscopy is combined in a single
structure calculation to obtain the atomic-resolution structure of
the ASC filament. Perturbations of NMR resonances upon filament
formation monitor the specific binding interfaces of ASC-PYD
association. Importantly, NMR experiments show the rigidity of the
PYD forming the core of the filament as well as the high mobility of
the CARD relative to this core. The findings are validated by structure-
based mutagenesis experiments in cultured macrophages. The 3D
structure of the mouse ASC-PYD filament is highly similar to the
recently determined human ASC-PYD filament, suggesting evolution-
ary conservation of ASC-dependent inflammasome mechanisms.
inflammation | protein structure | protein filament | ASC speck |
innate immune response
The innate immune system rapidly detects and responds todifferent types of pathogen- and danger-associated molecular
patterns (PAMPs and DAMPs, respectively) at minimal concen-
trations via specific, germline-encoded pattern-recognition re-
ceptors (PRRs) (1–3). A subset of cytosolic PRRs respond to
PAMPs and DAMPs by initiating the assembly of cytosolic mac-
romolecular inflammasome complexes (4–6). Inflammasome as-
sembly leads to the activation of caspase-1, the proteolytic
maturation of interleukins, and the induction of pyroptosis. The
correct assembly of inflammasome complexes is critical, and mal-
functions are related to major human diseases including cancer and
autoimmune syndromes (4, 7). Inflammasome signaling initiates
with the activation of dedicated sensor proteins, such as the NOD-
like receptor (NLR) family, through mechanisms that still are
poorly understood (2, 4). The typical domain architecture of NLRs
is tripartite, including an N-terminal effector domain (8). Based on
the type of effector domain, which can be pyrin domains (PYDs),
caspase-recruitment domains (CARDs), or baculovirus inhibitor of
apoptosis (IAP) repeat (BIR) domains, NLRs are classified as
NLRPs, NLRCs, or NLRBs, respectively (9). In the initial reaction
step upon recognition of the specific molecular pattern, the receptor
self-associates (Fig. 1A). Because death domains interact in a
homotypic fashion, NLRCs can activate procaspase-1, which
features a CARD, directly. In contrast, NLRPs require the re-
cruitment of the bipartite adaptor protein ASC (apoptosis-associated
speck-like protein containing a CARD) as an intermediate signaling
step. ASC interacts with the receptor via its N-terminal PYD and
activates procaspase-1 with its C-terminal CARD. Importantly, the
interaction with the receptor is not stoichiometric, but ASC oligo-
merizes in vivo to a micrometer-sized assembly, the ASC speck (Fig.
1 A and B) (10). Procaspase-1 is recruited to the speck, resulting in
its autoprocessing and the formation of the catalytically active het-
erotetramer of cleaved p10 and p20 subunits.
Given its central role in NLRP inflammasomes, a description
of ASC structure and dynamics in its soluble and filamentous
form is crucial to understand inflammation processes at the
atomic level. NMR spectroscopy is the method of choice for
the structural and functional characterization of PYDs that are
Significance
Invading pathogens and other danger-associated signals are
recognized by the innate immune system. Subsequently, the
eukaryotic protein ASC [apoptosis-associated speck-like protein
containing a caspase-recruitment domain (CARD)] assembles to
long filaments, which might serve to amplify the signal and
activate an inflammatory response. We have determined the
structure of the mouse ASC filament at atomic resolution. The
pyrin domain of ASC forms the helical filament core, and the
CARD, thus far elusive to experimental observation, is flexibly
unfolded on the filament periphery. The integration of data
from two structural methods, cryo-electron microscopy and
solid-state NMR spectroscopy, opens perspectives for structural
studies of inflammasomes and related molecular assemblies.
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difficult to crystallize (11–13). In particular, the solution structures
of isolated human ASC pyrin domain (ASC-PYD) and ASC full-
length protein (ASC-FL) have been determined, showing that the
PYD and the CARD, connected by a flexible linker, tumble in-
dependently in solution (14, 15). A suitable method for the
structural characterization of the insoluble ASC aggregates that
form at physiological pH conditions is cryo-EM, which recently has
provided the first structure of an ASC-PYD filament at near-
atomic resolution (16). Filaments of human ASC-PYD feature a
helical arrangement along well-defined molecular interfaces, in
agreement with other molecular assemblies of death domains (16–
18). An alternative method to determine structures of insoluble
protein assemblies at atomic resolution is solid-state NMR spec-
troscopy under magic-angle-spinning (MAS) conditions (19–22).
Cryo-EM density maps do not recover disordered or dynamic
polypeptide segments, but solid-state NMR spectroscopy renders
data from both the rigid and dynamic parts of a molecular as-
sembly. The two techniques thus can provide complementary in-
formation. Structural studies of inflammasomes from different
vertebrates remain of great interest because of the extensive di-
versification of inflammasome signaling pathways among species.
Here, we combine data from solid-state NMR spectroscopy
and cryo-EM to determine the atomic-resolution structure of
mouse ASC filaments formed by the PYDs via helical stacking
along well-defined interfaces. Additional solid-state NMR mea-
surements address the dynamic CARD as part of the ASC-FL
filament. A comparison of chemical shifts reveals conformational
changes upon filament formation. Structure-guided mutagenesis
in living cells confirms the network of interactions that are es-
sential for the integrity of the filament and thus ASC-dependent
inflammasome signaling.
Results
Reconstitution and Characterization of ASC Filaments in Vitro. The
mouse ASC-FL and ASC-PYD were soluble at low pH or in
chaotropic solution and showed a high propensity for assembling
into filaments at physiological pH conditions. Negatively stained
preparations visualized by EM showed that oligomerization leads
to the formation of long, well-defined filaments, with typical
lengths in the range of 500–2,000 nm (Fig. 1 C and D). The
filaments were organized in larger aggregates of variable size,
with the ASC-FL filaments branching more frequently than the
ASC-PYD filaments. In general, the atomic structure of filaments
depends on the assembly conditions in vivo and in vitro, and
polymorphism is common in some systems (23, 24). To charac-
terize the sample homogeneity in our preparations, we used solid-
state NMR spectroscopy, which is highly sensitive to even small
changes in the local molecular conformation (23). A 2D dipolar-
assisted rotational resonance (DARR) [13C,13C]-correlation spec-
trum as well as an NCA correlation spectrum of the filament of the
isolated PYD showed narrow cross-peaks, with typical carbon line
widths of about 0.5 ppm (Fig. 1 D and E and Fig. S1). The ob-
servation of a single set of peaks—one per carbon or nitrogen
atom—is a strong indication of a homogeneous preparation and
the absence of polymorphism. Notably, the observation of a single
set of resonances also indicates that all monomers in the filament
are symmetry-equivalent. We repeated the same experiments on
the filament of ASC-FL under the same conditions and observed
highly similar DARR and NCA spectra (Fig. 1 C and E and Fig.
S1). The two pairs of spectra feature a complete set of correlation
cross-peaks at the same positions, indicating that the CARD is es-
sentially invisible in the spectrum of ASC-FL and that the observ-
able PYD adopts the same structure in both types of filament. The
ASC-PYD alone thus forms the scaffold of the ASC-FL filament,
whereas the CARD is not strictly required for the filament core and
does also not perturb the PYD filament conformation. The absence
of additional strong signals in the full-length protein relative to the
PYD shows that the CARD is flexible relative to the filament core.
Consistently, although mouse ASC-PYD filaments feature a
smooth surface in negative-stained EM, filaments formed by
mouse ASC-FL have a rough surface, possibly because the ASC-
CARD is exposed outside the ASC filament (Fig. 1 C and D).
These data directly indicate that the two domains of mouse ASC,
which in human ASC have been shown to tumble independently
in solution (14), also are independent in the filament form.
Cryo-EM of the ASC-PYD Filament. Based on the observation that
the ASC-PYD is the minimal structural requirement for filament
formation, we studied the structure of filaments of the mouse ASC-
PYD without the CARD. Optimization of the filament formation
protocol by observation with cryo-EM showed that these filaments
are well-ordered (Fig. S2). Image collection was done manually on
an FEI Titan Krios transmission electron microscope using a Gatan
K2 Summit direct electron detector. Recorded image series were
automatically drift-corrected and averaged using the 2dx_automator
(25), employing MOTIONCORR (26). The averaged power spec-
trum of multiple individual segments of filaments from these cryo-
EM images shows a clear meridional reflection at 1/14.2 Å−1, cor-
responding to the reciprocal of the axial rise. Image processing with
the Iterative Helical Real Space Reconstruction (IHRSR) method
(27) yielded a final electron density map at a resolution of
∼4.0–4.5 Å (Fig. 2A). The ASC-PYD filament is a hollow helical
fiber with inner and outer diameters of 20 Å and 90 Å, re-
spectively. The polar filament has C3 point group symmetry with
53° right-handed rotation and a 14.2-Å axial rise per subunit.
Solid-State NMR of the Mouse ASC-PYD Filament. For the resonance
assignment, we recorded a set of correlation experiments on
uniformly 13C- and 15N-labeled filaments under MAS conditions
Fig. 1. Structural determinants of ASC filament formation. (A) Schematic rep-
resentation of ASC-mediated inflammasome assembly and caspase-1 activation.
Detection of specific molecular patterns by NLR or pyrin and HIN domain-
containing protein (PYHIN) family members results in their activation and
oligomerization. Activated receptors recruit the inflammasome adaptor ASC,
which in turn oligomerizes to ASC filaments. The effector protease caspase-1 is
activated by this complex. LRR, leucine-rich repeat. (B) Endogenous ASC specks in
immortalized murine macrophages stained with antibodies for ASC (red) appear
as large, macromolecular complexes. Nuclei are stained blue. (Scale bar, 5 μm.)
(C and D) Characterization of filaments from ASC-FL (C, black) and ASC-PYD
(D, blue) reconstituted in vitro. (Upper) EM images of negatively stained prep-
arations of ASC filaments. (Scale bars, 1 μm; 100 nm in Insets). (Lower) 2D [13C,13C]-
DARR solid-state NMR spectra of [U-13C]-labeled filaments (mixing time 20 ms).
The spectra were recorded on an 850-MHz spectrometer at 17 kHz MAS.
(E) Superimposition of a selected region of the 2D [13C,13C]-DARR spectra shown
in C and D. Sequence-specific resonance assignments are indicated.
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(28). The spectra were well resolved and allowed sequence-specific
resonance assignments of the backbone and amino acid side chains,
as detailed in ref. 29 (Fig. 2 B and C). The backbone assignment
was complete for residues 4–84, and in this segment most of the
side-chain carbon atoms were assigned also. The secondary
chemical shifts allowed a direct determination of the location of
secondary-structure elements. Mouse ASC-PYD in its filament
form features six α-helices at positions 3–14, 17–29, 41–46, 49–59,
62–76, and 80–84 (Fig. 2D). The last helix presumably extends until
residue 89, but resonances that could correspond to the segment
85–89 were not found in any of the spectra. Because an INEPT
(insensitive nuclei enhanced by polarized transfer)-based spectrum
of the ASC-PYD filaments did not show resonances, we assume
that these four residues feature millisecond dynamics, leading to
line broadening below the level of detection, a common feature of
terminal residues even in microcrystalline proteins (30).
Calculation of the Structure of the Mouse ASC-PYD Filament. The
cryo-EM density map of the ASC-PYD filament was combined
with solid-state NMR data toward a joined structure calculation,
which proceeded in three steps (Fig. 2E). Model 1 of the ASC-
PYD filament monomer is based on the EM electron density
map and on the location of the six α-helical segments in the
amino acid sequence, as determined from solid-state NMR
secondary chemical shifts. It was built by placing the helices in-
teractively into the cryo-EM density map using Coot (31) and
connecting them as indicated by electron density. Because some
of the side chains were well resolved in the electron density map,
matching them allowed a tentative rotational orientation. The
full-filament coordinates were created from this monomer by
application of the helical symmetry (C3, 53° rotation, 14.2-Å rise).
The resulting model 1 was refined further using the X-PLOR-NIH
program (32) under continuous symmetry enforcement, using the
cryo-EM structure factors (the Fourier transform of the density
map) as restraints, as well as the TALOS+ dihedral angles from
solid-state NMR chemical shifts for a total of 70 residues and i,i+4
backbone hydrogen-bond restraints for residues in α-helical sec-
ondary structure (see above). The resulting model 2 shows a well-
defined backbone structure, as indicated by a backbone rmsd
of 0.23 Å and an overall heavy atom rmsd of 0.94 Å for the
conformer bundle. Model 2 is cross-validated by a set of spec-
trally unambiguous cross-peaks in 2D [13C,13C]-CHHC and
[13C,13C]-proton assisted recoupling (PAR) solid-state NMR
experiments, which are all in agreement with the 3D structure
(Fig. S3A and Table S1).
In an attempt to improve side-chain orientations, we used
further NMR distance restraints from 2D [13C,13C]-CHHC and
[13C,13C]-PAR spectra. The spectra were peak-picked automat-
ically by Sparky (33) and assigned to 674 atom pairs with the
CANDID algorithm (34) using the 3D structure information of
model 2 as input (Fig. S3B). A structure calculation with X-PLOR-
NIH (32) under symmetry enforcement yielded model 3, using as
input the cryo-EM–derived structure factors, TALOS+-derived
dihedral angle restraints, and the 674 ambiguous NMR distance
restraints but no hydrogen-bond restraints. In model 3, the en-
semble of the 10 lowest energy conformers of the ASC-PYD
filament featured a backbone rmsd of 0.17 Å and an overall
heavy atom rmsd of 0.63 Å (Fig. 2 F–I, Table S2, and Movies S1
and S2). Because all data, including the EM map, were treated
with strict symmetry enforcement, these values are equally repre-
sentative for the individual monomer subunits.
A comparison of model 3 with model 1 showed significant
improvements. The models differ by backbone and all heavy
atom rmsds of 0.84 Å and 1.04 Å, respectively. The comparison
of model 3 with model 2 showed only small differences overall
(backbone and all heavy atom rmsds of 0.27 Å and 0.33 Å, re-
spectively). Visual inspection showed that the improvement is
not uniform but that a number of side-chain orientations were
Fig. 2. Structure determination of the ASC-PYD filament by the combination of cryo-EM and solid-state NMR data. (A) Electron density map of the ASC-PYD filament
obtained by cryo-EM and image processing. Darker segments are the inner bulk volume of the density map. (B) Strips from a 3D 13C-correlation spectrum of a [U-13C]-
labeled ASC-PYD filament. The strips were taken at the 13Cα positions of residues Ile-50 and Leu-32, respectively. (C) Strips from a 2D [13C,13C]-DARR (Upper) and a CHHC
(Lower) spectrum. Pairwise 13C–13C contacts as identified by CANDID are shown using the one-letter amino acid code and residue number. (D) Secondary chemical shifts
of ASC-PYD in the filament from solid-state NMR experiments. The data identify six α-helices, as indicated above the panel with the starting and ending residue
numbers. (E) Flowchart of the ab initio structure determination of the ASC-PYD filament. The data contributions from solid-state NMR spectroscopy and cryo-EM are
indicated by yellow and green rectangles, respectively. The individual structural models 1–3 are shown in light blue. Software packages are identified in gray rectangles.
See SI Materials and Methods for details. (F) Cryo-EM density reconstruction superimposed with the single-subunit ASC-PYD structure. (G and H) Backbone superim-
position of the 20 lowest-energy conformers of the ASC-PYD filament (G) and a single monomer within the assembled filament (H). The conformational ensemble of 10
arbitrarily selected side chains is shown as stick models in orange. (I) Structural features of a single ASC-PYDmonomer as part of the filament. The spectrally ambiguous
distance constraints between Tyr60 and Leu68 (orange) and the neighboring residues (gray), obtained from solid-state NMR experiments are shown as orange lines.
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better defined in model 3 through the integration of the distance
restraints. Therefore, we conclude that the resolution of the EM
map was high enough so that, in combination with NMR-derived
secondary structure information, a high-resolution structure can
be obtained de novo, without the requirement of prior knowl-
edge of the protein monomer structure (model 2). Because this
procedure requires only NMR chemical-shift assignments for the
protein backbone, this approach is accessible for even larger pro-
teins with contemporary technology (35). Additionally, the fact that
CANDID interprets 91% of all observed cross-peaks using the
narrow tolerance of 0.2 ppm for 13C chemical shifts is an important
cross-validation of models 2 and 3. Finally, the Fourier shell cor-
relation (FSC) between the final structural model and the density
map showed a resolution of 4.3 Å (Fig. S2E).
Structure of the Mouse ASC-PYD Filament.Mouse ASC-PYD forms
a triple-stranded, right-handed helical filament in which each
PYD interacts with six adjacent subunits through three asym-
metric interfaces, types I–III (Fig. 3 A–F and Movies S3 and S4).
Interface type I is formed by amino acid residues belonging to
helices 1 and 4 on one subunit and helix 3 in the adjacent sub-
unit, defining helical PYD strands winding around the helix axis
(Fig. 3D). It involves interactions between residues of opposite
charges that contribute to the filament stabilization. The solvent-
exposed positively charged side chains of Lys22, Lys26, and
Lys21 from helix 2 and Arg41 from helix 3 are involved in
electrostatic interactions with the negatively charged side chain
of residues Glu13 and Asp6 from helix 1 and residues Asp48 and
Asp54 from helix 4 of the neighboring subunit. In addition, a
network of hydrophobic interactions is formed by Leu9, Met25,
Val30, and Ile50. The lateral contact of strands parallel to the
filament axis emerges from interface type II (Fig. 3E). Residues
in helices 4 and 5 and in the central part of the loop between
helixes 2 and 3 on one subunit interact with residues at the corner
of helices 5 and 6 of the next subunit by specific hydrophobic
interactions. The interactions of Tyr59 and Tyr60 from the loop
between helices 4 and 5 and Gly77 and Leu78 from the loop
between helices 5 and 6 of the neighboring subunit define the
contact surface between two helical layers. In addition, the
contribution of further charged and uncharged side chains sug-
gests a more heterogeneous interaction network. The type III
interface is formed by residues from the end of helix 1 and the
sequential short loop on one subunit with helix 3 on the adjacent
subunit, mediating the contact of a helical strand with an adja-
cent helical layer (Fig. 3F). It is defined by interactions involving
both polar and hydrophobic side chains. The charged residues
Glu13, Glu19, and Arg41 are located close to this interface but
do not form specific salt-bridge interactions.
The Monomer Structure Is Maintained in the Filament. Mouse ASC-
PYD is soluble at low pH conditions, leading to well-folded,
monomeric species as indicated by the signal dispersion and
narrow line widths of the 2D [15N,1H]-heteronuclear single-
quantum coherence (HSQC) spectrum (Fig. S4A). Analysis of
the backbone secondary chemical shifts confirmed the position
of the six α-helices at positions 3–14, 17–29, 41–46, 49–59, 62–76,
and 80–84 as the secondary structure elements of mouse ASC-
PYD in solution. Thus these helices are located at the same
positions in the dissolved monomer as in the filament form.
Furthermore, a comparison of backbone dihedral angles ϕ and ψ
as predicted by TALOS+ (36) from the backbone chemical shifts
confirms that all secondary structure elements are equally
retained in the solution and filament forms of mouse ASC-PYD,
thus explaining the absence of major structural rearrangements
upon filament formation. A direct comparison of the backbone
chemical shifts of the monomer form of ASC-PYD in solution
with the filament form reveals a largely identical conformation,
with chemical-shift differences mostly smaller than 0.6 ppm.
Notable exceptions can be found; these exceptions point directly
to residues located at the subunit interfaces, where slight
Fig. 3. 3D arrangement of the ASC-PYD filament. (A and B) Top (A) and side (B) views of the ASC-PYD filament in surface representation. The three helical oligomer
strands are colored blue, teal, and dark blue, and individual ASC-PYD subunits have alternating darker and lighter shades. (C) Four ASC-PYD monomers are shown in
surface representation as part of the filament using the color code in A and B. Three interaction interfaces I–III are indicated by dashed square rectangles. (D–F) Detailed
view of interaction interfaces I–III, respectively. Intermolecular atom-pair contacts observed as ambiguous peaks by solid-state NMR spectroscopy and identified by CANDID
are indicated by solid black lines. The residues defining interfaces I, II, and III are labeled and colored orange, yellow, and red, respectively. (G) Chemical-shift differences
between solution- and solid-state chemical shifts for the nucleus 15N, 13Cα, and 13Cβ. Chemical-shift variations larger than the mean value are marked with different color
codes on the secondary structure elements. Residues that belong to the type I, II, and III interfaces aremarked in orange, yellow, and red, respectively. (H) Structural location
of the residues with significant chemical-shift differences between the monomeric and filament forms, as identified and using the color code in G. (I) Structural details of
interface type I as indicated by the dashed square rectangle in H. Side chains involved in intersubunit salt bridges are shown as stick models and with their sequence labels.
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conformational changes are induced by the packing effects upon
filament formation (Fig. 3 G–I and Fig. S4B–E). Thus these
chemical-shift data independently confirm the three asymmetric
interfaces that are characteristic of the filament architecture.
Conservation of the ASC-PYD Filament Architecture. A comparison
of the mouse ASC-PYD filament structure with the human ASC-
PYD filament (PDB ID code 3J63) (16) shows that the spatial
assemblies and the structures of the monomer subunits are
highly similar (Fig. S5). The structures of monomeric subunits
of human and mouse ASC-PYD from the respective filament
structures overlay with a backbone rmsd of 1.1 Å. Also the 3D
arrangement of the subunits toward the filament structure shows
the same overall arrangement (helical parameters: 53° rotation,
14.2-Å rise for mouse versus 52.9° rotation, 13.9-Å rise for hu-
man). Although an agreement in the tertiary structure between
mouse and human ASC is expected, because they differ in only
20 of the 93 residues, the identity in the quaternary structure is
noteworthy. This finding suggests functional conservation of the
ASC polymerization mechanism as part of the innate immune
response system in mouse, human, and possibly other species.
Dynamics and Flexibility of the CARD. MAS solid-state NMR spectra
can be recorded with different polarization-transfer schemes. Ex-
periments based on cross-polarization (CP) techniques filter for
rigid parts of the assemblies, whereas INEPT-based experiments
monitor flexible parts of the molecular assemblies. Our initial CP-
based experiments of ASC-FL filaments have established that the
rigid parts of the filament are formed entirely by the PYD and that
the CARD is a flexible part of the filament arrangement (Fig. 1).
Consequently, INEPT-based experiments (37) were used to obtain
spectral information on the conformation and dynamics of this
domain. The 2D [15N,1H]-INEPT spectrum of mouse ASC-FL
filaments shows a set of ∼105 strong and multiple additional weak
backbone amide correlation cross-peaks, with chemical-shift values
in the random-coil region and the small dispersion typical of
flexible polypeptide chains (Fig. 4A). These signals must arise
from the 14-residue linker and/or the 89-residue CARD, because
a corresponding INEPT spectrum of mouse ASC-PYD filaments
did not contain any peaks. Furthermore, the narrow dispersion of
amide proton chemical shifts indicates that the linker and prob-
ably a major part of or all the CARD populates a conformational
ensemble of flexibly unfolded structures in fast equilibrium,
similar to a random-coil ensemble. Consistently, 2D INEPT-
based [1H,13C]-correlation spectra of the mouse ASC-FL fila-
ment also feature no significant chemical-shift dispersion, re-
sulting in the observation of few resonance correlations at the
random-coil chemical-shift position (Fig. 4B). In our prepara-
tions of the mouse ASC filament, the CARD thus is flexible
while attached to the well-folded, rigid filament core (Fig. 4C).
Robustness of the ASC Inflammasome Architecture. To test the physi-
ological effects of ASC mutations on inflammasome signaling and
to avoid overexpression artifacts, we reconstituted immortalized
mouse Asc−/− macrophages with endogenous levels of WT and
mutant versions of N-terminally mCherry-tagged ASC-FL. Based
on the mouse ASC-PYD structure and previously reported studies
(38), mutations K21A and K26A in interface I were selected (Fig. 5
and Fig. S6). As expected, the induction of cell death and IL-1β
secretion upon activation of the PYD-containing inflammasome
sensors NLRP3 and absent in melanoma 2 (AIM2) was abrogated
by each of these mutations. Consistent with the deficiency in sig-
naling, no ASC specks could be detected in macrophages expressing
these two single-amino acid mutants. Furthermore, the induction of
cell death upon stimulation of the receptors NLRC4, which is ASC
independent (39, 40), is not affected by the K21A and K26A mu-
tations (Fig. S6D). However, the mutations significantly reduced
IL-1β release and completely abolished ASC speck formation dur-
ing Salmonella infection (Fig. S6D). In line with previous reports
that show the importance of functional ASC for these aspects of
NLRC4 biology (40, 41). These data show that mutations in the
type I interface can prevent ASC speck formation and inflamma-
some signaling during activation of the three best-studied inflam-
masome receptors, NLRP3, AIM2, and NLRC4. The disruption of
filament formation upon mutation of lysine 21 or 26 to alanine
confirms the importance of the precise balance of charged residues
in interface I and suggests that the mechanism of filament assembly
proposed for the in vitro reconstruction is extendable to cell cul-
tures. This finding indicates that, independently of which ligand and
receptor induce inflammasome activation, the architecture of the
filaments in the ASC speck remains conserved.
Discussion
The integration of solid-state NMR data with a cryo-EM density
map used here toward a joint determination of structure is one of
Fig. 4. The CARD in the mouse ASC-FL filament is flexibly unfolded. (A) Solid-
state 2D [15N,1H]-HSQC spectrumof [U-13C,15N]-labeled ASC-FL. (B) Carbon-detected
refocused INEPT spectrum of [U-13C,15N]-labeled mouse ASC-FL. Random-coil
chemical-shift positions for the 20 common amino acids are reported as red dots.
(C) Model of the ASC-FL filament. Multiple ASC-PYDs (blue) provide the structural
scaffold for the filament formation; the ASC-CARDs (orange) remain flexible rel-
ative to the ordered filament core and probably exist in random-coil form.
\
Fig. 5. Effect of single point mutations on ASC-
dependent signaling. (A and B) Cell death as mea-
sured by lactate dehydrogenase (LDH) release (A) and
IL-1β secretion (B). (C) Overview images showing DNA
in blue and ASC in red in LPS-primed immortalized
mouse macrophages from the indicated genotypes:
wild-type (wt), Asc−/−, or Asc−/− expressing endoge-
nous levels of wild-type (wt) or ASC-mCherry K21A
and K26A. Macrophages were stimulated with 5 mM
ATP. (Scale bars, 10 μm.)
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very few recent examples of this emerging approach. The other
published example comprises structural studies of the type III se-
cretion needle, also a helical arrangement (20, 42). Importantly, the
two techniques provide complementary information, leading to an
overall comprehensive description extending beyond the power and
resolution of cryo-EM or solid-state NMR alone. The EM density
map in combination with the identification of helix location and the
use of individual dihedral backbone angle restraints from solid-state
NMR data allow unambiguous determination of the backbone
structure de novo. Thereby, the amount of information for solid-
state NMR experiments can be increased gradually from backbones
to side chains to intermonomer correlations by recording and ana-
lyzing additional experiments. This feature allows a convergence of
the structure-determination procedure, as demonstrated here in the
stepwise protocol from models 1–3. The measurement of NMR
distance restraints, considerably more laborious than the determi-
nation of backbone angles, was shown to be consistent with, but not
necessary for, backbone localization. It did lead to a significant, al-
beit relatively minor, improvement of side-chain conformations.
The mouse ASC filament is a helical arrangement of individ-
ual PYDs mediated by electrostatic and hydrophobic inter-
molecular contacts along specific interfaces. The comparison
with the previously established human ASC-PYD filament (16)
shows that the molecular architecture is strongly conserved be-
tween the two species. The filament architecture thus is encoded
in the amino acid sequence of ASC and determines the correct
quaternary assembly upon inflammatory stimulation. This ob-
servation suggests that the molecular mechanism of the ASC-
dependent innate immune response is conserved and follows
the same biophysical principles in both species, implicating a
biological role for the filament structure. Thereby, the helical
arrangement and the interfaces I–III are in full agreement with
other reported helical arrangements of death domains (17, 43).
The CARD in ASC-FL filaments was found to be dynamic and at
least partially unfolded in our experimental conditions. Low
thermodynamic stability of a CARD has been reported before
[e.g., in the procaspase-1 CARD (44)], and a population shift
toward unfolded conformations upon filament formation might
constitute a general functional element of ASC. For example,
the dynamic nature of ASC-CARD could be required for the
interaction with downstream caspase-1, or it may reduce the
amount of CARD–CARD-mediated filament branching and
thus control the protein density in the 3D ASC speck in vivo. The
structure of mouse ASC filament provides an ideal basis for
structure-based mutagenesis, as demonstrated with our single point
mutation experiments in cultured macrophages. This approach
allows experiments at native expression levels of ASC, avoiding
artifactual induction of ASC filament formation.
Materials and Methods
Experimental details of sample preparation, cryo-electron microscopy, NMR
spectroscopy and the cell culture experiments are given in SI Materials
and Methods.
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SI Materials and Methods
Cloning, Expression, and Purification of ASC-FL and ASC-PYD. cDNA
coding for the mouse ASC-FL protein (residues 1–193) and for
the PYD (residues 1–91) were cloned with a C-terminal six-
histidine tag into a pET28a vector under the control of a T7
promoter. A GSGSLE linker was introduced at the C terminus
to minimize the His-tag effect on protein structures. Both pro-
tein constructs were transformed in BL21(DE3) Escherichia coli
strains, and the proteins were expressed by growing the cultures at
37 °C to an OD600 of 0.8 and by induction with 1 mM isopropyl
β-D-1-thiogalactopyranoside for 4 h. ASC-FL and ASC-PYD
[U-15N]- and [U-15N,13C]-labeled, were produced using 13C-glucose
and 15NH4Cl as the sole carbon and nitrogen sources. The cells
were harvested by centrifugation, and the pellet was resuspended in
50 mM phosphate buffer (pH 7.5), 300 mMNaCl, 0.1 mM protease
inhibitor.
The resuspended cells were incubated for 1 h at room tem-
perature with DNase I and then were sonicated on ice and
centrifuged at 20,000 × g at 4 °C for 30 min. The inclusion body
pellet was resuspended in 50 mM phosphate buffer (pH 7.5),
300 mM NaCl, 6 M guanidinium hydrochloride and was centri-
fuged at 20,000 × g at 4 °C for 30 min. The supernatant was
incubated for 2 h at room temperature with preequilibrated
Ni-NTA affinity resin (Thermo Scientific) and then was passed
through a column for gravity flow purification. The column was
washed with 20 column volumes of resuspension buffer con-
taining 20 mM imidazole, and the fusion protein was eluted with
three column volumes of the same buffer with 500 mM imidaz-
ole. To avoid aggregation, all the purification steps were carried
out at 4 °C, and 2 mM DTT was added to all buffers used for the
ASC-FL purification. An additional purification step was used to
obtain the monomeric soluble form of ASC-PYD. ASC precip-
itates at physiological pH conditions; thus the pH of the elution
fraction from the Ni column was decreased to 3.8 and dialyzed
against 50 mM glycine buffer (pH 3.8), 150 mM NaCl. The
protein was purified further on a preequilibrated Superdex 75 gel
filtration column (GE Healthcare) and was used immediately or
frozen in small aliquots in liquid N2.
ASC-FL and ASC-PYD Filament Formation in Vitro. Two protocols for
ASC-FL and ASC-PYD filament formation based on a pH or
dialysis step were used, leading to identical filament structures as
determined by negative-stain EM and solid-state NMR spec-
troscopy. For the method based on the pH step, the elution
fraction from the Ni column was concentrated to half of the
volume (∼5 mL) using Vivaspin and then was diluted with 150 mM
acetic acid (pH 2.5) in a 1:9 ratio (vol/vol). The neutral pH
condition was achieved by the addition of 3 M Tris buffer (pH 8)
in a 1:5 ratio (vol/vol). The solution was incubated overnight at
room temperature with continuous stirring to facilitate filament
formation. The solution was centrifuged at 20,000 × g at 4 °C for
30 min, yielding a gel-like pellet of ASC filaments that was re-
suspended in water and then was transferred into the rotor by
centrifugation or stored at 4 °C. For the dialysis-based filament
formation method, the elution fraction of NiNTA purification was
dialyzed overnight against 25 mM phosphate buffer (pH 7.5),
100 mM NaCl. The ASC filaments were centrifuged, washed, and
stored as described above.
Solution NMR Spectroscopy.NMR samples were prepared at 0.3 mM
[U-15N,13C]-labeled ASC-PYD in 20 mM glycine buffer (pH 3.7),
150 mM NaCl, 0.1 mM NaN3, 5% D2O/H2O. Under these
conditions the ASC-PYD remains soluble and monomeric ac-
cording to NMR line-width values. NMR experiments were ac-
quired at 298 K in Bruker 600, 700, and 800 MHz spectrometers
equipped with room-temperature and cryogenic triple-resonance
probes. Sequence-specific backbone chemical-shift assign-
ments were obtained from the experiments [15N-1H]-HSQC, 3D
HNCACB, and 3D C(CO)NH-TOCSY. All NMR data were
processed using the software PROSA (45) and analyzed with
CARA.
Solid-State NMR Spectroscopy. Protein filaments were packed into
3.2-mm ZrO2 rotors (Bruker Biospin) using ultracentrifugation
and a custom-made filling device in a SW41-T1 swing-out rotor
spinning at 25,000 rpm for 12 h in an Optima L90-K ultracen-
trifuge (Beckmann). The spectra used for the assignment and for
the distance restraints were recorded on a Bruker Advance II+
spectrometer operating at 850 MHz 1H Larmor frequency with a
sample temperature of 288 K. For the backbone assignment, a
standard set of experiments, NCOCA, NCACO, NCACB, and
CANCO, were recorded at 17 kHz MAS frequency. A second
set of experiments, N(CO)CACB, and CAN(CO)CA, was used
to complete the assignment in regions of spectral overlap.
The side-chain assignment was achieved using 3D CCC and
N(CA)CBCX and 2D DARR experiments. The spectra were pro-
cessed with Topspin (Bruker Biospin), using a shifted cosine square
as apodization function and were analyzed with CCPN. Long-range
spin contacts were obtained from 2D DARR, CHHC, and PAR
experiments, recorded at 15 kHz MAS to avoid overlap with the
sideband in the region of the aromatic carbons. See ref. 29 for fur-
ther details of the assignment procedure.
Cryo-EMMicroscopy and Image Reconstruction.ASC-PYD filaments
polymerized by dilution with buffer solution were applied to glow-
discharged thin carbon film-coated copper EM grids. The grids
were blotted for 1 s and vitrified by being plunged into liquid
nitrogen-cooled liquid ethane, using an FEI Vitrobot MK4. Grids
containing ASC-PYD filaments were imaged using an FEI Titan
Krios electron microscope operated at an acceleration voltage of
300 keV. Images were recorded using a 4k × 4k K2 Summit direct
electron detector with a back thinned CMOS chip, operated in
electron-counting mode. Images were recorded in movie-mode
format and were automatically drift corrected and averaged us-
ing a 2dx_automator (25), employing MOTIONCORR (26). In
total, 150 images were recorded by operating the microscope in
low-dose mode at a nominal magnification of 22,500× with a
cumulated dose below ∼20 e−/Å2 distributed over 30 frames re-
corded over 5 s. The effective pixel size of the images was 1.34 Å
on the sample level.
The defocus was determined using CTFFIND3, and the con-
trast transfer function (CTF) of the microscope was corrected by
multiplying the images with the theoretical CTF (a Wiener filter
in the limit of a low signal-to-noise ratio). Long filament sections
were cut from the images using the e2helixboxer routine within
EMAN2. The SPIDER software package was used for most of the
image processing and for the calculation of the FSC plot. Then a
total of 21,138 overlapping 320-pixel-long boxes, with 1.34 Å per
pixel, were cut from the long filament boxes, using a shift of 16
pixels (95% overlap). These segments initially were decimated by
a factor of three (to 4.02 Å per pixel) and were centered. Sub-
sequent processing involved the IHRSR algorithm (27) im-
plemented within SPIDER, with the imposition of a C3 rotational
symmetry about the helical axis. A negative B-factor of 150 was
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used. The defocus range was –1.0 microns to –3.5 microns. The
final reconstruction was corrected for the CTF (which had been
imposed twice, once by the microscope and once during image
processing) by dividing by the sum of the CTFs squared. A re-
construction was tried using a 384-pixel box length but suffered
from worse resolution, reflecting the limited long-range order in
these filaments.
Procedure for Structure Calculation. In the first step of calculation, a
single ASC-PYD subunit was constructed de novo using the
program Coot (31). Thereby, the ASC-PYD polypeptide chain
was placed into the cryo-EM density, and helical regions were
defined interactively according to secondary chemical shifts from
the solid-state NMR assignments. Well-defined side-chain elec-
tron densities for residues F23, R38, Y59, Y60, and Y64 facili-
tated the correct positioning of the polypeptide chain into the
density map. The structure of the single monomer then was
translated into all symmetrically identical positions of the electron
density map. The resulting model was refined locally to match
the electron density map. The model then was refined using
X-PLOR-NIH under continuous symmetry enforcement, using as
constraints the cryo-EM density map, TALOS+-determined di-
hedral angle constraints, and hydrogen-bond constraints (32, 36).
These i,i+4 backbone hydrogen-bond constraints for residues
4–10, 17–24, 41–42, 49–55, 62–71, and 79–90 were based on the
secondary structure prediction from solid-state NMR chemical
shifts by TALOS+. Only constraints for residues with good
TALOS+ prediction quality were kept. For use in X-PLOR-NIH,
the cryo-EM map was placed into an artificial crystal lattice
environment and transformed to reciprocal space representation
to calculate structure factors. The amplitudes and phases of the
structure factors were used as experimental diffraction data for
model refinement by crystallographic conjugate gradient mini-
mization, B-factor optimization, and simulated annealing re-
finement. This conversion from the real-space cryo-EM map
to reciprocal-space structure factors, fully preserving the in-
formation content of the data, is necessary for the simultaneous
refinement with NMR data. The X-PLOR-NIH structure cal-
culation protocol was repeated 100 times, and the 20 structures
with the lowest energy were selected. The resulting structural
ensemble was used as input for the automatic assignment of the
solid-state 2D [13C,13C]-CHHC and [13C,13C]-PAR spectra. The
spectra were automatically peak-picked, and the peak lists were
interpreted using the CANDID algorithm in the structure cal-
culation program CYANA (34). Chemical-shift tolerances for
CANDID were set at 0.2 ppm for 13C, and only the last cycle
(cycle 7) of the CYANA automatic protocol was applied. The
peak lists were converted to upper limit distance restraints as-
suming a uniform distance limit of 7 Å for every peak. A final
round of X-PLOR-NIH structure calculation was performed
under symmetry enforcement with the cryo-EM–derived struc-
ture factors, the dihedral angle restraints from TALOS+, but not
the H-bond restraints, and the distance restraints from CANDID.
The Rwork/Rfree ratio was obtained from a randomly selected
95%/5% work/free dataset. The 10 lowest-energy structures from
were selected from a total of 100 structures and were subjected to
local real-space refinement against the cryo-EM map. The N- and
C-terminal residues M1 and E91 were removed because of the
absence of any experimental data for these residues.
Cell Culture Experiments. WT and Asc−/− immortalized murine
bone marrow-derived macrophages (40) were cultured in
DMEM (Sigma) supplemented with 10% 3T3 macrophage-col-
ony stimulating factor (M-CSF) supernatant and 10% FCS (Bio-
Concept). Genes encoding mCherry and murine Asc were cloned
into a replication-defective mouse stem cell retroviral construct
(pMSCV2.2). Site-directed mutagenesis was performed with
QuikChange (Stratagene). Retroviral transduction of immortal-
ized bone marrow-derived macrophages (iBMDMs) with ASC-
mCherry and the K21A and K26A mutations was done as pre-
viously described (40), and monoclonal cell lines were generated by
limiting dilution. ASC protein levels were estimated by Western
blot using anti-ASC (Genentech) and anti–β-actin (Sigma) anti-
bodies, and clones expressing levels of ASC comparable to the
levels in WT cells were selected. iBMDMs were prestimulated for
4 h with 100 ng/mL LPS O55:B5 (Invivogen). NLRP3 was triggered
by 5 mMATP (Sigma) for 90 min, AIM2 by transfection of 1 μg/mL
poly(deoxyadenylic-deoxythymidylic) acid [poly(dA:dT)] (Invi-
vogen) in OptiMEM (Gibco) using Lipofectamine 2000 (In-
vitrogen) for 2.5 h, and NLRC4 by infection with log-phase
Salmonella enterica serovar Typhimurium SL1344 WT at a
multiplication of infection (MOI) of 10 for 60 min. Cell death
was measured by LDH release (Clontech LDH Cytotoxicity
Detection Kit) and IL-1β by ELISA (eBioscience).
Confocal Microscopy. To assess the formation of ASC-mCherry
specks, the cells were seeded on glass coverslips, and inflamma-
some activation was triggered as described above. To prevent cell
death and subsequent detachment from the coverslips, the cells
were treated with 25 μM Z-Val-Ala-DL-Asp-fluoromethylketone
(ZVAD; Bachem) to inhibit caspase activation at the time of in-
flammasome activation. iBMDMs were fixed with 4% para-
formaldehyde, mounted with VECTASHIELD containing DAPI,
and imaged using a Leica Point Scanning Confocal “SP8” with
either an HC PL APO CS 40× objective for speck quantification
or an HC PL APO CS2 63× objective for overview images. Images
were acquired using the Leica LAS AF software (version 3) and
analyzed using Fiji. For speck quantifications, Z-stacks of five
arbitrarily chosen regions per condition and replicate were ac-
quired, and the number of cells with specks was determined
manually.
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Fig. S1. Backbone correlation spectra of ASC-PYD and ASC-FL filaments are highly similar. Solid-state 2D NCA correlation spectra of filaments of ASC-PYD
(blue) and ASC-FL (black), recorded under MAS conditions. Sequence-specific assignments are shown for signals in the less crowded regions of the spectra.
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Fig. S2. Cryo-EM with the ASC-PYD filament. (A) Filaments of the ASC-PYD obtained by dilution of denatured protein with phosphate buffer are well-ordered
and separated. (Scale bar, 100 nm.) (B) Cryo-EM image of ASC-PYD filaments. (Scale bar, 50 nm.) (C) Layer-line analysis of average power spectra of ASC-PYD
filaments, showing the axial rise per subunit of 14.2 Å (n = 0 layer line). Because of the well-ordered nature of the filaments, there is no variable twist feature.
(D) Statistics of filament segments divided into separate bins according to out-of-plane tilts of −12° to +12°. (E) FSC between the NMR-refined model and the
cryo-EM map. FSCs of 0.2 and 0.5 are reached to resolutions of 3.7 Å (red line) and 4.3 Å (blue line), respectively.
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Fig. S3. Distance restraints from solid-state NMR experiments. (A) Structure of an ASC-PYD monomer from the filament. All unambiguous distance restraints
from 2D solid-state NMR experiments (Table S1) are indicated by red dashed lines. (B) Aliphatic region of a 2D [13C,13C]-PAR spectrum acquired on a [U-13C]-
labeled ASC-PYD filament. The spectra were recorded on an 850-MHz spectrometer at 15 kHz MAS conditions. Red crosses show site-specific cross-peak as-
signments determined using the CANDID algorithm.
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Fig. S4. Solution NMR spectroscopy of monomeric ASC-PYD and its comparison with the filament form. (A) 2D [15N, 1H]-HSQC spectrum of monomeric [U-15N]-labeled ASC-PYD recorded
in 50 mM glycine buffer and 150 mM NaCl (pH 3.7) at 25 °C. Sequence-specific resonance assignments obtained from 3D triple-resonance solution NMR experiments are shown using the
one-letter amino acid code and residue number. Correlations of NH2 moieties of Gln and Asn side chains are connected by solid lines. Cross-peaks that belong to the C-terminal tag are
labeled in gray. (B) Secondary chemical shifts of monomeric ASC-PYD in solution. (C) Comparison of isotropic chemical shift of monomeric ASC-PYD in solution versus the oligomerized
solid-state form computed as the absolute values of the differences (solid − solution). The mean values for 13Cα (0.56 ppm), 13Cβ (0.68 ppm), and 15N (1.18 ppm) are indicated by red
dashed lines. (D) Comparison of backbone dihedral angles predicted by TALOS+ for monomeric ASC-PYD in solution (black dots) versus ASC-PYD filament (orange dots). Data are shown
for all statistically significant predictions. Error bars for solid-state values are based on the 10 best database matches. (E) Structure of the ASC-PYD monomer as part of the filament. All
residues with a combined chemical-shift difference for 15N, 13Cα, and 13Cβ larger than the average value (Fig. 4C) are shown in red. All other residues are shown gray.
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Fig. S5. Structural comparison of mouse and human ASC filaments. (Left) Superimposition of ASC-PYD units within the assembled filament of mouse (blue)
and human (green) (PDB ID code 3J63) (16) ASC. (Right) Overlay of the full filament structure.
Fig. S6. Effect of single point mutations on ASC-dependent signaling. (A) Overview images showing LPS-primed immortalized mouse macrophages from the
indicated genotypes stimulated with 5 mM ATP to activate NLRP3. (Scale bars, 10 μm.) (B) Quantification of A. (C) Cell death as measured by LDH release, IL-1β
secretion, and quantification of ASC speck formation of LPS-primed immortalizedmacrophages of the indicated genotypes transfected with 1 μg/mL poly(dA:dT) to
activate AIM2. (D) As in C, but macrophages were infected with MOI of 10 S. enterica Typhimurium SL1344 (MOI of 10) to activate NLRC4.
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Table S1. Spectrally unambiguous distance restraints from 2D solid-state NMR experiments
and their distance in model 2
Experiment Nucleus 1 Nucleus 2 Distance restraint r, Å*
Intramolecular distance d
in model 2, Å
CHHC 23 Phe Cβ 76 Met Ce 7.0 4.1
69 Thr Cβ 8 Ile Cδ1 7.0 5.6
19 Glu Cγ 76 Met Ce 7.0 6.7
23 Phe Cα 76 Met Ce 7.0 4.5
PAR 23 Phe Cβ 76 Met Ce 7.0 4.1
19 Glu Cγ 76 Met Ce 7.0 6.7
23 Phe Cα 72 Val Cγ1 7.0 5.2
23 Phe Cα 76 Met Ce 7.0 4.5
8 Ile Cδ1 53 Thr Cβ 7.0 6.8
8 Ile Cγ2 53 Thr Cα 7.0 5.7
23 Phe Cζ 69 Thr Cγ2 7.0 5.2
23 Phe Ce 72 Val Cγ1 7.0 3.4
8 Ile Cδ1 69 Thr Cγ2 7.0 6.0
*All these distance restraints are fulfilled intramolecularly by model 2, because d < r. Note that the restraints are
spectrally unambiguous (only one assignment possibility in each dimension) but are not necessarily unambigu-
ous with respect to their intra-/intermolecularity.
Table S2. Structural statistics for the mouse ASC PYD filament
NMR distance and dihedral constraints
Distance constraints*
Total 674
Intraresidue 19
Interresidue 655
Sequential, ji – jj = 1 89
Medium range, ji – jj < 4 209
Long-range, ji – jj > 5 179
Intermolecular 65
Hydrogen bonds 0
Total dihedral angle restraints 140
ϕ 70
ψ 70
Cryo-EM
Resolution, Å 3.7
No. reflections 50,317 (work: 48,264;
test: 2,572)
Rwork/Rfree 0.32/0.33
Structure statistics
Violations (mean and SD)
Distance constraints, Å 0
Dihedral angle constraints, ° 2 (0)
Max. dihedral angle violation, ° 10.5 (0.3)
Max. distance constraint violation, Å 0.0
Deviations from idealized geometry
Bond lengths, Å 0.0028
Bond angles, ° 0.51
Impropers, ° 0.46
Ramachandran analysis
Most favored regions, % 99.0
Disallowed regions, % 0.0
Average pairwise rmsd†, Å
Heavy 0.48
Backbone 0.14
*Obtained from 2D [13C,13C]-CHHC and 2D [13C,13C]-PAR, interpreted by
CANDID.
†Pairwise rmsd was calculated among 10 refined structures.
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Movie S1. Electron density and structure of the mouse ASC-PYD filament. Top and side views of the filament are shown. The electron density from cryo-EM is
shown at the 3σ level as a shaded gray surface. Structural models 1, 2, and 3 are shown in backbone representation (beige, green, and blue, respectively).
Movie S1
Movie S2. Electron density and structure of the mouse ASC-PYD filament. Density and structural models for a single ASC-PYD monomer are shown in the
same representation as in Movie S1. Residues E34, Q31, Q79 and Y59 are shown in side-chain representation (in order of appearance). Note the improved
fitting of model 3 (blue) to the electron density compared with model 1 (beige).
Movie S2
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Movie S3. Structure of the mouse ASC-PYD filament. Top and side views of a rotating 15-subunit segment of the ASC-PYD filament are shown in surface
representation. The three helical oligomer strands are colored blue, teal, and dark blue, and individual ASC-PYD units within each strand are reported with
alternating darker and lighter shades.
Movie S3
Movie S4. Structure of the mouse ASC-PYD filament. Structural details of interfaces I (orange), II (yellow), and III (red), including side-chain positions,
are shown.
Movie S4
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ASC ﬁlament formation serves as a signal
ampliﬁcation mechanism for inﬂammasomes
Mathias S. Dick1, Lorenzo Sborgi2, Sebastian Ru¨hl1, Sebastian Hiller2 & Petr Broz1
A hallmark of inﬂammasome activation is the ASC speck, a micrometre-sized structure
formed by the inﬂammasome adaptor protein ASC (apoptosis-associated speck-like protein
containing a CARD), which consists of a pyrin domain (PYD) and a caspase recruitment
domain (CARD). Here we show that assembly of the ASC speck involves oligomerization of
ASCPYD into ﬁlaments and cross-linking of these ﬁlaments by ASCCARD. ASC mutants with a
non-functional CARD only assemble ﬁlaments but not specks, and moreover disrupt
endogenous specks in primary macrophages. Systematic site-directed mutagenesis of
ASCPYD is used to identify oligomerization-deﬁcient ASC mutants and demonstrate that ASC
speck formation is required for efﬁcient processing of IL-1b, but dispensable for gasdermin-D
cleavage and pyroptosis induction. Our results suggest that the oligomerization of ASC
creates a multitude of potential caspase-1 activation sites, thus serving as a signal ampliﬁ-
cation mechanism for inﬂammasome-mediated cytokine production.
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D
etection of pathogens by the innate immune system relies
on germline-encoded pattern recognition receptors
(PRRs), which recognize a variety of pathogen-derived
molecules, known as pathogen-associated molecular patterns
(PAMPs), and host-derived danger signals, known as danger-
associated molecular patterns1. Although most PRRs initiate
transcriptional responses, such as the expression of cytokines2,3, a
subset of cytosolic PRRs promote the assembly of inﬂammasome
complexes and subsequent activation of the cysteine protease
caspase-1 (refs 4,5). To date, only members of the NOD-like
receptor (NLR) family, the PYHIN protein family and PYRIN
were shown to assemble inﬂammasomes in response to different
cytosolic PAMPs or danger-associated molecular patterns5,6.
A unifying feature of all these receptors is either a pyrin domain
(PYD) or a caspase recruitment domain (CARD), both of which
belong to the death-fold domain superfamily. On the basis of the
presence of these domains, the receptors can be classiﬁed as PYD-
containing receptors (NLRP3: NLR family, PYD containing 3;
AIM2: absent in myeloma 2; pyrin) or CARD-containing
receptors (NLRC4: NLR family, CARD containing 4; NLRP1:
NLR family, PYD containing 1). After receptor activation and
oligomerization, these domains recruit the adaptor protein ASC
(apoptosis-associated speck-like protein containing a CARD) and
pro-caspase-1 into the complex through homotypic domain–
domain interactions. Within the inﬂammasome, pro-caspase-1 is
activated by dimerization and auto-proteolysis, and the
proteolytically active hetero-tetramer is released7. Several
substrates of caspase-1 have been identiﬁed, among them
the pro-forms of the cytokines interleukin (IL)-1b and IL-18
(refs 7–9). Another consequence of inﬂammasome activation is
the induction of a pro-inﬂammatory cell death called
pyroptosis10. Pyroptosis is driven by the amino-terminal
cleavage fragment of gasdermin-D, a protein cleaved by
caspase-1, and results in the lysis of the host cell and
subsequent release of cytoplasmic content, among them
processed IL-1b and IL-18 (refs 11,12).
Recent studies have started to elucidate the role of the
inﬂammasome adaptor protein ASC13–15, a bipartite protein
composed of a PYD and a CARD, also known as PYCARD16,17.
ASC has previously been regarded as a simple adaptor protein
that links PYD-containing receptors to the CARD-containing
caspase-1, via homotypic PYD–PYD and CARD–CARD
interactions18. However, its role appears to be more complex,
as on receptor activation ASC also forms the so-called ASC speck,
a macromolecular form of the inﬂammasome with a diameter of
B1–2 mm19,20. Formation of the ASC speck is independent of
caspase-1 activity, but requires the oligomerization of ASC into
large insoluble aggregates20,21. These ASC aggregates are stable
and have even been shown to be released into the extracellular
space, after pyroptosis induction, where they can trigger
prolonged inﬂammasome activation in phagocytic cells22,23.
Analyses of stimulated emission depletion microscopy images
and electron micrographs suggest an irregular, ﬁlamentous
shape22,23. Consistently, we and others have shown that ASC
oligomerizes into long helical ﬁlaments via its PYD13–15. Despite
the advances regarding the atomic structure of the ASC ﬁlament,
whether the ASC speck is the functional unit of the
inﬂammasome is unclear. Several inﬂammasome receptors (for
example, NLRC4 and mouse Nlrp1b) contain a CARD instead of
a PYD and are able to recruit caspase-1 even in the absence of
ASC. Indeed, we and others have shown that ASC is not required
for cell death induction by these receptors24–28. Nonetheless,
activation of CARD-containing receptors results in ASC speck
formation in wild-type (WT) cells, but how their CARD initiates
ASC ﬁlaments is unknown. Furthermore, it is unclear whether
ASC oligomerization itself is required for inﬂammasome
signalling. Previous mutagenesis studies of ASC could not
address the role of ASC oligomerization in signalling, as they
were based on overexpression of ASC mutants in HEK293 cells,
which is prone to artefact generation and lacks the means to study
the effects on downstream signalling13,29,30.
Here we use retroviral expression of ASC mutants in
Asc-deﬁcient immortalized mouse macrophages, to address the
mechanism of ASC speck formation and the functional relevance
of ASC ﬁlament formation for inﬂammasome signalling.
Our results reveal an architectural role for the ASCCARD, showing
that it is required to link individual ASC ﬁlaments towards
forming the dense ASC speck. Furthermore, we show that ASC
bridging molecules are necessary to allow CARD-containing
receptors the initiation of ASC ﬁlament formation. Finally, we use
site-directed mutagenesis of the ASCPYD–ASCPYD interaction
interfaces to identify mutations that disrupt ASC ﬁlament
formation without affecting the interaction to receptor PYDs.
Surprisingly, such ASC mutants are still able to initiate caspase-1-
dependent gasdermin-D maturation and subsequent cell death,
but lack the ability to form ﬁlaments, to assemble ASC specks and
to process IL-1b, thus uncoupling the two major downstream
signalling pathways. In conclusion, our data show that the ASC
speck has a function in inﬂammasome signalling and support a
model in which the rapid oligomerization of ASC via its PYD
creates a multitude of potential caspase-1 activation sites, thus
serving as a signal ampliﬁcation mechanism for inﬂammasome
signalling.
Results
Distinct roles for the ASCPYD and ASCCARD in speck assembly.
Although ASC is the main structural component of the ASC
speck20,24, conﬂicting reports have implicated either the ASCPYD
or the ASCCARD in speck assembly13,31,32. To address the role of
the ASCPYD and the ASCCARD in speck formation and
downstream signalling, we transduced immortalized Asc /
murine bone marrow-derived macrophages (BMDMs) with
ﬂuorescently tagged full-length ASC (ASCFL) or ASCPYD and
ASCCARD alone (Fig. 1a). As overexpression of ASCFL can result
in aggregation even in the absence of activated receptor19, we
selected individual clonal lines that did not display any
autoactivation when unstimulated (Supplementary Fig. 1a).
To test the functionality of these constructs, cells were primed
with lipopolysaccharide (LPS) and transfected with the synthetic
DNA analogue poly(deoxyadenylic-deoxythymidylic) acid
(poly(dA:dT)), an activator of AIM2 (refs 33,34). mCherry-
tagged ASCFL, expressed in Asc / cells, promoted pyroptosis
(as measured by the release of lactate dehydrogenase (LDH)) and
IL-1b release (measured by enzyme-linked immunosorbent assay
(ELISA)), to levels seen in immortalized WT macrophage
controls (Fig. 1b). We also observed comparable levels of IL-
1b/-18 and caspase-1 processing and release by western blotting
(Supplementary Fig. 1b). In contrast, neither the ASCPYD nor
ASCCARD restored cell death, IL-1b/-18 secretion or caspase-1
cleavage on AIM2 activation (Fig. 1b and Supplementary Fig. 1b).
Similarly, expression of the individual domains did not restore
inﬂammasome signalling in response to extracellular ATP,
an NLRP3 activator35 (Supplementary Fig. 1c,d).
Heterologous expression of ASCPYD and ASCCARD or CARDs
of mitochondrial antiviral-signalling protein (MAVS), retinoic
acid-inducible gene 1 (RIG-I) and pro-caspase-1 results in the
formation of ﬁlaments of varying length in different cell types and
in vitro13,36–40. However, it is possible that such ASCPYD or
ASCCARD ﬁlaments are overexpression artefacts, as ASCFL
normally forms a distinct dense speck structure20. To assess the
ability of ASCPYD and ASCCARD to form macromolecular
assemblies, we examined the above described cell lines by
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microscopy, following inﬂammasome stimulation. As expected,
activation of AIM2 or NLRP3 induced the formation of
perinuclear specks in cells expressing mCherry-tagged ASCFL
(Fig. 1c and Supplementary Fig. 1e,f). In line with the reported
ability of ASC to form ﬁlaments13,15, specks formed by ASCFL
had a dense core with emanating ﬁlaments (Fig. 1c). Instead of
forming similarly dense specks, the ASCPYD assembled into
ﬁlaments on the engagement of NLRP3 or AIM2 (Fig. 1c). Of
note, ﬁlaments formed after NLRP3 or AIM2 activation differed
in their appearance, possibly due to distinct modes of how NLR
and PYHIN family members assemble complexes and initiate
ASC ﬁlaments13,41. Remarkably, these ﬁlaments had varying
lengths and widths, with some appearing clearly thicker than
90Å, the reported diameter of an ASCPYD ﬁlament13,15. Unlike
reported before, we observed that the ASCCARD was not able to
form macromolecular assemblies (Fig. 1c and Supplementary
Fig. 1e,f). Taken together, these data suggest that although
both domains of ASC are necessary for signalling, only the
ASCPYD forms ﬁlaments on inﬂammasome activation. This is
consistent with reports by us and others showing that full-length
ASC forms helical ﬁlaments in vitro via the ASCPYD (refs 13,15),
whereas the ASCCARD is exposed on the surface and not involved
in ASC ﬁlament formation15. As straight ﬁlaments are formed by
ASCPYD and compact specks are formed by ASCFL, our data also
suggest that the ASCCARD must contribute signiﬁcantly to the
macroscopic structure of the ASC speck.
ASCCARDs condense ASCPYD ﬁlaments into ASC specks. To
test whether ASCCARD is required to form ASC specks, we gen-
erated immortalized Asc / macrophage lines expressing
ASCD130R or ASCD134R (Fig. 2a and Supplementary Fig. 2a), two
mutations in surface-exposed residues of the ASCCARD that
abrogate interaction of the ASCCARD with the pro-caspase-1CARD
(ref. 31). As expected, Asc / macrophages expressing
ASCD130R or ASCD134R did not activate caspase-1, release
mature IL-1b or undergo pyroptosis in response to DNA
transfection or ATP treatment (Fig. 2b and Supplementary
Fig. 2b–d). ASCD130R and ASCD134R formed long ﬁlaments rather
than dense ASC specks in response to AIM2
and NLRP3 activation (Fig. 2c,d and Supplementary Fig. 2e,f),
similar to the ASCPYD alone, thus supporting our hypothesis
that a functional ASCCARD is required to assemble ASCPYD
ﬁlaments into a speck. To conﬁrm that these mutations not
only disrupt ASCCARD–pro-caspase-1CARD interactions but also
ASCCARD–ASCCARD interactions, we expressed enhanced green
ﬂuorescent protein (eGFP)-tagged ASCCARD in the presence of
reconstituted inﬂammasomes, formed by co-transfection of AIM2
with mCherry-tagged ASCFL, ASCPYD, ASCD130R or ASCD134R in
HEK293T cells. Co-localization and co-immunoprecipitation
assays demonstrated that GFP-ASCCARD was only able to interact
with WT ASC and not with ASCD130R or ASCD134R, conﬁrming
that the two mutations blocked ASCCARD–ASCCARD interaction
(Supplementary Fig. 2g,h).
If the ASCCARD organizes ASC ﬁlaments into dense specks,
we speculated that increasing levels of ASCCARD mutants would
disrupt specks formed by WT ASC, resulting in larger but less
dense ASC specks. Therefore, we retrovirally transduced various
ratios of mCherry-tagged WT and mCherry-tagged ASCD130R
into primary WT C57BL/6 macrophages (containing endogenous
ASC) and measured median speck size on the activation of AIM2
by poly(dA:dT) transfection or NLRP3 by Nigericin, a pore-
forming toxin35. Indeed, increasing levels of ASCD130R resulted in
a signiﬁcant increase in ASC speck size (Fig. 2e,f). As expected,
microscopy analysis of these large ASC specks showed that they
were also less dense and had a ﬁlamentous nature (Fig. 2g). Taken
together, these results support a model in which the ASC speck
observed in WT cells is composed of individual ASC ﬁlaments
that are formed via their PYDs and cross-linked to each other via
their CARDs (Supplementary Fig. 3a).
NLRC4 oligomerizes ASC via a bridging ASC molecule. Most
inﬂammasome-forming receptors contain a PYD and initiate
ASC ﬁlaments directly by homotypic PYD–PYD interactions.
Notable exceptions are NLRC4 and mouse Nlrp1b, which contain
a CARD and thus might recruit and activate caspase-1
directly42,43. Nevertheless, ASC promotes caspase-1 processing
and efﬁcient IL-1b/-18 release after NLRC4 and Nlrp1b
activation26,44. ASC specks can be observed after NLRC4
activation, but how CARD-containing receptors initiate
oligomerization of ASC is unknown. Theoretically, NLRC4
could initiate ASC oligomerization either by (i) NLRC4CARD–
ASCCARD interaction and ASCCARD oligomerization, (ii) hetero-
typic interaction between related death-fold domains, that is,
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Figure 1 | Both domains of ASC are required for signalling. (a) Schematic
representation of the domain organization of ﬂuorophore-tagged (mCherry
or enhanced GFP (eGFP)) WT ASC (ASCFL), ASCPYD and ASCCARD
constructs. (b) Release of LDH (assessing cell death) and IL-1b from
LPS-primed immortalized WT, Asc / or Asc / BMDMs expressing
ASCFL, ASCPYD or ASCCARD 3 h after poly(dA:dT) transfection (1mgml 1).
(c) Representative images of cell lines from (b) 3 h after poly(dA:dT)
transfection (1 mgml 1) or 1 h after ATP treatment (5mM). DNA (blue,
Hoechst), ASCFL or ASCPYD (red) and ASCCARD (green). Scale bars,
10mm. Data (b,c) are representative of three independent experiments.
Graphs show the mean and s.d. from quadruplicate wells. See also
Supplementary Fig. 1.
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by a non-canonical NLRC4CARD–ASCPYD interaction or (iii) via
bridging ASC molecules that would be linked with NLRC4 via
CARD–CARD interactions and provide their free PYDs as seeds
for ASCPYD ﬁlament formation. To determine which domain of
ASC was necessary for ASC speck formation after NLRC4
activation, we infected the above described cell lines harbouring
the single domains of ASC with log-phase Salmonella enterica
serovar Typhimurium SL1344 (Salmonella Typhimurium), a
robust activator of NLRC4 (refs 45,46). Consistent with
published reports24,27,47, immortalized Asc / BMDMs still
induced cell death, whereas efﬁcient IL-1b processing and release
required ASC (Fig. 3a). Expression of ASCFL in Asc / cells
restored IL-1b release, but neither the ASCPYD nor ASCCARD
alone were able to functionally restore inﬂammasome activation
(Fig. 3a). We next analysed whether the ASCPYD or ASCCARD
would form specks or ﬁlaments after NLRC4 activation by
microscopy. Although ASCFL formed specks, ASCPYD alone did
not initiate ﬁlaments following activation of NLRC4 (Fig. 3b,c),
which was in contrast to what we had observed for PYD-
containing receptors (Fig. 1c). In addition, cells expressing
ASCCARD alone did not form any specks or macromolecular
ﬁlaments, again suggesting that the ASCCARD in the endogenous
setting is not able to form ﬁlaments (Fig. 3b,c). These results
exclude the possibilities that ASC specks form via CARD
oligomerization after NLRC4 activation, or that a heterotypic
NLRC4CARD–ASCPYD interaction initiates ASC ﬁlament
formation. Instead, they suggest that one or several bridging
molecules of ASC are required to initiate ASC ﬁlament formation
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Figure 2 | The CARD of ASC condenses PYD ﬁlaments into the speck. (a) Structural model of the mouse ASCCARD based on the human homologue
(PDB 2KN6 (ref. 67)). The structure is shown in ribbon (left) and electrostatic surface representation (right, blue, positive charge; red, negative charge).
Residues D130 and D134, involved in the interaction with pro-caspase-1, are highlighted31. (b) Release of LDH and IL-1b from LPS-primed immortalized
Asc / BMDMs and Asc /BMDMs expressing ASCFL, ASCD130R or ASCD134R 3 h after poly(dA:dT) transfection (1 mgml 1). (c,d) Representative
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(g) Representative images from e. DNA was stained with Hoechst (blue) and ASC (red). Scale bars, 5 mm. Data are representative of three (b–d)
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99, 92, 104, 94 and 108 in (e) and 149, 134, 85, 98 and 95 in (f). *Po0.05, **Po0.01 and ***Po0.001 (one-way analysis of variance). See also
Supplementary Figs 2 and 3.
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after NLRC4 activation, and that in these conditions ASC
oligomerization into ﬁlaments and specks also proceeds via the
ASCPYD.
We also examined cells expressing ASCD130R and ASCD134R
mutants, which are defective for CARD–CARD interactions
(Supplementary Fig. 2g,h (ref. 31)). As expected, expression of
these mutants in Asc / macrophages did not complement the
release of mature IL-1b after NLRC4 activation (Fig. 3d).
Furthermore, we did not observe the formation of ﬁlaments or
specks in cells expressing ASCD130R or ASCD134R (Fig. 3e),
conﬁrming the requirement for a functional ASCCARD for ASC
oligomerization by NLRC4. Finally, we also tested our notion that
the ASCCARD is required to condense ASC ﬁlaments into a speck
in the context of NLRC4 activation. Primary WT C57BL/6
BMDMs (containing endogenous ASC, thus enabling initiation of
ASC oligomerization) were retrovirally transduced with varying
ratios of mCherry-tagged ASCFL or ASCD130R and the speck
diameter was measured on S. Typhimurium infection (Fig. 3f).
The increase in speck size concurring with increasing concentra-
tions of the ASCD130R mutant indicated that also in the NLRC4
inﬂammasome the ASCCARD condenses the ASC ﬁlaments
into the speck. In conclusion, our results suggested a triple
functional role for ASCCARD in the NLRC4 inﬂammasome: (1)
mediating the interaction with pro-caspase-1 (refs 17,31), (2)
condensing ASCPYD ﬁlaments into the speck and (3) initiating
ASC oligomerization through bridging ASC molecules
(Supplementary Fig. 3b).
Pyroptosis induction is independent of ASC oligomerization.
Having elucidated the general architecture of the ASC speck, we
next investigated whether the ASC speck constitutes the active,
signalling-competent inﬂammasome. Higher-order signalosomes
were reported for other innate immune signalling pathways
(Toll-like receptors, receptor-interacting serine/threonine-protein
kinase 2 (RIP2K) and MAVS) and could promote signal ampli-
ﬁcation and digital all-or-nothing responses48, leading us to
hypothesize that ASC oligomerization and ﬁlament formation
might have a similar function for inﬂammasome signalling.
Within the ASCPYD ﬁlaments that form the backbone of ASC
specks in human and murine cells (Supplementary Fig. 4a
(refs 13,15)), individual ASCPYDs interact with other six adjacent
ASCPYDs through three asymmetric interfaces, types I–III
(Fig. 4a). Mutations targeting these interfaces can abrogate
ASC ﬁlament formation in vitro or in cell overexpression
systems13,29,49. As these mutations also most probably abrogate
the interaction between the receptorPYD and ASCPYD, and/or
were only tested in an artiﬁcial overexpression system, a deﬁnite
conﬁrmation that ASC ﬁlament formation is required for
inﬂammasome signalling is still missing50. Identiﬁcation of
mutations that abrogate ASC oligomerization but leave
ASC–receptor interaction intact allowed us to characterize the
role of ASC ﬁlaments in inﬂammasome signalling. Therefore, we
generated a number of clonal immortalized Asc / macrophage
lines expressing different mCherry-tagged ASC mutants targeting
all three interaction interfaces (Fig. 4a and Supplementary
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Figure 3 | A bridging ASC molecule is required for ASC speck formation after NLRC4 activation. (a) Release of LDH and IL-1b from LPS-primed
immortalized WT, Asc / or Asc / BMDMs expressing ASCFL, ASCPYD or ASCCARD after infection with log-phase WT S. Typhimurium SL1344
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of variance). See also Supplementary Fig. 3.
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Fig. 4b–d). Next, we assessed the effects of these mutations on
ASC speck/ﬁlament formation on AIM2 activation by poly(dA:dT)
transfection. Mutations targeting interface I (that is, K21A, K26A,
D48N and D51R) completely abrogated the ﬁlament formation as
determined by microscopy (Fig. 4b upper panel and
Supplementary Fig. 4e). This is consistent with interface I being
the most extensive interface and required for the propagation of
single layers of the ﬁlament13,15. In contrast, mutations in
interfaces II and III displayed a larger variability, ranging from no
defect in ASC speck formation (Y36A, E62A (interface II) or
P40A (interface III)), intermediate phenotypes (M76A (interface
II) or L15A (interface III)) to complete abrogation in ASC speck
formation (Y59A, Q79E, E80R (interface II) or E13R and R41E
(interface III)) (Fig. 4c,d upper panels and Supplementary
Fig. 4e). Taken together, these data suggest that the formation
of ASC specks requires all three interfaces of ASCPYD.
We next tested how these mutations affect downstream
inﬂammasome signalling by measuring IL-1b secretion
(Fig. 4b–d middle panels) and pyroptosis (Fig. 4b–d lower
panels). In line with the loss of ASC speck formation, interface I
proved to be essential for induction of downstream inﬂamma-
some signalling (Fig. 4b). Macrophages expressing mutants in
interface III of ASCPYD displayed similar phenotypes as interface
I mutations: the ability to form ASC specks correlated with both
IL-1b secretion and pyroptosis, that is, mutants either lost all
inﬂammasome signalling (E13R and R41E), were partially
affected (L15A) or not affected at all (P40A) (Fig. 4d). These
results show that interface III is important for induction of
downstream inﬂammasome signalling, albeit some mutations are
tolerated.
Mutants in interface II displayed a differential signalling
phenotype (Fig. 4c). Although some mutations had no or only a
very small effect on inﬂammasome signalling (Y36A, E62A and
M76A) or abrogated inﬂammasome signalling altogether (Q79E),
we identiﬁed two mutations (Y59A and E80R) that retained the
ability to induce cell death, while losing the ability to release
mature IL-1b and to form ASC specks in response to AIM2
stimulation (Fig. 4c middle and lower panels, highlighted in grey).
Of note, the ELISA assay displays a higher sensitivity for the
mature form of IL-1b than the pro-form, thus pro-IL-1b, which is
potentially released into the supernatant by pyroptosis, is poorly
detected (Supplementary Fig. 5). To test whether the phenotype
of the different mutants is speciﬁc to the AIM2 inﬂammasome,
we analysed ASC speck formation, secretion of mature IL-1b and
pyroptosis in response to NLRP3 stimulation by ATP treatment.
Asc / macrophages expressing the ASC interface I, II and III
mutants showed the same phenotype for NLRP3 stimulation as
for AIM2 stimulation (Supplementary Fig. 6a–c). Importantly,
also ASCY59A and ASCE80R mutations abrogated speck formation
and IL-1b secretion but still promoted pyroptosis on NLRP3
stimulation (Supplementary Fig. 6b, highlighted in grey). Finally,
we also examined IL-1b release and pyroptosis of macrophages
expressing interface II mutants treated with Clostridium difﬁcile
Toxin B (TcdB). TcdB was recently described to activate the pyrin
inﬂammasome, which senses modiﬁcations of Rho GTPases6.
Again, Asc / macrophages expressing ASCY59A or ASCE80R
were competent for cell death induction but could not efﬁciently
release IL-1b (Supplementary Fig. 6d, highlighted in grey). In
conclusion, our site-directed mutagenesis approach identiﬁed two
mutations, Y59A and E80R, in the inﬂammasome adaptor ASC
that uncouple pyroptosis from ASC speck formation and cytokine
secretion.
ASC oligomerization mutants maintain receptor interaction.
As cell death was still observed in cells expressing ASCY59A and
ASCE80R, we speculated that the mutant proteins retained the
ability to interact with the PYD of the receptor, but lost the
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ability to oligomerize into ASC ﬁlaments. To investigate this,
we reconstituted the AIM2 inﬂammasome by co-expressing
V5-tagged AIM2 with ASCFL or the ASCK21A, ASCY59A or
ASCE80R mutants in HEK293T cells. AIM2 interactors were then
immunoprecipitated using an anti-V5 antibody and analysed by
western blotting (Fig. 5a). Consistent with our notion, ASCY59A
and ASCE80R retained the ability to interact with AIM2, similar to
WT ASC. In contrast, ASCK21A did not interact with AIM2,
possibly explaining the clear-cut phenotypes of interface I
mutants (Fig. 4b and Supplementary Fig. 6b).
Given that ASCY59A and ASCE80R mutants still interacted with
the receptor (Fig. 5a), but did not form any ASC ﬁlaments/specks
(Fig. 4c and Supplementary Fig. 4e), we speculated that the
mutations abolished or reduced the ability of ASC to organize
itself into ﬁlaments following the recruitment to the activated
receptor. Based on our previous observation that puriﬁed
ASCPYD or ASCFL form ﬁlaments in vitro15, we established an
assay to monitor the kinetics of this oligomerization process by
dynamic light scattering and analysed the kinetics of ﬁlament
formation for WT ASCPYD and the above-mentioned mutants
(Fig. 5b,c and Supplementary Fig. 7a,b). Although WT PYD
rapidly formed well-structured ﬁlaments, the K21A mutant was
no longer able to oligomerize correctly and formed unspeciﬁc
aggregates (Fig. 5d). Interestingly, E80R also lost the ability to
oligomerize into ordered ﬁlaments, whereas the Y59A mutant
formed well-ordered ﬁlaments, but at a much slower rate than the
WT protein (Fig. 5b–d and Supplementary Fig. 7a,b). Thus, these
results conﬁrmed that the ASC–receptor interaction and the ASC
ﬁlament formation can be uncoupled, and that the ability to
rapidly form ﬁlaments/specks strongly correlates with the levels
of cytokine production but not cell death.
Gasdermin-D cleavage is independent of ASC oligomerization.
The observation that even in the absence of ASC oligomerization
inﬂammasome activation still promotes cell death but not
cytokine release (Fig. 4c, Supplementary Fig. 4e) was reminiscent
of NLRC4 activation in Asc / macrophages24. In the absence
of ASC, NLRC4 interacts with pro-caspase-1 to initiate cell death
but not efﬁcient caspase-1 autoprocessing and cytokine secretion.
We therefore examined to what level ASCY59A and ASCE80R were
able to promote caspase-1 autoprocessing on activation of the
AIM2 inﬂammasome. In contrast to cells expressing ASCFL,
macrophages expressing the mutant proteins displayed
signiﬁcantly reduced levels of caspase-1 processing, as
determined by western blotting for the released p20 subunit
(Fig. 6a). Furthermore, caspase-1 autoprocessing correlated with
the amount of released bioactive IL-1b (Figs 4c and 6a), but not
with the induction of cell death (Fig. 4c) and the release of the
danger signal high mobility group box 1 (HMGB1) into the cell
supernatants (Fig. 6a), an alternative marker for cell lysis during
inﬂammasome activation51. Similarly, results were obtained on
activation of the NLRP3 inﬂammasome (Supplementary Fig. 8a).
To exclude the possibility that the observed cell death is induced
through caspase-1-independent pathways, we knocked out Casp1
by CRISPR-Cas9-mediated gene targeting52,53 in the cell lines
expressing ASCFL, ASCY59A or ASCE80R. Western blotting for
pro-caspase-1 conﬁrmed successful targeting (Supplementary
Fig. 8b). Casp1 deﬁciency signiﬁcantly abrogated pyroptosis
induction in cells expressing ASCFL, ASCY59A or ASCE80R
(Fig. 6b), thus conﬁrming that the cell death observed in the
parental cell lines was caspase-1 dependent. Taken together, these
data conﬁrm that caspase-1 processing is not a prerequisite
for induction of cell death, expanding previous ﬁndings from
CARD-containing inﬂammasome receptors24 to PYD-containing
receptors.
Recent reports showed that a major substrate of caspase-1
responsible for pyroptosis is gasdermin-D, and that Gsdmd-
deﬁciency abrogates pyroptosis11,12. Caspase-1 cleaves
full-length gasdermin-D, whereby the active N-terminal
fragment (gasdermin-DNterm) is generated (Supplementary
Fig. 8c,d), which induces pyroptotic cell death11,12.
Consistently, CRISPR-Casp9-mediated Gsdmd knockout
(Supplementary Fig. 8e) reduced cell death signiﬁcantly in
response to AIM2 and NLRP3 activation (Supplementary
Fig. 8f,g). As ASCY59A and ASCE80R mutants induced cell
death, we speculated that gasdermin-D is still processed in cells
expressing these mutant forms of ASC. Indeed, although
gasdermin-D was not processed in Asc / macrophages on
stimulation of AIM2 or NLRP3, we observed gasdermin-D
processing to its 30 kDa gasdermin-DNterm fragment in Asc /
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Figure 5 | ASC–receptor interaction and ASC ﬁlament formation
can be uncoupled genetically. (a) Western blot analysis of the interaction
of AIM2 with ASCFL or the indicated ASC mutants. AIM2-V5 was
immunoprecipitated from lysates of HEK293T cells co-transfected with
AIM2-V5 and the indicated ASC mutants. Co-immunoprecipitating proteins
were identiﬁed using anti-ASC and anti-V5. *Immunoglobulin heavy chain.
Results shown are representative from two independent experiments.
(b) Filament formation of WT ASCPYD and its single amino-acid variants
K21A, Y59A and E80R in vitro monitored by dynamic light scattering.
Normalized growth signals (IN) are reported as a function of time for one
representative experiment for each variant (dots). Best ﬁts to single
exponential functions are shown with solid lines. (c) Kinetic rate constants
kF of ﬁlament formation obtained from three independent experiments.
(d) Representative negative-stained TEM micrographs of ﬁlament formed
by ASCPYD and its variants after 350min of incubation at physiological pH
condition. Scale bars, 200nm. See also Supplementary Figs 7 and 9.
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macrophages expressing ASCFL, ASCY59A and ASCE80R (Fig. 6c
and Supplementary Fig. 8h). Furthermore, processing of
gasdermin-D on AIM2 stimulation is dependent on caspase-1
in cells harbouring oligomerization-deﬁcient ASC mutants, as
Casp1 deﬁciency abrogated gasdermin-D cleavage (Fig. 6c). These
results indicated that gasdermin-DNterm causes the cell death
observed in these mutations. As signiﬁcant levels of cell death can
be observed in Asc-deﬁcient macrophages after NLRC4
activation24, but caspase-1 processing is reduced below
detection levels, we next determined whether gasdermin-D is
processed under these conditions. Indeed, we found that the
induction of cell death in S. Typhimurium-infected WT, Asc /
and Casp1 / /Casp11 / macrophages (Fig. 6d) correlated
with detectable levels of processed gasdermin-D (Fig. 6e).
Furthermore, CRISPR-Cas9-mediated Gsdmd knockout
conﬁrmed that gasdermin-D played an essential role in
inducing pyroptosis during S. Typhimurium infections
(Supplementary Fig. 8i). Taken together, these results conﬁrm
that even the smallest amounts of active caspase-1, as judged by
the amount of processed caspase-1 p20 subunits, are sufﬁcient to
efﬁciently process gasdermin-D and trigger gasdermin-D-induced
cell death. On the other hand, large amounts of processed, active
caspase-1 are required to produce detectable amounts of mature,
bioactive IL-1b as seen by the direct correlation of the level of
caspase-1 processing with the levels of cytokine release.
Importantly, the ability of ASC to form ﬁlaments and ASC
specks correlates with caspase-1 activation and cytokine
processing, thus supporting a model in which the rapid
formation of ASC ﬁlaments acts as a signal ampliﬁcation
mechanism for inﬂammasomes, generating a multitude of
caspase-1 activation sites and thus enabling the cells to rapidly
mature IL-1b before the onset of pyroptosis.
Discussion
The formation of higher-order signalling machineries, signalo-
somes, for transmission of receptor activation information to
cellular responses is an emerging theme in signal transduction48.
It is particularly important in innate immune signalling, where
the signal generated by a few ligand–receptor interactions needs
to trigger an appropriate cellular response. Formation of
oligomers has been reported for different signalling adaptors,
for example, B-cell lymphoma/leukemia 10 (Bcl10) or MAVS
ﬁlaments, the Myddosome36,54,55 and others. However, the
archetypical supramolecular assembly formed during
inﬂammasome activation, the ASC speck, has remained
relatively poorly understood. Here we present evidence that the
formation of ASC speck by oligomerization of the inﬂammasome
adaptor protein ASC acts as a signal ampliﬁcation mechanism for
inﬂammasomes (Fig. 7), as the rapid formation of ASCPYD
ﬁlaments that expose ASCCARD on their surface creates a
multitude of pro-caspase-1 recruitment and activation sites. We
speculate that such a system might therefore be able to detect the
smallest amounts of PAMPs in the host cell cytosol, as recent
reports have shown that a single ligand molecule (ﬂagellin, PrgJ)
is sufﬁcient to initiate assembly of a NLR family, apoptosis
inhibitory protein (NAIP) and 10–12 NLRC4 proteins into a
wheel-shaped receptor oligomer that acts as seed for ASC
oligomerization39,56.
Our result reveals that this signal ampliﬁcation mechanism
only applies to cytokine maturation, whereas gasdermin-D-
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Figure 6 | Caspase-1 but not gasdermin-D processing depends on ASC oligomerization. (a) Western blot analysis for cleaved caspase-1 p20, IL-1b p17,
and HMGB-1 in cell supernatants (SN) and pro-caspase-1, pro-IL-1b and HMGB-1 in cell lysates (lys) of LPS-primed immortalized Asc / BMDMs or
Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R 3 h after poly(dA:dT) transfection (1mgml 1). (b) Release of LDH from LPS-primed
immortalized Asc / BMDMs or Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R, or derived Casp1 knockouts 3 h after poly(dA:dT) transfection
(1mgml 1). (c) Western blot analysis for processing of full-length gasdermin-D (GSDMDFL) into the active N-terminal fragment (GSDMDN-term) in
combined lysates and supernatants (lys þ SN) of LPS-primed immortalized Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R, or derived Casp1
knockouts 3 h after poly(dA:dT) transfection (1 mgml 1). Arrowhead, gasdermin-DNterm p30; *a cross-reacting band. (d) Release of LDH from LPS-primed
primary C57BL/6 WT (WT), Casp1 //Casp11 / or Asc / BMDMs infected with S. Typhimurium (multiplicity of infection (MOI)¼ 10, 1 h). (e)
Western blot analysis for processing of full-length gasdermin-D (GSDMDFL) into the active N-terminal fragment (GSDMDN-term) in combined lysates and
supernatants (lysþ SN) of LPS-primed primary C57BL/6 WT (WT), Casp1 //Casp11 / or Asc / BMDMs infected with S. Typhimurium (MOI¼ 10,
1 h) or left uninfected. Arrowhead, gasdermin-DNterm p30; *a cross-reacting band; ** a S. Typhimurium-speciﬁc cross-reactive band. See also
Supplementary Figs 8 and 9.
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induced pyroptotic cell death could be observed even in the
absence of ASC oligomerization. Why would cells need to amplify
the receptor-generated signal to process IL-1b/-18? We speculate
that a cell will inevitably progress towards pyroptosis, once a few
molecules of caspase-1 have been activated, given the rapid
kinetics by which gasdermin-D is processed57 and the strong
toxicity of the gasdermin-DNterm fragment11,12. This fate leaves a
limited time window to mature the pro-forms of IL-1b/-18 to
their bioactive form. As processing of IL-1b/-18 occurs with slow
kinetics, increasing the amount of active caspase-1 is a means to
generate large amounts of bioactive IL-1b/-18 in the available
time window. Consistent with this notion we have observed that
gasdermin-D processing does not correlate with the overall level
of active caspase-1. Furthermore, pyroptosis has been observed to
occur within 30–60min in stimulated cells, whereas ASC speck
formation was reported to proceed much faster23,58, with all
cytosolic ASC being incorporated into a speck in o3min20,59.
Thus, ASC speck formation might serve to activate sufﬁcient
amounts of caspase-1 to generate enough bioactive cytokines
before the cell lyses and releases its intracellular content,
including proteolytically matured cytokines.
Although recent studies revealed that ASC specks are
ﬁlamentous in nature22,23, consistent with recently reported
structures of human and murine ASCPYD ﬁlaments13,15, it was so
far unknown how these ﬁlaments assemble into a speck. Our
mutagenesis studies indicates that the clustering of ASCPYD
ﬁlaments and ﬁnally their condensation into a dense ASC speck
structure is mediated by the ASCCARD, which, as we have
shown15, is exposed on the surface of the ASCPYD ﬁlament. These
results have uncovered a function for the ASCCARD in ASC speck
formation, beyond its role as adaptor domain between receptor
and caspase-1. How ASCCARDs condense ASCPYD ﬁlaments is
unknown, but it can be assumed that either dimeric interactions
between ASCCARDs or limited oligomerization of ASCCARD from
different ﬁlaments could build lattices interconnecting the
ASCPYD ﬁlaments. Interestingly, the same residues in ASCCARD
NLRC4
CARD
LRR
NBD
NLRP3
PYD
LRR
NBD
ASC
ASCCARD
ASCPYD
Pro-caspase-1
Caspase-1P20/p10
Caspase-1CARD
Pro-IL-1β Active caspase-1
PYD-containing receptors
ASCFL
ASCY59A
ASCE80R
Mature 
IL-1β
Mature 
IL-1β
‘Death complex’
Cell death
Gasdermin-DN-term
CARD-containing receptors
ASCFL
Mature 
IL-1β
Mature 
IL-1β
‘Death complex’
Cell death
Gasdermin-DN-term
Gasdermin-D
a b
Figure 7 | Model of signal ampliﬁcation by ASC ﬁlaments. (a) CARD-containing receptors recruit the adaptor protein ASC via homotypic CARD–CARD
interactions, that is, a bridging ASC molecule. This step nucleates the ASCPYD of several bridging ASC molecules, leading to the formation of an ASCPYD
ﬁlament, which is condensed into the ASC speck by the ASCCARD. Filament formation promotes the activation of large quantities of caspase-1, thus
promoting the proteolytic maturation of large amounts of cytokines (pro-IL-1b). In the absence of ASC, CARD-containing receptors directly interact with
pro-caspase-1, leading to the formation of so-called ‘death complexes’. In these small complexes, only few molecules of caspase-1 are activated and
pro-caspase-1 processing might not happen. The few molecules of caspase-1 are sufﬁcient to effectively induce pyroptosis, but cytokine processing is
reduced. (b) PYD-containing receptors can directly interact with ASC via homotypic PYD–PYD interactions, leading to ASCPYD ﬁlaments and ﬁnally the
ASC speck. As for CARD-containing receptors, this leads to caspase-1 activation and subsequent cytokine processing and pyroptosis. Mutations blocking or
slowing ASC ﬁlament formation (for example, ASCE80R or ASCY59A) only allow for few molecules of caspase-1 being activated. This is sufﬁcient to induce
pyroptosis, but insufﬁcient to produce large amounts of mature cytokines before the cell lyses.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11929 ARTICLE
NATURE COMMUNICATIONS | 7:11929 | DOI: 10.1038/ncomms11929 | www.nature.com/naturecommunications 9
Results
71
that are required for ASC–pro-caspase-1 interaction are also
needed for ASC speck formation. Notably, it has previously been
shown that phosphorylation of the ASCCARD at Y144/Y146 is not
only required for caspase-1 activation, but also for ASC speck
formation60,61 Our model of the ASC speck, which includes
interactions between the ASCCARD domains, now provides a
structural rationale for these data. To which extent ASC ﬁlaments
are still formed in the absence of ASCCARD phosphorylation
remains to be determined.
Recently, a uniﬁed assembly mechanism was proposed for the
PYD-containing receptors AIM2 and NLRP3: the receptors
nucleate clusters of ASC through PYD–PYD interactions, which
in turn nucleate caspase-1 ﬁlaments13. In analogy, it was
proposed that the CARD-containing receptor NLRC4 directly
nucleates caspase-1 ﬁlaments13,39, as in theory CARD-containing
receptors do not require ASC for caspase-1 recruitment.
Although direct recruitment of pro-caspase-1 to NLRC4 might
indeed happen in Asc-deﬁcient cells as we hypothesized before24,
it does not seem to efﬁciently activate caspase-1, because we and
others have reported that caspase-1 processing into its p20/p10
subunits and the levels of released mature cytokines are reduced.
Furthermore, a large number of ASC specks can be observed in
WT cells on NLRC4 activation24–28, indicating that ASC
nevertheless plays an important role in NLRC4 signalling. Our
results now indicate that the ASCCARD lacks the ability to form
higher-order oligomers at physiological concentrations, and that
even on NLRC4 activation ASC speck formation relies on the
ASCPYD. Our data thus support a model in which CARD-
containing receptors initiate ASC speck formation with the help
of ASC bridging molecules, and that the PYDs of these ASC
molecules nucleates an ASCPYD ﬁlament. Thus, the ASCCARD can
have a triple function in inﬂammasome signalling on CARD-
receptor activation.
In conclusion, our study gives insights into the architecture of
the ASC speck and the mechanism by which ASC ﬁlaments
assemble this structure. Furthermore, we provide experimental
evidence that ASC ﬁlament formation serves as an ampliﬁcation
mechanism in inﬂammasome signalling, and that this ampliﬁca-
tion serves to generate sufﬁcient mature cytokines before the
onset of pyroptotic cell death. Nevertheless, important questions
remain; the higher-resolution structure of the activated NLRC4
receptor has been recently reported39,56, yet how exactly such
receptor complexes with C10–C12 stoichiometry initiate the
3-start ASCPYD ﬁlaments is still unknown. Furthermore, the
structure of the whole ASC speck assembly, including receptor,
ASC and caspase-1, is still lacking and it remains unknown
whether other proteins participate in its formation. Finally,
additional theoretical and experimental approaches will be
necessary to understand if and how ASC speck formation
might impart threshold responses, reduce biological noise and
control temporal and spatial control of inﬂammasome signalling.
Methods
Cell culture. Immortalized BMDM cell lines were generated from bone marrow
using infection with a v-myc/v-raf-expressing J2 retrovirus24,62. WT and Asc /
immortalized murine BMDMs were cultured in DMEM (Sigma) supplemented
with 10% FCS (Bioconcept) and 10% 3T3-MCSF supernatant, and incubated at
37 C with 5% CO2.
Generation of monoclonal cell lines with mutations in ASC. Murine AscFL and
AscPYD were cloned with a carboxy-terminal mCherry tag and AscCARD with an
N-terminal enhanced GFP tag into V48, a derivative of the replication-defective
murine stem cell retroviral construct pMSCV2.2 (excision of the IRES-GFP by
EcoRI digestion, gift from Thomas Henry). Mutations were introduced by SOE
PCR using appropriate oligonucleotides (Supplementary Table 1) and cloned into
V48. GP2 packaging cells were transfected with the individual vectors (9 mg per
1.5 106 cells) and the lentviral envelope vector VSV-G (Addgene, 6 mg per
1.5 106 cells), and the retroviral particles were used to transduce Asc /
iBMDMs (106 cells). Seven days later, the transduced iBMDMs were sorted into
single cells based on the mCherry or enhanced GFP expression (FACS) and
grown up to clonal cell lines. Up to ten clones of each cell line were tested for
inﬂammasome activation and the level of ASC expression was assessed by western
blotting and a representative clone was selected for further analysis.
Retroviral transduction of primary BMDMs. For transduction of primary bone
marrow cells, retroviral particles were generated in Phoenix-Eco packaging cells
and used to transduce WT C57BL/6 bone marrow cells after 48 and 72 h of culture
in medium with 10% 3T3-MCSF supernatant. Inﬂammasome stimulation was
performed 4 days after the ﬁrst transduction24.
Inﬂammasome stimulation. Immortalized BMDMs (seeded at 250 000 cells
per ml in 96-well plates) were primed for 4 h with 100 ngml 1 LPS O55:B5
(Invivogen). The NLRP3 inﬂammasome was triggered by addition of 5mM
extracellular ATP (Sigma-Aldrich) for 60min. The AIM2 inﬂammasome was
triggered by transfection of 1 mgml 1 of the synthetic DNA analogue poly(dA:dT)
(Invivogen) using Lipofectamine 2000 (Invitrogen), according to the manu-
facturer’s protocol, in OptiMEM (Gibco) for 3 h. The NLRC4 inﬂammasome
was triggered by infection of the cells with S. enterica serovar Typhimurium
SL1344 at a multiplicity of infection of 10. The infection was synchronized by
centrifugation and continued for 60min. The pyrin inﬂammasome was triggered
by addition of 1 mgml 1 (ﬁnal concentration) of C. difﬁcile toxin B (CdtB, Enzo
Biotech) for 2.5 h.
Cell death and IL-1b release measurements. IL-1b release was measured by
ELISA (eBiosciences). Cell death was quantiﬁed by measuring LDH release
using the LDH Cytotoxicity detection kit (TaKaRa Clontech). To normalize
for spontaneous cell lysis, the percentage of cell death was calculated as follows:
[(LDH sample) (LDH negative control)]/[(LDH positive control) (LDH
negative control)] 100.
Imaging and quantiﬁcation of ASC speck formation. Cells were seeded on
coverslips (150 000 cells per coverslip) and treated as described above with the
addition of 25mM Z-VAD-fmk (Bachem) to prevent detachment of pyroptotic
cells and therefore loss of cells with ASC specks. Coverslips were ﬁxed with 4%
paraformaldehyde (PFA) (15min, 37 C, Alfa Aesar) and washed with PBS. Nuclei
were stained with Hoechst 33342 (Life Technologies) for 10min and the slides
mounted using Vectashield (Vector Laboratories). For quantiﬁcations of ASC
aggregates (specks or ﬁlaments), ten random regions of interest were imaged at
 20 magniﬁcation (Leica DMI3000B inverted ﬂuorescence microscope, HCX PL
FLUOTAR objective, Leica DFC3000G camera and LAS AF Version 3 software)
and the number of ASC aggregates and cells were counted. For representative
images, the slides were imaged at  63 magniﬁcation (Leica point scanning
confocal ‘SP8’, HC PL APO CS2  63 objective, Leica AF software version 3).
For measurements of speck sizes, random regions of interest were images at
 63 magniﬁcation (Leica point scanning confocal ‘SP8’) and the largest diameters
of individual specks were measured using Fiji63.
Western blotting. For western blotting of supernatant and lysate samples, cells
were seeded at 106 cells per well in six-well plates and treated as described above.
Supernatants were precipitated with 10% trichloracetic acid, precipitates washed
with acetone and resuspended in 40 ml 1 SDS–PAGE sample buffer and boiled at
95 C for 10min. Cells were lysed with 200ml 1 RIPA (50mM Tris-HCl pH 7.5,
150mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, 1 protease
inhibitor cocktail (Roche)) for 30min on ice. Lysates were re-suspended in
5 SDS–PAGE sample buffer and boiled at 95 C for 10min64. For combined
supernatant and lysates, samples were prepared as above, but supernatant
precipitates were resuspended in lysate samples. Samples were run on 14%
(supernatants or lysates) or 12% (combined SNþ lysates) acrylamide gels (1 h,
170V, 40mA per gel), transferred to polyvinylidene diﬂuoride membranes (1 h,
100V constant), blocked in 5% milk in Tris-buffered salineþTween-20 (TBS-T)
and incubated with primary antibodies in 5% BSA–TBS-T for 16 h at 4 C or 2 h at
room temperature with agitation. Secondary antibodies were diluted 1:5,000 in 5%
milk–TBS-T and incubated for 1 h at room temperature. The membranes were
developed using either LumiGLO (KPL) or LumiGLO Reserve (KPL). The
following antibodies and dilutions were used: rat anti-Caspase-1 p20 (Genentech,
1:1,000; Supplementary Figs 1b,d and 2c,d) or mouse anti-Caspase 1 p20 (1:4,000,
AG20B-0042, AdipoGen; Fig. 6a and Supplementary Fig. 8a), rat anti-ASC
(Genentech, 1:2,000; Fig. 5a and Supplementary Fig. 2a,h) or rabbit anti-ASC
(1:1,000, AG25B-006, Adipogen, all other ﬁgures), rabbit anti-IL-18 (5180R-100,
Biovision, 1:1,000), goat anti-IL-1b (AF-401-NA, R&D, 1:1,000), mouse anti-GFP
(632381, Clontech, 1:1,000), mouse anti-mCherry (ab125096, Abcam, 1:1,000),
mouse anti-V5 (R960-25, Invitrogen, 1:1,000), rabbit anti-HMGB1 (GTX-101277,
Genetex, 1:1,000), mouse anti-gasdermin-D (GSDMDC1 (A-7), Santa Cruz
Biotechnology, 1:1,000; Supplementary Fig. 7), rabbit anti-gasdermin-D (1:2,000,
G7422, Sigma, all other ﬁgures) and mouse anti-b-actin (A1987, Sigma, 1:1,000).
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Co-immunoprecipitation. Co-immunoprecipitation was done according to a
modiﬁed protocol published previously49. For assessment of ASC/AIM2
interactions, 3 800,000 HEK293T cells were transfected with 2 mg per
well AIM2-V5 and ASC-mCherry (ASCFL, ASCK21A, ASCY59A or ASCE80R)
encoding plasmids at a ratio of 1:4 using linear polyethylenimine (PEI,
Polysciences) at a ratio DNA:PEI of 1:4 (refs 65,66). Twenty-four hours after
transfection, the cells were washed twice with ice-cold 1 PBS and lysed using
HEK lysis buffer (20mM HEPES pH 7.4, 10mM KCl, 1mM EDTA, 0.1mM
phenylmethylsulfonyl ﬂuoride, 1mM Na3VO4, 5mM NaF, 0.5 % Nonidet P-40 and
1 protease inhibitor cocktail (Roche)). Lysates were sonicated for 5 7 s before
removing debris and non-lysed cells by centrifugation (10,000 g, 15min, 4 C). The
samples were incubated with 1 mg mouse anti-V5 antibody (R960-25, Invitrogen)
or a control antibody (mouse anti-GFP, 632381, Clontech) with agitation for 16 h
at 4 C. For assessment of ASCCARD/ASCCARD interactions, 3 800 000 HEK293T
cells were transfected with 1 mg per well ASC-mCherry (ASCFL, ASCPYD,
ASCD130R or ASCD134R), 1 mg per well ASCCARD-GFP and 0.2 mg AIM2-V5, to
initiate ASC/ASC interactions using linear PEI. Forty hours after transfection, the
cells were washed, lysed and sonicated as described above. The samples were then
incubated with 1 mg mouse anti-mCherry antibody (ab125096, Abcam) or a control
antibody (mouse anti-HA, MMS-101R-200, Covance). The samples were then
incubated with agitation for 2 h at 4 C with 25 ml Pierce Protein A Plus Agarose
bead slurry (22810, Thermo Scientiﬁc). Beads were washed three times with lysis
buffer (centrifugation 1min 1,000 g, 4 C), resuspended in 2 SDS–PAGE sample
buffer (30 ml) and boiled at 95 C, before analysing the eluted proteins by western
blotting as described above.
CRISPR-Cas9-mediated Caspase1 and Gasdermin-D knockout. Two guide
RNAs52 targeting exon 4 of Casp1 (50-gagggcaagacgtgtacgag-30 and 50-cgagtgg
ttgtattcattat-30) and one guide RNA targeting exon 2 of Gsdmd (50-ggtca
agaatgtgatcaagg-30) were cloned into lentiCRISPRv2 harbouring a puromycin
resistance cassette (Addgene53). These constructs were transfected into HEK293T
cells using PEI (as described above) together with the lentiviral packaging vector
PsPax2 (Addgene) and the lentviral envelope vector VSV-G (Addgene). Sixteen
hours after transfection, medium was exchanged with macrophage medium and
incubated at 37 C for 2 days to produce lentiviral particles. The lentiviral particles
were used to transfect the immortalized macrophage cell lines (800,000 cells per
well in 6-well plates) using polybrene (Merck) to favour virus attachment.
Two days after viral transduction, the macrophages were expanded. Attached
macrophages were then treated with 10 mgml 1 puromycin (Gibco) for 6 days to
select for successful lentiviral transduction. After puromycin selection, the cells
were tested for successful knockout by western blotting.
Expression and puriﬁcation of ASCPYD. The ASCPYD (residues 1–91) was cloned
with a C-terminal His6 tag into the pET28a vector under the control of a T7
promoter. Protein expression was induced by isopropyl-b-D-thiogalactopyranosid
addition in BL21(DE3) Escherichia coli at an OD600 of 0.8 for 4 h at 37 C. Bacteria
were harvested by centrifugation and resuspended in 50mM phosphate buffer pH
7.5, 300mM NaCl, with Complete protease inhibitor (Roche).
Resuspended bacteria were incubated for 1 h at room temperature with DNase I,
sonicated on ice and centrifuged at 20,000 g at 4 C for 30min. The pellet, including
ASCPYD-containing inclusion bodies, was solubilized in 50mM phosphate buffer
pH 7.5, 300mM NaCl, 6M guanidinium hydrochloride and centrifuged at 20,000 g
at 4 C for 30min. The supernatant was incubated for 2 h at room temperature
with pre-equilibrated Ni-NTA afﬁnity resin (Thermo Scientiﬁc) and then passed
through a plastic body column for gravity ﬂow puriﬁcation. The column was
washed with 20 column volumes of solubilization buffer containing 20mM
imidazole and eluted with 3 column volumes of solubilization buffer with 500mM
imidazole. The pH of the elution fraction was decreased to 3.8 and dialysed against
50mM glycine buffer pH 3.8, 150mM NaCl. The protein was further puriﬁed
on a pre-equilibrated Superdex 75 gel ﬁltration column (GE Healthcare). This
gel-ﬁltration step removed traces of pre-existing aggregates and yielded highly
pure, monomeric soluble form of ASCPYD. Samples were either used immediately
or stored after ﬂash-freezing in small aliquots in liquid N2.
Measurements of ASCPYD ﬁlament formation kinetics in vitro. Immediately
before the experiments, samples of monomeric soluble ASCPYD were centrifuged at
20,000 g at 4 C for 30min and ﬁltered with 0.1 mM ﬁlter (Millipore). The protein
concentration was adjusted to 25 mM by dilution from a higher-concentrated stock
solution. Filament formation was triggered by rapid dilution to neutral pH.
Thereby, 70 ml of monomeric ASCPYD was mixed with 0.45 ml of 2.75M NaOH
solution to a reach the pH of 7.5. The solution was mixed at room temperature by
careful pipetting, to avoid introduction of air bubbles, and immediately transferred
to a quartz cuvette with 1 cm path length. Between runs, cuvettes were carefully
cleaned with 1M Hellmanex solution (Sigma-Aldrich) to avoid cross-seeding
effects between sequential measurements. Filament growth was monitored by
dynamic light scattering with a Malvern Zetasizer Nano ZS series instrument. The
laser focal spot was positioned in the middle of the cuvette and maintained ﬁxed
for all the measurements. To maximize the intensity of the scattered light, the
minimal attenuation level was used. Data were acquired in 60 s intervals by
averaging three runs of 20 s, until a total time of 350min. Afterwards, the protein
solution was blotted on EM grids, negatively stained and imaged with transmission
electron microscopy to visualize ﬁlament formation.
Data analysis. Filament growth was modelled assuming pseudo-ﬁrst-order
kinetics where the ﬁlament propagation step occurs by the addition of monomers
to the initial growth centre. The time-dependent growth signal I was ﬁtted
independently for each measurement by a single exponential function,
I tð Þ ¼ I1 1 e  kF tð Þ
 
where IN corresponds to the signal at time t and at inﬁnitive time, respectively, and
kF is the ﬁrst-order rate constant. Fits were done with nonlinear least-square
minimization.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon request.
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Supplementary Figure 1 (Related to Fig. 1) 
(a) Expression of the ASC constructs in immortalized Asc−/− BMDM cell lysates 
(lys) as assessed by immunoblotting against eGFP, mCherry, ASC and β-actin. * 
denotes degradation bands resulting from a degraded mCherry, but with intact 
ASC. (b) Immunoblot analysis for cleaved caspase-1 p20, IL-1β p17 and IL-18 
p19 in cell supernatants (SN) and pro-caspase-1, pro-IL-1β, pro-IL-18 and β-
actin in lysates (lys) of LPS-primed immortalized wildtype (WT), Asc−/− or Asc−/− 
BMDMs expressing wildtype ASC (ASCFL), ASCPYD or ASCCARD 3 h after 
poly(dA:dT) transfection (1 µg ml-1). (c) Release of LDH and IL-1β from LPS-
primed immortalized wildtype, Asc−/− or Asc−/− BMDMs expressing ASCFL, 
ASCPYD or ASCCARD 1 h after ATP treatment (5 mM). (d) Immunoblots analysis 
for cleaved caspase-1 p20, IL-1β p17 and IL-18 p19 in cell supernatants (SN) 
and pro-caspase-1, pro-IL-1β, pro-IL-18 and β-actin in lysates (lys) of LPS-
primed immortalized wildtype, Asc−/− or Asc−/− BMDMs expressing ASCFL, 
ASCPYD or ASCCARD 1 h after 5 mM ATP treatment. (e-f) Quantification of ASC 
aggregates (specks and filaments) in LPS-primed immortalized Asc−/− BMDMs 
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2 
expressing ASCFL, ASCPYD or ASCCARD 3 h after poly(dA:dT) transfection (1 µg 
ml-1) (e) or 1 h after ATP treatment (5 mM) (f). Graphs show the mean and s.d. of 
quadruplicate wells or ten random fields of view. Results shown are 
representative of at least three (a, c, e-f) or two independent experiments (b, d). 
See also Supplementary Figure 9. 
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Supplementary Figure 2 (Related to Fig. 2) 
(a) Equal expression of ASCCARD mutants (ASCD130R and ASCD134R) in 
immortalized Asc−/− BMDM cell lysates (lys) as assessed by immunoblotting 
against ASC and β-actin. * denotes a degradation band. (b) Release of LDH and 
IL-1β from LPS-primed immortalized Asc−/− BMDMs and Asc−/− BMDMs 
expressing ASCFL, ASCD130R or ASCD134R 1 h after ATP treatment (5 mM). (c-d) 
Immunoblots analysis for cleaved caspase-1 p20, IL-1β p17 and IL-18 p19 in cell 
supernatants (SN) and pro-caspase-1, pro-IL-1β, pro-IL-18 and β-actin in lysates 
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(lys) of LPS-primed immortalized Asc−/− BMDMs and Asc−/− BMDMs expressing 
ASCFL, ASCD130R or ASCD134R 3 h after poly(dA:dT) transfection (1 µg ml-1) (c) or 
1 h after 5 mM ATP treatment (5 mM) (d). (e-f) Quantification of ASC aggregates 
(specks and filaments) from LPS-primed immortalized Asc−/− BMDMs and Asc−/− 
BMDMs expressing ASCFL, ASCD130R or ASCD134R 3 h after poly(dA:dT) 
transfection (e) or 1 h after ATP treatment (5 mM) (f). (g) Co-localization of 
mCherry-tagged ASCFL, ASCPYD, ASCD130R and ASCD134R (red) with GFP-tagged 
ASCCARD (green) overexpressed in HEK293T cells together with AIM2-V5 (to 
induce inflammasome assembly, not shown). DNA was stained with Hoechst 
(blue). Scale bars 10 µm. (h) Immunoblot analysis of the interaction of ASCCARD 
with ASCFL, ASCPYD, ASCD130R or ASCD134R. ASC-mCherry was 
immunoprecipitated from lysates of HEK293T cells co-transfected with AIM2-V5, 
ASCCARD-GFP and the indicated ASC-mCherry constructs. Co-
immunoprecipitating proteins were identified using anti-GFP, anti-ASC and anti-
β-actin antibodies. Graphs show the mean and s.d. of quadruplicate wells or ten 
random fields of view. Results shown are representative of at least two (a, c-d, g-
h) or three (b, e-f) independent experiments. See also Supplementary Figure 9. 
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Supplementary Figure 3. Model describing ASC filament initiation and ASC 
speck assembly. (Related to Fig. 2 and Fig. 3) 
(a) Activation of PYD-containing inflammasome receptors leads to the 
recruitment of ASC by homotypic receptorPYD–ASCPYD interaction and nucleation 
of ASCPYD filaments. ASCCARDs are exposed on the surface of ASCPYD filaments. 
CARD–CARD interactions between ASCCARDs of different filaments connect the 
different ASCPYD filaments and condense them into the dense ASC speck 
Results
80
6 
structure. At the same time surface exposed ASCCARD serves as the recruitment 
and activation point for pro-caspase-1. (b) CARD–containing receptors recruit 
ASC bridging molecules by homotypic receptorCARD–ASCCARD interactions. The 
PYDs of the ASC bridging molecules act as a nucleation point for ASCPYD 
filaments, a function that is otherwise executed by the receptorPYD, as described 
in (a). The different ASCPYD filaments are then condensed into the ASC speck by 
the ASCCARD.	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Supplementary Figure 4 (Related to Fig. 4) 
a) Structure of the mouse ASCPYD filament [PDB 2N1F1]. The three helical layers 
are colored blue, teal and light blue. A zoom up view shows the surface 
representation of ASCPYD monomers as part of the filament. (b-d) Equal 
expression of wildtype ASC (ASCFL) and ASC interaction interface I (b), interface 
II (c) and interface III (d) mutants in immortalized Asc−/− BMDM cell lysates (lys) 
as assessed by immunoblotting using anti-ASC and anti-β-actin antibodies. * 
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denotes a degradation band. (e) Representative images from LPS-primed 
immortalized Asc−/− BMDMs expressing mCherry-tagged ASCFL or the indicated 
ASC interaction interface mutants after 3 h of poly(dA:dT) transfection (1 µg ml-1). 
DNA was stained with Hoechst (blue), ASC (red). Scale bars 10 µM. Results 
shown are representative of two (b-d) or three (e) independent experiments. See 
also Supplementary Figure 9. 
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Supplementary Figure 5. The IL-1β ELISA kit is more specific for the 
cleaved IL-1β p17. 
(a-b) Release of LDH (a) and IL-1β from LPS-primed immortalized Gsdmd−/− 
BMDMs left uninfected or infected with log phase S. Typhimurium SL1344 (MOI 
10 for 1 h). (c) Release of IL-1β as detected by the ELISA kit used for this study 
(Mouse IL-1 beta ELISA Ready-SET-Go!® from eBiosciences, CatNo. 88-7013) 
from the cells in (a) and lysed by freezing and thawing in water. Numbers above 
bars indicate the average values. (d) Immunoblot analysis for pro-IL-1β (*) and 
bioactive IL-1β p17 (**) in lysates of the cells as in (c). Graphs show the mean 
and s.d. of quadruplicate wells and results shown are representative of at least 
three independent experiments. See also Supplementary Figure 9. 
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Supplementary Figure 6. Cell death is uncoupled from IL-1β release in 
NLRP3 and PYRIN inflammasomes (Related to Fig. 4) 
(a-c) Quantification of ASC aggregates or the release of LDH and IL-1β from 
LPS-primed immortalized Asc−/− BMDMs and Asc−/− BMDMs expressing ASCFL 
or the indicated ASC mutants 1 h after ATP treatment (5 mM). (d) Release of 
LDH and IL-1β from LPS-primed immortalized Asc−/− BMDMs and Asc−/− BMDMs 
expressing ASCFL or the indicated ASC interface type II mutants 2.5 h after 
treatment with Clostridium difficile toxin B (TcdB, 1 µg ml-1). ASCY59A and 
ASCE80R are highlighted in grey. Graphs show mean and s.d. from quadruplicate 
wells or ten random fields of view. Data are representative of at least three 
independent experiments. 
  
Results
85
11 
 
 
Supplementary Figure 7. Measurement of filament formation kinetics in 
vitro (Related to Fig. 5) 
(a) Filament formation of wild-type ASCPYD and its single amino-acid variants 
Y59A, K21A and E80R in vitro monitored by dynamic light scattering. Normalized 
growth signals (IN) are reported as a function of time for three independent 
replicates of each variant (dotted lines). Three independent replicates are shown 
for each protein variant. Figure 5b displays one of these replicates. (b) Kinetic 
rate constants kF of filament formation obtained from fitting the data in A with 
single exponential functions. Figure 5c displays the average and standard 
deviation of these data. 
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Supplementary Figure 8 (Related to Fig. 6) 
(a) Immunoblot analysis for cleaved caspase-1 p20, IL-1β p17, and HMGB-1 in 
cell supernatants (SN) and pro-caspase-1, pro-IL-1β, and HMGB-1 in cell lysates 
(lys) of LPS-primed immortalized Asc−/− BMDMs or Asc−/− BMDMs expressing 
ASCFL, ASCY59A or ASCE80R after ATP treatment (5 mM, 1 h). (b) Confirmation of 
CRISPR-Cas9 mediated Casp1 knock-out in immortalized Asc−/− BMDMs 
expressing ASCFL, ASCY59A or ASCE80R by immunoblotting. (c-d) Immunoblot 
analysis for processing of GSDMD into the active N-terminal fragment in 
combined lysates (lys) and supernatants (SN) of LPS-primed primary C57BL/6 
WT (WT), Casp1−/−/Casp11−/− or Asc−/− BMDMs transfected with 1 µg ml-1 
poly(dA:dT) for 3 h (c), treated with 5 mM ATP for 1 h (d) or left untreated. (e) 
Confirmation of CRISPR-Cas9 mediated Gsdmd knock-out in immortalized WT 
BMDMs. (f-g) LDH release from immortalized WT or Gsdmd−/− BMDMs primed 
with LPS and then transfected with poly(dA:dT) (1 µg ml-1, 3 h [f]) or treated with 
ATP (5 mM, 1 h [g]). 
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(h) Immunoblot analysis for processing of GSDMD into the active N-terminal 
fragment in combined lysates and supernatants (lys + SN) of LPS-primed 
immortalized Asc−/− BMDMs expressing ASCFL, ASCY59A or ASCE80R 1 h after 
ATP treatment (5 mM). (i) LDH release from immortalized WT or Gsdmd−/− 
BMDMs, primed with LPS and then infected with S. Typhimurium (MOI = 10, for 1 
h). Arrowheads indicate the GSDMDNterm p30, * indicate a cross-reacting band. β-
actin immunoblots serve as loading controls. Graphs show mean and s.d. from 
quadruplicate wells. Results shown are representative of two (a-b) or three (c-i) 
independent experiments. See also Supplementary Figure 9. 
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Supplementary Figure 9 
Full images of blots shown in the main text and supplementary figures. 
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SUPPLEMENTARY TABLE 
Supplementary Table 1. Oligonucleotides used for plasmid construction 
 
Name No. Sequence Restriction Site Description 
ASC_D48R
_fw O94 
GCCCTGCTGCAGATGcgcG
CCATAgatCTCACTGACAAA
C 
 site directed mutagenesis, ASCD48R 
ASC_D48R
_rv O95 
GTTTGTCAGTGAGatcTATG
GCgcgCATCTGCAGCAGGG
C 
 site directed mutagenesis, ASCD48R 
ASC_D51N
_fw O104 
CTGCAGATGGACGCCATAa
acCTCACTGACAAACTTGTC
AGC 
 site directed mutagenesis, ASCD51N 
ASC_D51N
_rv O105 
GCTGACAAGTTTGTCAGTG
AGgttTATGGCGTCCATCTGC
AG 
 site directed mutagenesis, ASCD51N 
ASC_Y59A
_fw O108 
CACTGACAAACTTGTCAGCg
ccTATCTGGAGTCGTATGGC
TTG 
 site directed mutagenesis, ASCY59A 
ASC_Y59A
_rv O109 
CAAGCCATACGACTCCAGA
TAggcGCTGACAAGTTTGTC
AGTG 
 site directed mutagenesis, ASCY59A 
ASC_Y36A
_fw O155 
gcaactgcgagaaggcgccgggcgc
atcccac  
site directed 
mutagenesis, ASCY36A 
ASC_Y36A
_rv O156 
gtgggatgcgcccggcgccttctcgcag
ttgc  
site directed 
mutagenesis, ASCY36A 
ASC_E62A
_fw O159 
gacaaacttgtcagctactatctgGCCt
cgtatggcttggagctc  
site directed 
mutagenesis, ASCE62A 
ASC_E62A
_rv O160 
gagctccaagccatacgaGGCcaga
tagtagctgacaagtttgtc  
site directed 
mutagenesis, ASCE62A 
ASC_M76
A_fw O161 
caatgactgtgcttagagacGCCggct
tacaggagctgg  
site directed 
mutagenesis, ASCM76A 
ASC_M76
A_rv O162 
ccagctcctgtaagccGGCgtctctaa
gcacagtcattg  
site directed 
mutagenesis, ASCM76A 
ASC_Q79E
_fw O163 
gtgcttagagacatgggcttaGAAgag
ctggctgagcag  
site directed 
mutagenesis, ASCQ79E 
ASC_Q79E
_rv O164 
ctgctcagccagctcTTCtaagcccat
gtctctaagcac  
site directed 
mutagenesis, ASCQ79E 
ASC_E80R
_fw O165 
cttagagacatgggcttacagCGCctg
gctgagcagctg  
site directed 
mutagenesis, ASCE80R 
ASC_E80R
_rv O166 
cagctgctcagccagGCGctgtaagc
ccatgtctctaag  
site directed 
mutagenesis, ASCE80R 
ASC_E13R
_fw_XhoI O243 
GATCctcgagCCACCatggggcg
ggcacgagatgccatcctggacgctctt
CGCaacttgtcag 
XhoI site directed mutagenesis, ASCE13R 
ASC_R41E
_fw O244 gggcgcatcccaGAAggggccctgc  
site directed 
mutagenesis, ASCR41E 
ASC_R41E
_rv O245 gcagggccccTTCtgggatgcgccc  
site directed 
mutagenesis, ASCR41E 
ASC_L15A
_fw_XhoI O246 
GATCctcgagCCACCatggggcg
ggcacgagatgccatcctggacgctctt XhoI 
site directed 
mutagenesis, ASCL15A 
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gaaaacGCCtcaggggatg 
ASC_P40A
_fw O247 
gctatgggcgcatcGCCcgcggggc
cc  
site directed 
mutagenesis, ASCP40A 
ASC_P40A
_rv O248 
gggccccgcgGGCgatgcgcccata
gc  
site directed 
mutagenesis, ASCP40A 
ASCfwXho
I O7 
GATCctcgagCCACCatggggcg
ggcacgagatgc XhoI 
cloning of ASC into V48, 
forward 
ASC1-
92rvEcoRI O4 
GATCgaattcGctcttctttagtcgtttg
cagct EcoRI 
cloning of ASCPYD into 
V48, reverse 
ASC-
CARD-
GFPprimer
A 
O21 
GATCGCGGCCGCCACCATG
GGAGCTGTGGCAGCTGCA
G 
NotI 
cloning of ASCCARD-
GFPinto V48 by SOE 
PCR 
ASC-
CARD-
GFPprimer
B 
O22 GATCCACCGGTCGCCACCATGGTGAGCAAGGGCGAGG  
cloning of ASCCARD-
GFPinto V48 by SOE 
PCR 
ASC-
CARD-
GFPprimer
C 
O23 CCTCGCCCTTGCTCACCATGGTGGCGACCGGTGGATC  
cloning of ASCCARD-
GFPinto V48 by SOE 
PCR 
ASC-
CARD-
GFPprimer
D 
O24 GATCGTTTAAACTTATCTAGATCCGGTGGATCCC PmeI 
cloning of ASCCARD-
GFPinto V48 by SOE 
PCR 
RV_ascfl_
EcoRI O59 
GATCgaattcggctctgctccaggtcc
atca EcoRI 
cloning of ASCFL into 
V48, reverse 
FWascD13
0R O13 
CACAGAAGTGAGGGGAGTG
CTG  
site directed 
mutagenesis, ASCD130R 
RVascD13
0R O14 
CAGCACTCCCCTCACTTCT
GTG  
site directed 
mutagenesis, ASCD130R 
FWascD13
4R O15 
CGGAGTGCTGAGGGCTTTG
CATG  
site directed 
mutagenesis, ASCD134R 
RVascD13
4R O16 
CATGCAAAGCCCTCAGCAC
TCCG  
site directed 
mutagenesis, ASCD134R 
  
Results
93
19 
SUPPLEMENTARY REFERENCES 
1. Sborgi, L. et al. Structure and assembly of the mouse ASC inflammasome 
by combined NMR spectroscopy and cryo-electron microscopy. Proc. Natl. 
Acad. Sci. (2015). doi:10.1073/pnas.1507579112 
 
Results
94
Results
2.2.1 Additional results related to research article II
Apart from the Casp1 CRISPR-Cas9 knock-outs in immortalized BMDMs (bone mar-
row derived macrophages) expressing ASC-mCherry mutants (Asc–/–, Asc–/– + ASCFL,
Asc–/– + ASCY59A, Asc–/– + ASCE80R) and the Gsdmd KO in wild type immortalized
BMDMs, I knocked out Gsdmd in immortalized Asc–/– BMDMs or immortalized Asc–/–
BMDMs expressing ASCFL, ASCY59A, or ASCE80R (for materials and methods see re-
search article II322). The goal was to show that gasdermin-D is indeed responsible for
cell death in absence of ASC oligomerization.
Figure 2.1: Effect of Gsdmd deletion on pyroptosis. (a) Western blot analysis for
CRISPR-Cas9 mediated Gsdmd deletion in immortalized Asc–/– BMDMs
and immortalized Asc–/– BMDMs expressing ASCFL, ASCY59A or ASCE80R.
(b-c) Release of LDH from LPS-primed immortalized BMDMs from (a) after
poly(dA:dT) transfection (1 µg/mL for 3 h, b) and S. Typhimurium infection
(MOI 10 for 1h, c). Graphs show means and s.d. from quadruplicate wells.
Data are representative of three independent experiments.
Western blotting confirmed that the CRISPR-Cas9 Gsdmd knock-out was successful
in all cell lines (Fig. 2.1a). To assess the effect of Gsdmd ablation on PYD-containing
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inflammasomes, cells were transfected with poly(dA:dT) for 3 h to activate AIM2. The
results showed that gasdermin-D was responsible for the cell death observed in both,
absence and presence of ASC oligomerization (Fig. 2.1b). As S. Typhimurium depen-
dent NLRC4 activation proceeds also in absence of ASC, I also tested the effect of Gs-
dmd deficiency on NLRC4-dependent cell death. The results indicated that gasdermin-
D was not only responsible for cell death upon activation of PYD-containing receptors,
but also CARD-containing receptors (Fig. 2.1c) as deletion of Gsdmd in absence of
Asc abrogated cell death. Consistently, gasdermin-D was also required for NLRC4-
dependent pyroptosis in absence of ASC oligomerization (Fig. 2.1).
Collectively, these results suggested that the cell death observed in cells express-
ing ASC mutants that were no longer able to oligomerize and form specks (Y59A or
E80R) was not only dependent on caspase-1 (see research article II322) but also on
gasdermin-D. Furthermore, they implied that NLRC4-dependent, ASC-independent py-
roptosis was relying on gasdermin-D as well.
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2.3 Small-molecule inhibitor screen for ASC speck formation
Introduction
Even though aberrant inflammasome activation was implied in a variety of diseases,
current treatment options are limited and target mostly IL-1β signaling172,178. For some
diseases like rheumatoid arthritis or CAPS the IL-1β targeting drugs anakinra, rilona-
cept and canakinumab are approved for clinical use178,179,181. These drugs significantly
ameliorate disease outcome but there are some disadvantages. The first is the high
price ranging from 20’000 US$ up to 250’000 US$ per patient per year41–43. Addition-
ally, some of these drugs need to be administered by a daily subcutaneous injection
hampering patient compliance172,178,323. Furthermore, an increased incidence of bac-
terial infections, mainly with Streptococcus, occurs in patients treated with anakinra324.
For FMF on the other hand, colchicine is in use as a treatment since decades. Even
though colchicine does not display the two main disadvantages of the IL-1β target-
ing treatments as it can be administered orally and the price is considerably lower, it
still has some disadvantages. First, it only exhibits a very narrow therapeutic window
with possibly debilitating side effects and secondly some patients are unresponsive to
colchicine. Furthermore, the mechanism by which it ameliorates symptoms in FMF pa-
tients is poorly understood229–233. Therefore, the need for safe, easily administrable
and affordable treatments for these diseases persists.
Additionally, more and more data accumulate indicating that aberrant NLRP3 inflamma-
some activation is involved in multiple inflammatory diseases like diabetes, Alzheimers
disease or gout325–328. Novel work even implied obesity-induced NLRC4-dependent
IL-1β in breast cancer progression329. Thus, small-molecule inhibitors of inflamma-
somes would provide an alternative to the established treatments. Recently, two small-
molecule inhibitors of the NLRP3 inflammasome were described. Both, β-hydroxybu-
tyrate and MCC950 selectively inhibit NLRP3 activation while they did not influence
AIM2 or NLRC4 activation330,331. Yet, whether any of the two compounds or derivatives
thereof will ever be approved for clinical use in humans is not known.
Additional lead compounds would enhance the chance of bringing a new drug onto
the markets. Small molecules could also help to further elucidate the mechanisms by
which inflammasomes are regulated and, in the case of NLRP3, activated. Thus, we
performed a screen for small molecule inhibitors of ASC speck formation in immortal-
ized BMDMs and an in vitro screen for inhibitors of ASCPYD oligomerization. The goal
of the screen was to find compounds that specifically inhibit ASC oligomerization and
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would therefore reduce IL-1β secretion irrespective of the activated receptors.
Statement of contribution
The full screen was done in collaboration with Lorenzo Sborgi and Johanna Ude of
the group of Prof. Sebastian Hiller at the Biozentrum and performed with the BSF
(Biomolecular Screening Facility) at EPFL (Ecole Polytechnique Federale Lausanne). I
set up the initial protocol and performed the laboratory part of the screen in immortalized
BMDMs at the BSF while Fabien Kuttler of the BSF improved the protocol for the high
throughput screen as well as established and performed the image acquisition and
analysis. The in vitro screen was entirely done by Lorenzo Sborgi, Johanna Ude and
the BSF team.
Materials and methods
The screening cell lines was an Asc deficient immortalized BMDM cell line constitutively
expressing an ASC-mCherry fusion protein and being a functional (CRISPR) knock-out
for Casp1. This cell line was generated during the work for research article II and pub-
lished therein322. As the read out for the screen was formation of ASC specks, a cell
line expressing an ASC-mCherry fusion protein was chosen as this allowed skipping
the time and cost intensive staining step for ASC. The deficiency in caspase-1 was cho-
sen to enable an accumulation of cells with an ASC speck as these cells did not die
and detach through pyroptosis efficiently providing a higher dynamic range. The cells
were cultured in DMEM (Dulbecco’s modified Eagle’s medium, Sigma) supplemented
with 10% FCS (fetal calf serum) and 10% 3T3-MCSF (macrophage colony-stimulating
factor) supernatant at 37 ◦C with 5% CO2. Compounds were distributed in 384-well
plates in duplicates in DMSO (dimethyl sulfoxide) at a final concentration of 10µM.
DMSO alone served as negative control while MCC950330 served as positive control
for blocking NLRP3 dependent ASC specks. 10’000 cells/well were seeded in 40µL
using the Multidrop Combo dispenser (Thermo). The next day, 10µL/well LPS O55:B5
in medium was dispensed to get a final concentration of 100 ng/uL followed by 10 sec
shaking for a better distribution of the LPS. After 4 h, 10µL/well ATP (pH 7.0 in PBS
[phosphate buffered saline]) was dispensed per well for a final concentration of 5 mM
followed by 30 sec shaking. After 3.5 h, the cells were fixed with 4% PFA (final concen-
tration, Sigma) and concomitantly stained with 2.5µg/mL Hoechst (final concentration)
for 30 min at room temperature. Plates were washed three times with 1x PBS and im-
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aged using an automated microscope (GE Healthcare) with a 10x objective, 2x binning
and acquiring 4 images/well of both channels, ASC specks (red) and cell nuclei (blue).
Image analysis was done using CellProfiler and the percentage of cells containing an
ASC speck was calculated. In parallel, the reduction of absolute cell numbers served
as measurement for the toxicity of the compounds.
Results and discussion
The first screen was done using the Prestwick Chemical Library (http://www.prestwick-
chemical.com/prestwick-chemical-library.html). It consists of 1280 compounds which
are all approved for human use by administrations. The relative small size (eight 384-
well plates, including 32 wells per plate for the positive and 32 wells for the negative
control) of the library allowed for a proof of concept of the screen and showed that
hits can be found. The initial threshold to consider a compound as a hit was a rela-
tive reduction of speck formation by 25% compared with DMSO (negative control, 0%
speck reduction) and MCC950 (positive control, 100% relative speck reduction). Using
this, a total of 60 compounds were considered to be hits (Fig. 2.2). However, most of
the hits were detected due to a strong reduction of cell numbers of more than 66.6%.
Only 15 compounds diminished cell numbers by less than 33.3%. While many of the
compounds have no existing links to inflammasomes, there are some hits which were
previously described to inhibit the NLRP3 inflammasome.
Ebselen lead to a reduction of speck formation by approximately 30% in the screen.
It acts as hydrogen peroxide scavenger and was shown to inhibit NLRP3 inflamma-
some dependent IL-1β release153,332. The strongest hit of the Prestwick Chemical Li-
brary was auranofin (Fig. 2.2). Auranofin is a thioredoxin reductase inhibitor, inhibits
the NLRP3 pathway333 and it is used to treat rheumatoid arthritis, an inflammatory
disease with a known involvement of the NLRP3 pathway334,335. Additionally, multi-
ple members of the glucocorticoid family (betamethasone, prednisolone, fluticasone,
isoflupredone, lumethasone pivalate) were detected as hits. Glucocorticoids are reg-
ularly used to treat inflammatory conditions. They bind to the glucocorticoid receptor
leading to pleiotropic anti-inflammatory effects. Amongst others, glucocorticoids inhibit
NF-κB signaling336. Blocking NF-κB signaling prevents NLRP3 upregulation during the
LPS-priming step134,135 thereby leading to the reduction of ASC specks observed with
the glucocorticoid family members in this screen (Fig. 2.2).
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Thus, our initial concerns about the effect of blocking NF-κB signaling on speck for-
mation were confirmed. This might be circumvented by using a cell line constitutively
expressing NLRP3 thereby overcoming the necessary LPS priming step. A more so-
phisticated approach could use the inducible expression of constitutive active receptors.
This would allow to use not only ATP as an NLRP3 trigger, but also using CAPS asso-
ciated NLRP3 mutants and other receptor mutants like FMF associated Pyrin mutants
or LRR deficient NLRC4, which were shown to be constitutively active241. A problem
with this approach could be the need for de novo protein expression for inflammasome
activation opening up the possibility of finding other, inflammasome unrelated hits. This
might be circumvented by using co-expression of the receptor with a fluorophore from
the same promoter. All conditions where cells failed to induce fluorophore expression
would be disregarded as these compounds would block protein expression and would
therefore not be specific for inflammasome activation and speck formation.
In conclusion, the proof of concept screen was successful as known inhibitors were
found and blocking NF-κB signaling had an effect as well. So far, no new inhibitor was
found to be equally effective as MCC950 and non-toxic, but additional libraries will be
screened as well.
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Figure 2.2: Hits of the first screen with the Prestwick Chemical Library. Relative
reduction of speck numbers compared to the negative control DMSO (0%,
black) and positive control MCC950 (100%, black). All compounds reduc-
ing the relative speck numbers by more than 25% were considered as hits.
Colors correspond to the reduction of cell numbers by compounds, where
green denotes ≤33.3% reduction, orange 33.3%-66.6% reduction and red
≥66.6% reduction. Data represent mean and s.d. of duplicate wells.
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2.4 Generation and initial characterization of Casp12
knock-out mice
Introduction
As outlined in the introduction (see above), caspase-12 is an inflammatory caspase
closely related to caspase-1, murine caspase-11, human caspase-4 and human caspase-
5. However, caspase-12 is comparably ill-characterized and conflicting reports regard-
ing its role in inflammation and especially inflammasome signaling exist301,302,309–313.
Knock-out mice had previously been generated by disrupting the Casp12 gene in 129SV
mice embryonic stem cells, but were later shown to carry an inactivating passenger
mutation in the neighboring Casp11 gene, thus rendering them deficient in both cas-
pases312,313. Due to the conflicting reports of the physiological role of caspase-12, we
set out to generate a new Casp12 deficient mouse line employing the CRISPR-Cas9
system. The goal was to determine the role of murine caspase-12 in inflammasome
signaling, elucidate its physiological role and hopefully shed light on the selective pres-
sure driving the pseudogenization in humans.
Statement of contribution
The gRNA design and injection into murine embryos were done by Petr Broz and Pawel
Pelczar of the Centre for Transgenic Models of the University Basel. I designed the
breeding strategy, performed the sampling and sequencing of the offspring and per-
formed the initial testing of BMDMs.
2.4.1 Materials and methods
Generation and genotyping of Casp12 knock-out mice
gRNAs targeting exon 2 of the Casp12 gene were designed using CRISPR Design
(crispr.mit.edu) leading to the gRNA sequence (including PAM) atattatttttacagccaggagg.
Injection of gRNAs and Cas9 protein into mouse embryos was done as described be-
fore337. Offspring were marked and samples taken for genotyping (toes) at an age of 10-
12 days. DNA extraction was performed using the KAPA HotStart Mouse Genotyping
Kit according to the manufacturers protocol (Kapa). Genotyping PCR was done with Q5
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polymerase (NEB) according to the cycling protocol in Tab. 2.1 using primers Oligo.482
(Casp12exon2FW2; aagccaggcagctagtttga) and Oligo.483 (Casp12exon2RV2; gggata-
tggggaggtcagat), which were designed using Primer3 (http://bioinfo.ut.ee/primer3-0.-
4.0/338,339) giving a fragment of 923 bp. The standard reaction contained 31 µL H2O,
10 µL 5x Q5 polymerase buffer (NEB), 1 µL 10 mM dNTPs (Sigma), 2.5 µL of each
primer (10 µM, Sigma), 1.5 µL DMSO (Sigma), 1 µL of the template and 0.5 µL Q5
polymerase (NEB). PCR samples were run on 1% agarose gels (Sigma), DNA was
extracted from excised bands (Macherey-Nagel), and sequenced using Oligo.482 (Mi-
crosynth).
Table 2.1: Casp12 genotyping PCR cycling program.
Step Temp. Time
Initialization 98◦ 2 min
Denaturation 98◦ 10 sec
35 xAnnealing 67◦ 20 min
Elongation 72◦ 23 sec
Final elongation 72◦ 2 min
Hold 4◦ ∞
Cell culture
BMDMs were cultured in DMEM (Sigma) supplemented with 10% FCS (Bioconcept),
20% 3T3-MCSF supernatant, penicillin/streptomycin (Bioconcept), non-essential amino
acids (Bioconcept) and HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, Bio-
concept), and incubated at 37 ◦C with 5% CO2.
Inflammasome stimulation
Cells were seeded at 250’000 cells/mL in 96-well plates and primed with 100 ng/mL
Pam3CSK4 (Invivogen) overnight. NLRP3 inflammasome activation was triggered by
incubation with 20 µM nigericin (Invitrogen) for 60 min, the AIM2 inflammasome was
triggered by transfection of 1 µg/mL poly(dA:dT) (Invivogen) using 0.5 µL/well Lipofec-
tamine2000 (Invitrogen) in optiMEM (Gibco) for 2 h. The NLRC4 inflammasome was
triggered by infection of the cells with Salmonella enterica serovar Typhimurium SL1344
103
Results
at a multiplicity of infection of 10 for 60 min after a short centrifugation step (5 min, 1’000
rpm) to synchronize the infection. The non-canonical caspase-11 inflammasome was
triggered by transfecting 200 ng LPS O111:B5 (Invivogen) per well using FuGene HD
(Promega) according to the manufacturers instruction for 4 h.
Cell death and IL-1β release measurements
IL-1β release was measured by ELISA (enzyme-linked immunosorbent assay, eBio-
sciences). Cell death was quantified by measuring LDH (lactate dehydrogenase) re-
lease using the LDH Cytotoxicity detection kit (TaKaRa Clontech). To normalize for
spontaneous cell lysis, the percentage of cell death was calculated as follows: [(LDH
sample)-(LDH negative control)]/[(LDH positive control)-(LDH negative control)]x100.
2.4.2 Results and discussion
Figure 2.3: Alignments of mutant Casp12 alleles generated by CRISPR-Cas9. (a)
Exon structure of Casp12 (1260 bp, drawn to scale) with the alignment of
the section targeted by CRISPR-Cas9 of wild type Casp12 and the two
targeted knock-out alleles. (b) Schematic representation of the wild type
caspase-12 protein (420 amino acids) and the two hypothetical caspase-12
KO proteins (8 and 6 amino acids, respectively) with the alignments of the
respective amino acid sequences. Alignments performed using T-Coffee
(http://www.ebi.ac.uk/Tools/msa/tcoffee/72,73,340).
The gRNA and Cas9 protein injection into oocytes at the Center for Transgenic Mod-
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els of the University of Basel (www.ctm-basel.ch) yielded two different animals with a
targeted Casp12 sequence. These animals were transferred to the breeding facility of
the Biozentrum/Pharmazentrum and mated with wild type C57BL/6J mice. One of the
animals had a 4 base pair deletion and the other a 1 base pair insertion in exon 2 of
Casp12 on one allele (Fig. 2.3a). Both mutations lead to a premature stop codon and a
considerably shortened hypothetical transcript (Fig. 2.3b). Offspring of the first animals
were further crossed in order to establish a homozygous knockout line harboring a 4
base pair deletion in exon 2.
To test the involvement of caspase-12 in inflammasome signaling, BMDMs were gen-
erated from Casp12+/+, Casp12+/– and Casp12–/– animals and subjected to NLRP3,
AIM2, NLRC4 as well as non-canonical caspase-11 activation. The results suggested
that ablation of caspase-12 expression did influence neither canonical NLRP3 (Fig.
2.4a), AIM2 (Fig. 2.4b), NLRC4 (Fig. 2.4c) nor non-canonical caspase-11 (Fig. 2.4d)
signaling, i.e. pyroptosis and IL-1β release were unchanged compared to wild type
cells. These preliminary findings are in accordance with a recent publication where the
authors did not observe any difference in response to canonical inflammasome stimuli
in BMDMs and only a small, but not significant, reduction in cytokine secretion upon
LPS challenge or Listeria monocytogenes infection in Casp12 deficient mice313. How-
ever, bone marrow derived macrophages might not be the perfect model to study the
role of caspase-12. Even tough expression of caspase-12 can be induced up to 20
fold by LPS priming313 other cell types might express higher levels of caspase-12, for
example adipocytes or MEFs (mouse embryonic fibroblasts)311,312. Also other phe-
notypes attributed to caspase-12, e.g. the role in ER-stress induced apoptosis300,307,
the involvement in resistance to Plasmodium or West Nile virus infections309,311 or the
modulation of NOD and NF-κB signaling309,310 require careful review since most studies
have been done in either overexpression systems or Casp11/Casp12-double deficient
mice. Furthermore, the role of caspase-12 during infections with S. Typhimurium or F.
novicida in vivo remains to be investigated.
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Figure 2.4: Caspase-12 is not involved in canonical and non-canonical inflam-
masome signaling in murine BMDMs. (a-d) Release of LDH (assess-
ing cell death) and IL-1β from Pam3CSK4 primed Casp12+/+, Casp12+/–
and Casp12–/– BMDMs 1 h after nigericin treatment (20 µM, [a]), 2 h af-
ter poly(dA:dT) transfection (1 µg/mL [b]), 1 h after infection with S. Ty-
phimurium MOI 10 (c) or 4 h after transfection of LPS O111:B4 (1 µg/mL
[d]). Data are representative of two (a-c) or three (d) independent experi-
ments. Graphs show the mean and s.d. from quadruplicate wells.
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2.5 Generation of Gsdmd knock-out mice and involvement of
gasdermin-D in IL-1β secretion
Introduction
Recent publications30,31 showed that gasdermin-D plays a central role in pyroptosis
downstream of active caspase-1 and that caspase-1 cleaves and activates gasdermin-
D. The active gasdermin-D N-terminal fragment then forms a pore in the plasma mem-
brane which is theoretically large enough to accommodate the secretion of IL-1β and
IL-18317. However, there is no experimental evidence so far that gasdermin-D con-
stitutes the pore through which mature IL-1β or IL-18 is released. Therefore, we set
out to create a Gsdmd deficient mouse line to further study the role and function of
gasdermin-D and to elucidate weather it constitutes an IL-1β permissive pore. As for
Casp12 (see above) the mouse line was generated using the CRISPR-Cas9 system at
the Centre for Transgenic Models of the University of Basel.
Statement of contribution
The gRNA injection into murine embryos was done by Pawel Pelczar at the Centre for
Transgenic Models of the University Basel. I designed the breeding strategy, performed
the sampling and sequencing of the offspring and did the experiments presented here.
2.5.1 Materials and methods
Generation and genotyping of Gsdmd knock-out mice
gRNAs targeting exon 2 of the Gsdmd gene were designed as described30 leading to
gRNA sequence (including PAM) ggagaagggaaaatttctgg. Injection of the gRNAs and
Cas9 protein into mouse embryos was done as described before337. Offspring were
marked and samples taken for genotyping (toes) at an age of 10-12 days. DNA ex-
traction was performed using the KAPA HotStart Mouse Genotyping Kit according to
the manufacturers protocol (Kapa). Genotyping PCR was done with Q5 polymerase
(NEB) according to the cycling protocol in Tab. 2.2 using primers Oligo.507 (GS-
DMD ex2 fw2; ggttgtgagccaccgtctat) and Oligo.508 (GSDMD ex rv2; ctgtggagggactcc-
attgt), which were designed using Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/338,339) giv-
ing a fragment of 768 bp. The standard reaction contained 31 µL H2O, 10 µL 5x Q5
polymerase buffer (NEB), 1 µL 10 mM dNTPs (Sigma), 2.5 µL of each primer (10 µM,
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Sigma), 1.5 µL DMSO (Sigma), 1 µL of the template and 0.5 µL Q5 polymerase (NEB).
PCR samples were run on 1% agarose gels (Sigma), DNA was extracted from excised
bands (Macherey-Nagel), and sequenced using Oligo.507 (Microsynth).
Table 2.2: Gsdmd genotyping PCR cycling program.
Step Temp. Time
Initialization 98◦ 2 min
Denaturation 98◦ 10 sec
35 xAnnealing 68◦ 20 min
Elongation 72◦ 20 sec
Final elongation 72◦ 2 min
Hold 4◦ ∞
Cell culture
BMDMs were differentiated in DMEM (Sigma) supplemented with 10% FCS (Biocon-
cept), 20% 3T3-MCSF supernatant, penicillin/streptomycin (Bioconcept), non-essential
amino acids (Bioconcept) and HEPES (Bioconcept), and incubated at 37 ◦C with 5%
CO2. BMDCs (Bone marrow derived dendritic cells) were differentiated as described
before341. Red blood cells from the bone marrow were lysed with H2O for 5 seconds
before lysis was quenched with 10x PBS. The remaining cells were cultured in RPMI-
1640 (Sigma) supplemented with 10% FCS (Bioconcept), HEPES (Bioconcept), peni-
cillin/strepmycin (Bioconcept), 50 µM β-mercaptoethanol (Sigma) and 20 ng/mL recom-
binant murine GM-CSF (granulocyte macrophage colony-stimulating factor, Peprotech),
and incubated at 37 ◦C with 5% CO2. The cells were fed with medium after 2 days and
half the medium exchanged after 4 days. BMDCs were seeded after 6 or 8 days of
differentiation.
Inflammasome stimulation
BMDMs were seeded at 250’000 cells/mL and BMDCs at 500’000 cells/mL in 96-well
plates and primed with 100 ng/mL Pam3CSK4 (Invivogen) overnight. The NLRP3 in-
flammasome was triggered by incubation with 20 µM nigericin (Invitrogen), the AIM2
inflammasome was triggered by transfection of 1 µg/mL poly(dA:dT) (Invivogen) using
0.5 µL/well Lipofectamine2000 (Invitrogen) in optiMEM (Gibco) for 1 h after a short cen-
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trifugation (5 min, 1’000 rpm). The NLRC4 inflammasome was triggered by infection of
the cells with Salmonella enterica serovar Typhimurium SL1344 at a multiplicity of infec-
tion of 10 for 60 min after a short centrifugation step (5 min, 1’000 rpm) to synchronize
the infection process. The cytoprotectant glycine (Sigma) was added concomitantly to
inflammasome stimulation at a final concentration of 5 mM. The NLRP3 pathway de-
scribed by Underhill and colleagues152 was triggered by priming the BMDMs with 100
ng/mL LPS O55:B5 (Invivogen) for 3-4 h followed by treating the cells with 20 µg/mL
peptidoglycan from Staphylococcus aureus (Sigma), Bacillus subtilis (Sigma) or Strep-
tomyces sp. (Sigma) for 6 h after a short centrifugation (5 min, 1’000 rpm). Alternatively,
N-acetylglucosamine (Roth) or sucrose (negative control, Sigma) were transfected us-
ing Lipofectamine2000 (Invitrogen) according to the manufacturers protocol using a final
sugar concentration of 50 mM.
Cell death and IL-1β release measurements
IL-1β release was measured by ELISA (eBiosciences). Cell death was quantified by
measuring LDH release using the LDH Cytotoxicity detection kit (TaKaRa Clontech).
To normalize for spontaneous cell lysis, the percentage of cell death was calculated
as follows: [(LDH sample)–(LDH negative control)]/[(LDH positive control)-(LDH neg-
ative control)]x100. Membrane permeabilization was quantified by incubating cells
with 25µg/mL PI (propidium iodide, Sigma) in HBSS (Hanks’ balanced saline solution,
Gibco) for 5 min on ice and measuring fluorescence emission at 617 nm (excitation at
530 nm). Cells lysed by one freeze-thaw cycle served as positive control. Wells with-
out cells served as blank for the measurement. Percentage of PI positive cells was
calculated as follows: [(treated cells–blank)/(positive control–blank)]x100.
2.5.2 Results
The gRNA and Cas9 protein injection into oocytes at the Center for Transgenic Models
of the University of Basel (www.ctm-basel.ch) yielded a single male animal with one WT
allele and one targeted Gsdmd allele. This animal was transferred to the breeding facil-
ity of the Biozentrum/Pharmazentrum and mated with two wild type C57BL/6J females.
The targeted Gsdmd allele had a 2 bp deletion in exon 2 (Fig. 2.5a). The mutation
lead to a frame-shift resulting in a premature stop codon and thereby to a shortened
hypothetical transcript (Fig. 2.5b). Offspring of this first animal were further crossed
in order to establish a homozygous knockout line of Gsdmd. For functional analyses,
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Figure 2.5: Comparison of wild type and Gsdmd knock out. (a) Exon structure
of Gsdmd (1464 bp, drawn to scale) with alignment of the section tar-
geted by the CRISPR-Cas9 of the Gsdmd knock-out allele with the Gsdmd
wild type allele. (b) Schematic representation of the wild type gasdermin-
D protein (487 amino acids) and the hypothetical gadermin-D ”knock-out”
protein (111 amino acids, drawn to scale) with the alignment of the sec-
tions of wild type and ”knock-out” gasdermin-D. (c) Western blot analysis of
gasdermin-D expression in wild type and knock-out cells. Alignments per-
formed using the EMBOSS (Nucleotide or Protein Alignment) Needle Tool
(http://www.ebi.ac.uk/Tools/psa/71–73). Blot representative of three indepen-
dent experiments. * denotes unspecific bands.
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BMDMs were generated from homozygous knock-out animals. Western blotting con-
firmed successful ablation of gasdermin-D expression (Fig. 2.5c).
As expected30,31, stimulation of the canonical inflammasome receptors AIM2 by poly-
(dA:dT) transfection (Fig. 2.6a), NLRC4 by S. Typhimurium infection (Fig. 2.6b) or
NLRP3 by nigericin treatment (Fig. 2.6c) for short periods showed that gasdermin-D
deficient cells were deficient in cell death induction (LDH release and PI uptake) and
IL-1β secretion, similar as caspase-1/-11 deficient cells.
Figure 2.6: Canonical inflammasome activation in Gsdmd–/– BMDMs. (a-c) Quan-
tification of LDH release, PI uptake and IL-1β release in presence or ab-
sence of glycine after stimulation of (a) AIM2 by poly(dA:dT) transfection
(1 µg/mL for 1 h), (b) NLRC4 by S. Typhimurium infection (MOI 10 for 1h),
and (c) NLRP3 by treatment with nigericin (20 µM for 1h). Graphs show
means and s.d. from quadruplicate wells. Data are representative of three
independent experiments.
The result showed that gasdermin-D was required not only for cell death, but also for
cytokine release. The simplest explanation of this observation would be that lysis as
a result of pyroptosis result in the unspecific release of the mature cytokine. On the
other hand, IL-1β release could also proceed through the gasdermin-D pore itself. To
assess these possibilities, the cytoprotectant glycine was used342. Glycine prevents
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the cells from rupturing by preventing ion fluxes through non-specific leaks343. Indeed,
extracellular glycine reduced the release of LDH considerably (Fig. 2.6) while it did
not affect pore formation as PI incorporation was unaltered. Importantly, extracellular
glycine reduced IL-1β secretion only marginally. These results suggested that even
though pyroptosis contributed to the release of IL-1β, the largest part was released in
a pyroptosis-independent manner, possibly through the gasdermin-D pore.
Figure 2.7: Canonical inflammasome activation in Gsdmd–/– BMDCs. (a-c) Quantifi-
cation of LDH release, PI uptake and IL-1β release of bone marrow derived
dendritic cells (BMDCs) in presence or absence of glycine after stimulation
of (a) AIM2 by poly(dA:dT) transfection (1 µg/mL for 1 h), (b) NLRC4 by
S. Typhimurium infection (MOI 10 for 1h), and (c) NLRP3 by treatment with
nigericin (20 µM for 1h). Graphs show means and s.d. from quadruplicate
wells. Data are representative of two independent experiments.
These observations can also be extended to bone marrow derived dendritic cells (BM-
DCs) (Fig. 2.7). Again, cell death, PI influx and IL-1β release after stimulation of
canonical inflammasome receptors were dependent on caspase-1/-11 and also largely
dependent on gasdermin-D. Furthermore, blocking pyroptosis with glycine in wild type
BMDCs did only partially reduce IL-1β secretion while it strongly blocked LDH release,
again suggesting a pyroptosis-independent IL-1β release pathway in BMDCs.
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To further substantiate the role of gasdermin-D in pyroptosis independent IL-1β release,
the involvement of gasdermin-D in the recently described atypical NLRP3 pathway was
assessed152. Cytosolic N-acteylglucosamine derived from the peptidoglycan of gram-
positive bacteria displaces hexokinase from the mitochondrial outer membrane leading
to NLRP3 activation without the induction of pyroptosis152. Therefore, LPS primed WT
B6, Casp1–/–/Casp11–/– and Gsdmd–/– BMDMs were treated with peptidoglycan from
different gram-positive bacteria, i.e. Bacillus subtilis, Staphylococcus aureus and Strep-
tomyces sp. and the inflammasome signaling was analyzed (Fig. 2.8a). The response
was not equal to all of the peptidoglycans and S. aureus peptidoglycan generally elicited
the strongest response. LDH release levels as well as PI influx were generally low and
the small responses detected were largely independent of caspase-1/caspase-11 or
gasdermin-D. In comparison with published results152, the amounts of released IL-1β
were only small. Yet, it was clearly dependent on caspase-1/caspase-11 but indepen-
dent of gasdermin-D. Very similar results were obtained if N-acetylglucosamine was
transfected into BMDMs while transfection of sucrose did not elicit inflammasome ac-
tivation (Fig. 2.8b). These results indicate that not gasdermin-D-dependent but other,
lysis-independent, mechanisms are involved in IL-1β release in this atypical NLRP3
inflammasome pathway. Possible, previously described, IL-1β release mechanisms
would be exosome shedding or microvesicular release of IL-1β344.
Collectively, the results suggest that the generation of a Gsdmd deficient mouse line
was successful and the cells derived thereof behave as expected. Furthermore, gas-
dermin-D seems to play a role in IL-1β secretion beyond its role in pyroptosis. Yet, other
gasdermin-D-independent IL-1β release mechanism seem to exist.
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Figure 2.8: Atypical NLRP3 inflammasome activation by PGN treatment or NAG
transfection. (a) Treatment of WT B6, Casp1–/–/Casp11–/– and Gsdmd–/–
BMDMs with peptidoglycans (PGN) from different gram-positive bacteria for
6 h. (b) Transfection of N-acetylglucosamine (NAG) or sucrose for 6 h with
Lipofectamine2000. Graphs show means and s.d. of quadruplicate wells.
Results are representative of two independent experiments.
114
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Since the inception of the term inflammasome in 200228 immense advances were made
regarding function, regulation and structure of inflammasomes23,24. In parallel, it be-
came more and more evident that inflammasomes, especially the NLRP3 inflamma-
some, do not only play pivotal roles in fighting infections but they are also important
drivers of many non-communicable diseases like rheumatoid arthritis or gout345–347.
Still, many open questions regarding the underlying molecular mechanisms remain. In
this work we elucidated the structure and signal transduction mechanism of the murine
ASC speck, an important component of the inflammasome. Yet, most of the data pre-
sented in this thesis were already published and thus discussed in the respective arti-
cles (research article I and II321,322). Therefore, in this section only further considera-
tions regarding the results will be addressed.
How comparable is the structure of the ASCPYD filament to other innate
immunity-related filaments?
A common feature of proteins belonging to the death fold subfamilies is the ability
to form higher order filaments and the structure has been solved for selected fila-
ments of all subfamilies81,348–350. However, not all filaments display the same ar-
chitecture. While the human and murine ASCPYD filaments are right-handed three-
start helices81,321, the short AIM2PYD filaments and the caspase-1CARD filaments are
single-start helices100,194. The AIM2PYD filaments display a right-handed orientation
and the caspase-1CARD filaments display a left-handed orientation100,194. The non-
inflammasome filaments formed by the CARD of MAVS (mitochondrial anti-viral sig-
naling), which is involved in antiviral signaling, or formed by the CARD of Bcl-10 (B-
cell lymphoma 10), which is involved in NF-κB signaling, display both a left-handed,
single-stranded helical structure349,351. A slightly different organization is presented
by the tandem DEDs (death effector domain) of caspase-8 (caspase-8tDED). Despite
the low sequence conservation between the two caspase-8DEDs, they take over quasi-
equivalent roles in the filament. Even though always two subunits are covalently linked,
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the parameters of the caspase-8tDED filament are very similar to the ones of the ASCPYD
filament350.
Thus, even though the formation of helical filaments is a conserved feature of death
fold domains, the proteins assemble in different conformations despite the similar ter-
tiary structures of all death fold domains. As helical filaments are conserved, they must
provide a clear evolutionary advantage. It has been suggested that filament formation
serves to elicit a digital all-or-none signal amplification mechanism. This is in contrast
to the gradual signal amplification by second messenger controlled mechanisms like
the cGAS (cyclic GMP-AMP synthase) – cGAMP (cyclic guanosine monophosphate-
adenosine monophosphate) – STING (stimulator of interferon genes) pathway352,353.
Filaments are assembled as soon as the stimulation reaches a certain threshold. This
filament assembly then leads to signal amplification and the initiation of a downstream
effect, for example caspase-1 activation in the case of ASC. Therefore, a small in-
flammatory stimulus could trigger an immense inflammatory reaction through filament-
dependent signal amplification. The results from our structure-guided mutagenesis ap-
proach (research article II322) support this model.
Why is the ASCCARD flexibly unfolded in the ASC filament structure?
The NMR structure determination of the ASC filament suggested that while the ASCPYD
forms the rigid filament backbone, the ASCCARD is dynamically disordered on the out-
side of the filament (research article I321). However, the structure of the monomeric, sol-
uble ASC published by de Alba showed that only the linker is flexible but the ASCCARD
adopts, as the ASCPYD, a defined tertiary structure77. There are several possibilities
why the ASCCARD was not completely folded in the ASC filament in our structural anal-
ysis. First and foremost, the solution NMR spectra of monomeric ASC were recorded
at an acidic pH in order to prevent ASC oligomerization77 while we recorded the fila-
ment structure at a neutral pH. Thus, different pH could influence the structure of the
ASCCARD.
Alternatively, a partially folded ASCCARD at a neutral pH might reflect the situation
in vivo. In this scenario, the ASCCARD would only adopt a fixed conformation upon
binding of an interaction partner, i.e. another ASCCARD or caspase-1CARD. A com-
pletely different possibility would be that an only partially folded ASCCARD reduces
ASCCARD/ASCCARD interactions in vivo and thus keeps the ASC speck less dense (see
below).
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Lastly, the flexibly unfolded ASCCARD in the ASC filament could constitute an in vitro
artifact. The oligomerization conditions employed prior to structure determination might
have been unfavorable for ASCCARD folding and changing the conditions could sup-
port folding. Alternatively, a posttranslational modification might be required for proper
ASCCARD folding at neutral pH but not at acidic pH. Phosphorylation of human ASCCARD
Y146 (or Y144 in murine ASC) in a Syk and/or JNK dependent manner was shown to
be important for speck formation after NLRP3 and AIM2 activation107–109. This phos-
phorylation was absent in vitro as ASC was purified from E. coli for structure deter-
mination. A possibility to assess whether ASCCARD phosphorylation is important for
proper ASCCARD folding would be the introduction of a phosphomimetic mutation in the
ASCCARD. Alternatively, ASC could be phosphorylated in vitro or purified from cells
where this phosphorylation is taking place. Furthermore, the NMR structure determi-
nation could be done in presence of unlabeled caspase-1CARD or ASCCARD to check
whether an interaction partner is required for complete ASCCARD folding. The difficulty
with the last approach is, however, the intrinsic propensity of CARDs to aggregate into
filaments themselves86,100. In any case, further experimental work is needed to clarify
why the ASCCARD is flexibly unfolded in the ASC filament in vitro and what the folding
state of the ASCCARD is in vivo.
How do CARD-containing receptors like NLRC4 initiate ASC speck formation?
The CARD-containing inflammasome receptors like NLRC4 or murine NLRP1b pos-
sess CARDs instead of PYDs as protein-protein interaction modules65,258. Our re-
sults suggested that these receptors do not nucleate ASCPYD filaments directly but
rely on CARD/CARD interactions to recruit bridging ASC molecules which in turn nu-
cleate ASCPYD filaments (see Figure 7 of research article II322). Recently, Schmidt
and colleagues also investigated this question but employed a different approach354.
They expressed a fluorophore-tagged nanobody directed against the human ASCCARD
in the monocytic cell line THP-1. Their results show that the anti-ASCCARD nanobody
assembles along ASC filaments indicating that also in the case of NLRC4 activation
ASC oligomerization is mediated via the ASCPYD. Importantly, they also reached the
conclusion that CARD-containing receptors require bridging or linking ASC molecules
to nucleate ASC oligomerization. This process is functional even in the presence of the
anti-ASCCARD nanobody as only a few ASC molecules with free ASCCARDs are required
to interact with NLRC4 and initiate ASCPYD filament formation354. Since they used a
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human and we employed a murine system, the mechanism of ASC recruitment and
filament initiation by CARD-containing receptors seems to be conserved.
An important question regarding speck initiation by CARD-containing receptors re-
mains. One activated NAIP recruits 9-11 NLRC4 molecules together assembling a
wheel-shaped complex with a 10-12 fold symmetry242–245. How is this 10-12 fold sym-
metry transformed into the three-start helix of the ASCPYD filament?
One possibility would be that the NLRC4CARDs recruit ASCCARDs in an unstructured way
thereby leading to a locally increased concentration of ASCPYDs which auto-nucleate
and form the filament. Another possibility is that only some of the NLRC4CARDs take
part in ASC recruitment. For example three or six NLRC4CARDs would assemble into a
disk- or filament-like structure to which ASC would be recruited via the ASCCARD, ini-
tiating ASCPYD filament formation. The third possibility would be that all NLRC4CARDs
participate in a short filament-like structure and ASC is recruited via its CARD to this
short NLRC4CARD filament. The observation that the presence of NLRC4CARDs leads to
an aggregation of two disk-like NAIP/NLRC4 structures244 suggests that NLRC4CARDs
are capable of interacting with each other, at least in vitro. Thus, it seems unlikely
that only some NLRC4CARDs are involved in ASC recruitment or that NLRC4CARDs do
not form any ordered superstructure favoring the third possibility. In any case, further
experimental work is required. For example, one might reconstruct the NAIP/NLRC4
inflammasome in vitro in presence of full-length ASC, ASCCARD only or ASCCARD mu-
tants that are not able to interact with themselves anymore but still with the NLRC4CARD.
Structure determination with these extended NAIP/NLRC4 complexes might shed light
on the organization of the NLRC4CARD in the receptor complex. Yet, again the propen-
sity of CARDs and PYDs to auto-aggregate could impede such an approach.
Another open question is why both, CARD- and PYD-containing inflammasome recep-
tors are present in the same organism? Evolutionary, the CARD seems to be older than
the PYD as CARD-containing proteins along with DD (death domain)-containing pro-
teins are present in Drosophila melanogaster and Caenorhabditis elegans while PYD-
and DED-containing proteins appeared only later in zebrafish74. Thus, the direct inter-
action between NLRC4 and caspase-165 seems to be evolutionary older than the inter-
action between PYD-containing receptors and ASCPYD. This implies that PYD/PYD in-
teractions in inflammasome signaling has evolved later and possibly surpassed CARD/
CARD interactions for the largest part. This offers an explanation why more PYD-
containing inflammasome receptors exist than CARD-containing receptors24. The re-
maining CARD-containing receptors like NLRC4 might have survived due to a specific
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selective advantage. It might be possible that the direct NLRC4/caspase-1 interaction,
which only leads to pyroptosis but not cytokine maturation and release64, provides a
sufficient defense mechanism in some cases. Alternatively, distinct expression patterns
of the different inflammasome components could be a reason for the retention of CARD-
containing receptors. Some cell types might only express NLRC4 and caspase-1 but
not NLRP3 or ASC. Thus, these cells would still be able to fight infections elicited by
some bacteria but would not release IL-1β and possibly confine the ensuing inflamma-
tion locally.
What are the advantages of an ASC speck compared to ASC filaments?
Our results presented in research article II322 put forth a model in which the ASC speck
is formed by ASCPYD filaments, which are bound together by ASCCARDs. Using the ex-
pression of the human anti-ASCCARD nanobody, Schmidt and colleagues354 proposed
the same model of how the ASC speck is built up. As they investigated the human and
we investigated the murine system, the results suggest that the architecture of the ASC
speck is conserved amongst mammals. Even in various fish species, the most distantly
related animals expressing an ASC homologue, ASC is able to oligomerize into speck-
like structures355–358. Thus, it seems that speck formation is an intrinsic property of all
ASC homologues.
But why did ASC evolve to form the dense specks and not just filaments? One possi-
bility would be to increase the local concentration of caspase-1 more than what would
be possible with filaments alone. But would that even be required? It was reported that
the caspase-1CARD is able to form filaments itself, at least in vitro, which would increase
the local concentration of caspase-1 by itself81,100. Additionally, it was shown that there
is at least 3.5-fold more caspase-1 in the ASC speck than ASC itself81. Yet, the ASC
speck is also formed in absence of caspase-1 that speck formation is an intrinsic prop-
erty of ASC64. Therefore, it seems that there would be more space for caspase-1CARD
filaments if ASC formed only filaments instead of specks and this could in turn lead to
a more active caspase-1. Yet, there has to be an evolutionary reason why specks are
favored over filaments.
So far it is not clear to what extent caspase-1CARD filaments are formed in cells and
whether ASC filaments would be more efficient in caspase-1 activation than the ASC
speck itself. To test whether ASC speck formation is required for inflammasome signal-
ing, a similar approach than we used for the ASCPYD might be employed. Point muta-
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tions in the ASCCARD might be found which abrogate ASCCARD/ASCCARD interactions
and thus ASC speck formation86,322, yet these mutants would need to be able to interact
with the caspase-1CARD as efficiently as wild type. As neither the ASCCARD/caspase-
1CARD nor the ASCCARD/ASCCARD interactions are characterized, finding these muta-
tions using a direct approach might prove difficult. Alternatively, a screen-like approach
with a library of ASCCARD mutants could be used. An example would be a two-step
yeast-2-hybrid approach screening for retained interaction with caspase-1CARD but loss
of interaction with wild type ASCCARD.
An approach to determine the presence of caspase-1 filaments in cells might be the
expression of catalytic inactive caspase-1, which is expected to be retained in the ASC
speck. Additionally, the ASC speck could be rendered less dense by introducing low lev-
els of ASCCARD mutants that interfere with ASC crosslinking thus allowing better obser-
vation of the ASC speck architecture86,322. This would allow the detection of caspase-1
filaments by immunofluorescence or even high resolution microscopy.
If the long caspase-1CARD filaments81,100 were in vitro artifacts, the ASC speck would
indeed be required to increase the local concentration of caspase-1 to enhance its
auto-activation. But if the caspase-1CARD filaments were found in cells at physiological
caspase-1 levels, they would increase caspase-1 concentrations on their own. But why
having a speck in the latter case? It could either enhance caspase-1 activation more or
be a consequence from the architecture of ASC. Speck formation would have evolved
in parallel to the ASC/caspase-1 interaction and if ASC formation speck was at least not
disadvantageous, it would have been retained during evolution. Yet, the truth might also
lie somewhere in between and in any case, the relevance for caspase-1CARD filaments
in vivo needs to be determined before this question might be answered.
How is the inflammasome regulated on the level of ASC speck formation?
Our hypothesis that the ASC oligomerization is only required for cytokine processing but
not for pyroptosis (research article II322) opens up some interesting theoretical possibil-
ities for cell-intrinsic inflammasome regulation. If any of the proposed post-translational
modifications on ASC, e.g. phosphorylation of Y144 (or Y146 in human ASC), blocked
only ASCCARD/ASCCARD interactions but left the interaction with caspase-1 mostly in-
tact, this would only block cytokine release but not pyroptosis. While the effect of
missing ASC Y144 phosphorylation on IL-1β processing and release is well docu-
mented107,108,227, its effect on NLRP3 or AIM2 dependent cell death is not yet reported.
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This leaves the possibility that pyroptosis is not affected. Thus, it might be possible
that Syk-dependent ASC Y144 phosphorylation by Pyk2 is only required for cytokine
processing but not pyroptosis.
Besides posttranslational modifications, POPs (pyrin only proteins) and COPs (CARD
only proteins) can regulate inflammasome signaling, specifically IL-1β secretion115,116.
But the mode of action of these two protein families is controversially discussed. This
controversy probably originated from the use of different model systems or different
overexpression levels. POP1 was initially proposed to enhance IL-1β secretion but
was later shown to block both NLRP3 dependent IL-1β release and pyroptosis by in-
teracting with ASCPYD and thus blocking NLRP3/ASC interaction. This prevents ASC
speck formation, caspase-1 recruitment and activation122,124. POP1 also blocks AIM2
and NLRC4 dependent IL-1β release124 but the effect on AIM2 or NLRC4 dependent
pyroptosis was not reported. Even though it is likely that AIM2-dependent pyroptosis
is blocked as well, it is possible that AIM2-dependent pyroptosis is unchanged if the
AIM2/ASC interaction is not blocked by POP1. The same is probably true for NLRC4-
dependent pyroptosis as it can progress even in absence of ASC64. If pyroptosis is not
affected, two different mechanisms could be envisioned. First, POP1 could integrate
into the ASCPYD filament without obstructing filament formation yet increasing the dis-
tance between ASCCARDs rendering them unable or at least less efficient in caspase-1
recruitment and activation. Therefore, only low levels of caspase-1 would be active
and unable to effectively mature cytokines. The second possibility would be that POP1
blocks ASCPYD oligomerization and this is the mechanism by which caspase-1 recruit-
ment and activation is blocked. High resolution microscopy could provide an answer to
this question as in the first case ASC filaments should be observed but not in the latter.
The literature concerning the role of COPs is even more complicated than for POPs115,116.
The short isoform of CARD16 was reported to interact with ASC and caspase-1 and to
promote the formation of caspase-1 filaments and therefore IL-1β maturation119. Yet,
it remains unknown how CARD16 could integrate into caspase-1CARD filaments and
promote caspase-1 activation while not separating the catalytic domains of caspase-
1 too far apart for proximity-induced autocatalytic activation. A possibility would be
that the ASCCARD/CARD16 and CARD16/caspase-1CARD interactions are stronger than
ASCCARD/caspase-1CARD interactions. Therefore, CARD16 could promote the associ-
ation of caspase-1 with the ASC speck in an adaptor-like manner. This would suggest
that CARD16 facilitates the formation of caspase-1 filaments leading to more active
caspase-1 and thus higher levels of mature IL-1β. Yet, the authors did not investigate
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the effect of CARD16 on pyroptosis119 but based on our results, it might be expected
that CARD16 does not change pyroptosis as the levels of pyroptosis are largely inde-
pendent of the levels of caspase-1 activation.
CARD17, also known as INCA (inhibitory CARD), was reported to interact with caspase-
1CARD and block formation of caspase-1CARD filaments by a capping mechanism ef-
ficiently blocking IL-1β maturation after NLRP3 activation, at least when CARD17 is
overexpressed100. This is in agreement with our results that blocking caspase-1 auto-
processing leads to reduced levels of IL-1β maturation (research article II322). Once
again, the effect of CARD17 overexpression on pyroptosis was not reported leaving the
possibility that it is not affected by CARD17.
Thus, the discrepancy of the requirement of ASC speck formation for cytokine mat-
uration and pyroptosis might be important for cell-intrinsic inflammasome regulation.
Especially POPs and COPs have the potential to differentially regulate cytokine secre-
tion and pyroptosis, at least in humans and related primates. In rodents, which lack
COPs and POPs, this role might be taken over by the various known ASC isoforms
whose functions are only poorly characterized so far130,131. But also humans have dif-
ferent ASC isoforms131 and therefore inflammasome regulation by ASC isoforms might
represent a more ancient regulatory mechanism compared to the evolutionary younger
COPs and POPs.
Collectively, regulation of ASC speck formation, may it be organ, tissue or time spe-
cific, could provide the host with a possibility to mitigate the potentially debilitating out-
comes of prolonged inflammasome activation. However, the effects on pyroptosis by
the various cell-intrinsic mechanisms are only poorly studied and thus warrant further
investigations.
How could the function of the ASC speck affect treatment of inflammatory
diseases?
The pivotal role of the ASC speck for generation of bioactive IL-1β and IL-18 puts it forth
as a possible drug target. Blocking ASC speck formation but not the interaction between
ASC and the receptor by a drug could be expected to block IL-1β release but not py-
roptosis. The advantage of such a drug would lie in the receptor independence. It could
potentially be used in NLRP3 associated diseases like CAPS (cryopyrin-associated
periodic syndrome), gout or rheumatoid arthritis but also Pyrin-associated FMF (famil-
ial Mediterranean fever), NLRC4 associated MAS (macrophage activation syndrome)
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and even AIM2 associated psoriasis172,173,187,214,215,253–255. Furthermore, pyroptosis
was shown to be the main inflammasome-mediated innate immune effector mecha-
nism against some bacterial infections, e.g. S. Typhimurium50. Therefore, even long
term use of such a drug, as required for the treatment of autoinflammatory disorders, is
not expected to be associated with an increased risk of infection with S. Typhimurium
and similar bacteria. A drug that is currently used in rheumatoid arthritis and CAPS
patients is the IL-1 receptor antagonist anakinra. Anakinra treatment was, however,
shown to be associated with an increased risk of infections with gram-positive bacteria,
especially GAS (group A streptococcus)324. A potential drug targeting ASC speck for-
mation would also block IL-1β signaling systemically. Thus it might increase the risk for
GAS infections similar to anakinra treatment.
An alternative approach would aim at finding a drug that specifically targets the inter-
action between ASC and a single receptor, e.g. NLRP3 that was shown to be involved
in multiple different inflammatory diseases325–328. Such a drug would block both, cy-
tokine release as well as pyroptosis after activation of a specific receptor. But it would
not impair the function of any other inflammasome receptor leaving them capable of
fighting infections. The disadvantage of such an approach would be that every receptor
would need its specific inhibitor thus increasing cost and time for development of new
and efficient therapies.
Does gasdermin-D form the pore through which IL-1 is released?
It was recently shown that gasdermin-D is the central executioner of canonical and non-
canonical pyroptosis30,31. The active N-terminal domain of gasdermin-D is able to insert
itself into the plasma membrane and form a pore consisting of 16-24 monomers with a
diameter of approximately 15 nm317–319. Furthermore, in absence of gasdermin-D nei-
ther caspase-1 nor the biologically active IL-1β and IL-18 are released from the cell30,31.
This was also confirmed by our experiments with Gsdmd deficient macrophages and
dendritic cells. However, whether IL-1β is released unspecifically by pyroptosis, i.e.
during cell bursting, or specifically through the pore formed by gasdermin-D is not yet
known. In favor of the latter speaks the fact that the pore formed by gasdermin-D is
large enough to facilitate the crossing of IL-1β and IL-18 with diameters of approxi-
mately 4.5 nm317 but direct experimental evidence was missing so far.
We used the cytoprotectant glycine in the cell medium to prevent pyroptosis and thereby
123
Discussion and Outlook
pyroptosis-dependent IL-1β release342,343. Glycine did not diminish IL-1β release but
significantly decreased the levels of pyroptosis suggesting that IL-1β release was inde-
pendent of cell lysis. This was further substantiated by the fact that IL-1β was released
from vesicles through a gasdermin-D pore in vitro (Lorenzo Sborgi, personal communi-
cation) and that neutrophils, which did not show caspase-1 dependent pyroptosis, re-
leased IL-1β in a gasdermin-D dependent manner (Etienne Meunier and Rosalie Heilig,
personal communication). It is, however, clear that pyroptosis also lead to unspecific
release of processed IL-1β along with the cyotosolic contents. Recently, an atypical
NLRP3 pathway was described152. Cytosolic N-acetylglucosamine from gram-positive
bacteria leads to dissociation of hexokinase from the mitochondria leading to activation
of NLRP3. This pathway only leads to the release of IL-1β but not pyroptosis152. Our
results showed that IL-1β release after atypical NLRP3 activation was independent of
gasdermin-D clearly suggesting additional IL-1β release mechanisms.
Collectively, our experimental evidence supports a model in which the gasdermin-D
pore is able to facilitate IL-1β and probably IL-18 secretion. However, direct experi-
mental confirmation in cells is still missing. Furthermore, many open questions remain:
How specific is the gasdermin-D pore and how is this specificity established? Does
the gasdermin-D pore only release IL-1β and IL-18, all IL-1 family cytokines, other cy-
tokines or even everything below a certain size? Are pores formed by other gasdermin
family members able to facilitate IL-1β secretion? Is this process reversible? What are
the signals and proteases activating and cleaving other gasdermin family members?
Is the late, gasdermin-D independent cell death and IL-1β release after activation of
canonical inflammasomes described by Kayagaki and colleagues30 dependent on an-
other gasdermin pore? Why did multiple IL-1β release mechanisms evolve and what
is the purpose of them? And how important is IL-1β release through the gasdermin-D
pore in vivo?
Some of these questions might be easily addressed experimentally. The specificity of
the gasdermin-D pore but also the ability of other gasdermins to release IL-1β could
be addressed in a liposome release assay in vitro. Additionally, the released cellular
contents by the gasdermin-D pore could be assessed by Western blot or mass spec-
trometry. This should be done in presence and absence of glycine assessing the re-
lease via pores versus nonspecific lysis. Furthermore, the established Gsdmd deficient
mouse line enables the elucidation of the role of gasdermin-D in vivo during bacterial
infections.
124
Discussion and Outlook
What are the technical limitations of the approaches presented here and how
could they be overcome?
We performed most of the experiments with a classical retroviral expression system in
immortalized bone marrow derived macrophages using fluorescently labeled proteins.
Thus, our model system offered an improvement over inflammasome reconstitution sys-
tems used in many previous studies79–81,85,86 as we only needed to manipulate the ex-
pression of a single component of the inflammasome while keeping all other proteins at
physiological levels. Yet, there are shortcomings associated with every model system
employed in biological sciences.
A first limitation comes from the fluorophore tag itself. Using fluorophore tags on ASC
poses the risk of interfering with the native function of ASC and presented us some
difficulties regarding degradation of the fluorophore tags. To circumvent this, small
epitope-tags like HA (hemagglutinin) or V5 could reduce the risks of protein degrada-
tion and interference with protein function.
A second limitation comes from the retroviral expression system. Retroviral constructs
integrate randomly and with multiple copies into the genome frequently leading to over-
expression of the protein359. With the emergence of the CRISPR-Cas9 system it be-
came feasible to introduce mutations or epitope-tags in the native locus thus leaving
expression levels unchanged360. Currently, the efficiency of CRISPR-Cas9 mediated
mutations is relatively low resulting in a time consuming process to set up and confirm
mutated cell lines. The best approach to overcome classical retroviral expression sys-
tems would be a transgenic mouse model. However, setting up a mouse model requires
even more time and is associated with high costs.
However, in a fast moving field time is always an issue and using a model system which
can be set up relatively quick is advantageous. In any case, the model system cho-
sen for our work proved to be efficient and reliable enough as a completely different
approach corroborated parts of our results354.
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Caspase-11 activation requires lysis of
pathogen-containingvacuolesbyIFN-inducedGTPases
Etienne Meunier1, Mathias S. Dick1*, Roland F. Dreier1*, Nura Schu¨rmann1, Daniela Kenzelmann Broz2, Søren Warming3,
Merone Roose-Girma3, Dirk Bumann1, Nobuhiko Kayagaki3, Kiyoshi Takeda4, Masahiro Yamamoto4 & Petr Broz1
Lipopolysaccharide fromGram-negative bacteria is sensed in thehost
cell cytoplasmby a non-canonical inflammasome pathway that ulti-
mately results in caspase-11 activation and cell death1–3. In mouse
macrophages, activation of this pathway requires the production of
type-I interferons4,5, indicating that interferon-induced genes have
a critical role in initiating this pathway.Herewe report that a cluster
of small interferon-inducibleGTPases, the so-calledguanylate-binding
proteins, is required for the full activityof thenon-canonical caspase-11
inflammasome during infections with vacuolar Gram-negative bac-
teria.Weshowthatguanylate-bindingproteinsare recruited to intra-
cellular bacterial pathogens and are necessary to induce the lysis of
the pathogen-containing vacuole. Lysis of the vacuole releases bac-
teria into the cytosol, thus allowing the detection of their lipopo-
lysaccharide bya yet unknown lipopolysaccharide sensor.Moreover,
recognition of the lysed vacuole by the danger sensor galectin-8 ini-
tiates the uptake of bacteria into autophagosomes, which results in
a reduction of caspase-11 activation. These results indicate that host-
mediated lysis of pathogen-containing vacuoles is an essential immune
function and is necessary for efficient recognition of pathogens by
inflammasome complexes in the cytosol.
Previous studies have reported that induction of caspase-11-dependent
cell death by Gram-negative bacteria requires Trif-dependent production
of type-I interferons (type-I-IFNs)4,5 (Extended Data Fig. 1a). Type-I-
IFN production is however not required for pro-caspase-11 induction4,6,7
and is dispensable for caspase-11 activation by transfected lipopolysac-
charide (LPS; Extended Data Fig. 1b)2. This indicates that interferon-
stimulated genes (ISGs) play a major role in activating caspase-11 in
response to intracellular bacteria. To investigatewhich ISGswere involved
in activating caspase-11,weusedproteomics-based expression analysis
to identify proteins that were highly induced following Salmonella infec-
tion. Among the most strongly upregulated proteins were interferon-
inducedGTPases, suchas the large 65–67kDaguanylate-bindingproteins
(GBPs) and small 47 kDa immunity-related GTPases (IRGs) (data not
shown). These proteins function in cell-autonomous immunity, that is,
mechanismsthatallowhostcells tokillpathogensorrestrict their replication,
and have even been associatedwith the activation of inflammasomes8–10.
Mice have 11 GBPs, which are highly homologous and are clustered
in two genomic loci on chromosomes 3 and 5, respectively8,11. Recently,
GBPs on chromosome 3 have been shown to restrict the replication of
Toxoplasma gondii inperitonealmacrophages andmice11.We therefore
infected bone-marrow-derived macrophages (BMDMs) from Gbpchr3
KOmice,which lackGBP1, 2, 3, 5 and 7 (ExtendedData Fig. 2a–e), and
wild-type littermateswithanumberofGram-negativevacuolarpathogens
that trigger caspase-11 activation (data not shown)1,4,5 and determined
the activity of the non-canonical inflammasome pathway at 16 h post-
infection (Fig. 1a, b).Macrophages fromGbpchr3KOmice showed a sig-
nificant reduction of cell death (as measured by lactate dehydrogenase
(LDH) release) and IL-1b secretion when infected with wild-type Sal-
monella typhimurium, a type three secretion system (T3SS)-deficient
mutant of S. typhimurium (DSPI-2), Vibrio cholerae, Enterobacter clo-
acae or Citrobacter koseri (Fig. 1a), and this was independent of LPS
or polyinosinic:polycytidylic acid (poly(I:C)) priming (Extended Data
Fig. 2f, g).Gbpchr3-deficiency also reduced secretion of caspase-1 p20 sub-
unit, caspase-11andmature IL-1b, IL-18andIL-1a (Fig. 1b).Because inter-
ferons induceGBP expression (ExtendedData Fig. 2b, c)8, we investigated
whether IFN-c treatment would accelerate LDH release in response to
Salmonella infection. IFN-c-treated wild-type BMDMs released LDH
as soonas4hafter infection,whereasGbpchr3KOBMDMsfailed to release
LDHat early time points even after IFN-c priming (Fig. 1c), indicating
thatGBP inductionwas required for activityof thenon-canonical inflam-
masome pathway.
Wenext exploredwhetherGBPsplay a role in theactivationof canon-
ical inflammasomes. LPS-primed wild-type and Gbpchr3-deficient mac-
rophages released comparable levels of LDH and mature IL-1b when
infectedwith logarithmic phase S. typhimurium, which exclusively engage
theNLRC4inflammasomevia theSPI-1T3SS(Fig.1d)12. Similarly,Gbpchr3-
deficiency did not affect AIM2 inflammasome activation upon poly
(deoxyadenylic-deoxythymidylic) acid (poly(dA:dT)) transfection (Fig. 1d).
Although GBP5 had been previously linked to NLRP3 activation9, we
did not observe a defect in NLRP3 activation inGbpchr3KOs (Fig. 1d),
possibly owing to differentmodes of pre-stimulation. These data indi-
cate that GBPs are dispensable for canonical inflammasome activity,
but are required for the activation of the non-canonical inflammasome
pathway.
To investigate whether GBPs directlymediated the detection of intra-
cellular LPS, we engaged the non-canonical inflammasome by trans-
fecting macrophages with different types of ultra-pure LPS (Fig. 1e).
Cytoplasmic LPS triggered LDH release and IL-1b secretion to a sim-
ilar extent in both wild-type andGbpchr3-deficient BMDMs, indicating
that GBPswere required upstreamof LPS sensing and only during bac-
terial infection.Wenext investigated ifGBPswere required for immune
detection of vacuolar or cytosolic bacteria by infecting BMDMs with
DsifA S. typhimurium and Burkholderia thailandensis, which rapidly
enter the cytosol and activate caspase-11 (ref. 13). UnprimedGbpchr3KO
andwild-typeBMDMsrespondedcomparably to thesebacteria (Extended
Data Fig. 3a–c). Because GBPs might affect this response when pre-
induced, we also infected IFN-c-primed BMDMs with DsifA S. typhi-
murium (Extended Data Fig. 3d). IFN-c-priming indeed resulted in a
small difference betweenwild-type andGbpchr3KOBMDMsafter infec-
tion with DsifA Salmonella, yet not to the extent seen with wild-type
Salmonella (Fig. 1c), indicating that GBPs mainly participate in the
activation of the non-canonical inflammasome by vacuolar bacteria.
Finally, to investigate which GBP controls caspase-11 activation, all
11 murine Gbps were individually knocked down in BMDMs and the
cells were infected with flagellin-deficient Salmonella, which activate the
non-canonical inflammasome but not NLRC4 (Extended Data Fig. 4a
and Supplementary Information)4. Only knockdown of Gbp2 resulted
in reduced LDHrelease and IL-1b secretion (ExtendedData Fig. 4b–d).
*These authors contributed equally to this work.
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To validate these data we obtained BMDMs from Gbp22/2 mice and
wild-type littermates14 and infected themwith vacuolarGram-negative
bacteria. As expected, we observed reduced levels of cell death, cytokine
secretion and caspase release in Gbp22/2 BMDMs, indicating attenu-
ated activationof thenon-canonical inflammasome (Fig. 1f andExtended
Data Fig. 4e), whereas direct LPS sensing or the activation of canonical
inflammasomeswasnot affected (ExtendedData Fig. 4f, g). In contrast,
Gbp5-deficiency did not have any effect on canonical andnon-canonical
inflammasome activation (Extended Data Fig. 5). Nevertheless,Gbp2-
deficiencydidnot reduce caspase-11 activation asmarkedly asGbpchr3-
deficiency, indicating that whereas caspase-11 activationmainly requires
GBP2, other GBPs might also be partially involved.
Reducednumbers of intracellular bacteria could account for low levels
of caspase-11 activation in Gbpchr3- and Gbp2-deficient macrophages.
However, a comparison of wild-type andGbpchr3KOBMDMs showed
thatGbpchr3-deficiency resulted in significantly highernumbers of total
and live Salmonellaper cell (Fig. 2a), consistentwithhigher colony form-
ing units numbers in Gbpchr3 KO BMDMs (Extended Data Fig. 6). In
addition, fluorescence-activated cell sorting (FACS)-based analysis of
dead (mCherry-negative, FITC1) and live (mCherry-positive, FITC1)
Salmonella at 16 h post-infection found significantly fewer dead bac-
teria (,20%) inGBPchr3KOandGbp22/2BMDMswhen compared to
wild-type BMDMs (.30%) (Fig. 2b). Importantly, bacterial killing in
Casp112/2 BMDMswas comparable to wild-type BMDMs, indicating
that the control of bacterial replicationwas directly linked toGBP func-
tion and not to the activation of the non-canonical inflammasome
(Fig. 2b). In conclusion, we show that GBPs control bacterial replica-
tion on a cell-autonomous level,which is consistentwith a previous report
that GBP1 partially restrictsMycobacterium bovis and Listeria mono-
cytogenes replication10.
Restrictingbacterial replicationhas beenproposed to require the asso-
ciation ofGBPs with pathogen-containing vacuoles and the recruitment
of antimicrobial factors8.We therefore investigatedwhetherGBPs targeted
intracellular Gram-negative bacteria. Indeed, GBP2 could be detected
on intracellular bacteria within hours after infection (Fig. 2c). Very little
GBP-positive bacteriaweredetected in Stat12/2BMDMs,whichdonot
respond to type-I- and type-II-IFNs and largely failed to induce GBP
expression (data not shown). Remarkably, GBP-positive Salmonella
seemed to have lost mCherry expression (Fig. 2c), indicating that these
bacteria were dead. To determine whether GBPs are recruited to dead
bacteria we infected BMDMs with Salmonella killed by heat, parafor-
maldehydeor 70%ethanol treatment, yet only live Salmonella acquired
GBP staining andactivated the inflammasome(Fig. 2d). To examine this
mechanism in vivo, we immunostained spleen tissue sections of mice
infected with Salmonella for GBPs. Indeed, GBPs could also be found
associated with approximately 20% of bacteria in vivo, and a signifi-
cantly higher proportion of these bacteria were dead, based on the loss
of mCherry expression (Fig. 2e–g). Furthermore, treatment with IFN-
c-neutralizing antibodies reduced the percentage of GBP-positive bac-
teria (Fig. 2f), consistent with reports that IFN-c controls Salmonella
replication in vivo15,16. Taken together, these results indicated thatGBPs
either kill bacteria directly or control an antimicrobial effector pathway,
and raised the interesting possibility that GBP-mediated killing of bac-
teria might result in the release of LPS and caspase-11 activation2,3.
To identify the antimicrobial effector pathway that is controlled by
GBPs we first examined the role of free radicals8. Although GBP7 was
reported to be required for reactive oxygen species (ROS) production
and to interact with the phagosome oxidase complex10, we did not find
any role for ROS orNOproduction in caspase-11 activation (Extended
Data Fig. 7). Furthermore, GBPs were also proposed to recruit com-
ponents of the autophagymachinery to pathogen-containing vacuoles
(PCVs), possibly resulting in bacterial killingwithinautophagosomes8,10.
Indeed, many GBP-positive S. typhimurium, E. cloacae and C. koseri
co-stained for the commonly used autophagymarker LC3 (Fig. 3a and
ExtendedData Fig. 8a). Recruitment of LC3 to intracellular Salmonella
waspartiallyGBP-dependent, becausewe found significantly lowernum-
bers of LC3-positive Salmonella inGbpchr3KO compared to wild-type
macrophages (Fig. 3b, c). Therefore, we speculated that autophagy-
mediated killing might result in the release of LPS from bacteria and
caspase-11 activation. Unexpectedly, however, pharmacological inhi-
bition of autophagy with 3-methyladenine (3-MA) resulted in signifi-
cantly higher levels of LDH release, IL-1b secretion and caspase-1/
caspase-11 activation in macrophages infected with S. typhimurium,
E. cloacae orC. koseri (Fig. 3d, e), indicating increased activation of the
non-canonical inflammasome. Consistently, cell death was still caspase-
11-dependent because Casp112/2 BMDMs did not release LDHwhen
treated with 3-MA and infected with Gram-negative bacteria (Fig. 3f).
Direct activation of caspase-11 by LPS transfectionwas independent of
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Figure 1 | Caspase-11 activation by intracellular bacterial pathogens
requires GBPs. a, b, LDH release, IL-1b secretion (a) and immunoblots for
caspase-1, caspase-11, IL-1b, IL-18 and IL-1a (b) from unprimed BMDMs
infected for 16 h with the indicated bacteria (grown to stationary phase).
c, Time course measuring LDH release from unprimed or IFN-c-primed
BMDMs infected with S. typhimurium. d, e, LDH release and IL-1b secretion
from primed BMDMs infected with SPI-1-expressing logarithmic phase
S. typhimurium, treated with monosodium urate, alum and nigericin or
transfectedwith poly(dA:dT) and LPS. f, LDH release and IL-1b secretion from
unprimed wild-type andGbp22/2 BMDMs infected for 16 h with the indicated
bacteria (grown to stationary phase). Graphs show mean and s.d. of
quadruplicate wells and data are representative of two (b) and three
(a, c–f) independent experiments. *Crossreactive band; **P, 0.01; NS, not
significant (two-tailed t-test).
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autophagy (Fig. 3g), indicating that autophagy only counteracts non-
canonical inflammasome activation during bacterial infections. To fur-
ther confirmourdata,we infectedAtg52/2BMDMswithS. typhimurium
andwe also observed significantly higher levels of non-canonical inflam-
masome activation compared to wild-type BMDMs (Fig. 3h, i). Taken
together, these results indicated that, although GBPs promoted the
uptake of bacteria into autophagosomes, autophagy actually counter-
acted caspase-11 activation. Thus,GBP-dependent LPSdetection occurs
before bacteria are targeted to autophagosomes.
A possible explanation could be that autophagy sequesters bacteria
that had escaped from the vacuole, and thus prevents further LPS release
into the cytosol. Recently, the cytosolic danger receptor galectin-8 was
reported to function as a marker for lysed vacuoles. Galectin-8 binds
b-galactosides, which are normally found on the inner leaflet of the vac-
uolar membrane and get exposed to the cytosol upon vacuolar lysis17.
Indeed, quantification of galectin-8-positive Salmonella showed that
significantly fewer bacteria were targeted by galectin-8 in Gbpchr3 KO
BMDMs than in wild-type macrophages (Fig. 4a). Because galectin-8
colocalizedwithGBP- andLC3-positive Salmonella (Fig. 4b, c), we spec-
ulated that GBPs promote LC3 recruitment through galectin-8. Con-
sistently, we found lower levels of galectin-8-positive Salmonella among
LC3-positive Salmonella inGbpchr3KO compared to wild-type BMDMs
(Fig. 4d).Galectin-8 interactswith the autophagy adaptor proteinNDP52,
which in humans contains binding sites for galectin-8, ubiquitin and
LC318. In line with a role for NDP52 in linking galectin-8 to LC3, murine
NDP52 colocalizedwith galectin-8 on intracellular Salmonella (Extended
Data Fig. 8b). Targeting of Salmonella to autophagosomes might also
involve other autophagy cargo adaptors, because p62was associatedwith
themajority of LC3-positive bacteria, yet thiswas independent ofGBPs
(ExtendedData Fig. 8c, d).Altogether, these results suggested thatGBPs
might promote the lysis of vacuoles or help to recruit galectin-8 to lysed
vacuoles.
To confirm a direct role of GBPs in vacuolar lysis, we adapted a pha-
gosome integrity assay based on differential permeabilizationwith dig-
itonin (Extended Data Fig. 9). Comparing wild-type and GBPchr3 KO
BMDMs, we found significantly lower numbers of cytosolic (FITC1)
S. typhimurium inGbpchr3-deficient cells (Fig. 4e, f). Similarly,Gbp22/2
BMDMs also harboured fewer cytosolic S. typhimurium compared to
BMDMs from wild-type littermates (Fig. 4g). In contrast, we did not
find a defect in cytosolic localizationbetweenwild-type andGbpchr3KO
BMDMs infected with the specialized cytosolic pathogen Shigella flex-
neri, which uses its T3SS to destabilize the phagosome and escape into
the cytoplasm (Fig. 4h)19. Althoughwe cannot exclude thatGBPsmight
also be involved in the recruitment or assembly of the non-canonical
inflammasome, these results indicate that GBPs, in particular GBP2,
directly promote the destruction of vacuoles.
In conclusion, our data demonstrate that host-induced destruction
of PCVs or phagosomes is an essential immune function and assures
recognition of vacuolar bacteria by cytosolic innate immune sensors
(Extended Data Fig. 10). Additional studies are required to determine
howGBPsdistinguish ‘self’ and ‘non-self’membranes andbywhichmech-
anism phagosomes are lysed. In mice, this might involve the IRGM
proteins that can act as GDI (guanine nucleotide dissociation inhib-
itor) and inhibit IRG and GBP activity. Absence of IRGMs results in
mislocalization of both IRGs andGBPs and even in degradation of lipid
droplets20–22, supporting a model in which IRGM proteins would pro-
tect ‘self’-vacuoles frombeing targeted by host IRGs andGBPs23. Because
both commensals and pathogens activate caspase-11 (ref. 1), it can be
assumed thatGBPs are not specific towards pathogens but are a general
innate immune response against bacteria trapped in thephagosomes of
macrophages. Finally, given the important roleofLPS-induced caspase-11
activation in septic shock1–3, pharmaceutical targeting of the above-
described pathways might be used to modulate inflammation during
bacterial sepsis.
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Figure 2 | GBPs control bacterial replication. a, b, Quantification of live
(mCherry-positive) and dead (mCherry-negative) S. typhimurium per cell by
immunofluorescence (a) or as percent of total by flow-cytometry (b) in
unprimed BMDMs at 16 h post-infection. c, Immunostaining for GBP2 and
quantification of live and dead Salmonella at 4 h post-infection. Arrowheads,
bacteria shown in insets. d, Quantification of GBP-positive bacteria, LDH
release and IL-1b secretion at indicated time points fromBMDMs infectedwith
Salmonella, live or killed by different means. e, Immunohistochemistry for
GBP2 and Salmonella on spleen tissue from Salmonella (mCherry-positive)-
infected mice (representative of n5 3 per group). S. tm., S. typhimurium.
f, g, Quantification ofGBP-positive Salmonella in anti-IFN-c-treated or control
animals (f) and live and dead bacteria among GBP2-negative/-positive
Salmonella (g) (n5 3 per group). Scale bars, 10mm (c), 1mm (e). Graphs show
mean and5–95 percentile (box plots) or s.d. of technical triplicates, anddata are
representative of three independent experiments. *P, 0.05, **P, 0.01
(two-tailed t-test).
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release and IL-1b secretion from BMDMs infected
for 16 h or transfected with LPS. Graphs show
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Figure 4 | GBP-mediated lysis of the PCV
releases Salmonella into the cytosol.
a, Quantification of galectin-8-positive Salmonella
in unprimed BMDMs at 4 h post-infection.
b, c, Unprimed BMDMs infected with
S. typhimurium for 4 h and immunostained for
galectin-8, GBP2 and LC3. Arrowheads,
bacteria shown in insets. Scale bars, 10mm.
d, Quantification of galectin-8/LC3-double-
positive Salmonella at indicated time points
post-infection. e–h, Quantification of cytosolic and
vacuolar bacteria by flow cytometry in BMDMs
infected with mCherry-positive S. typhimurium
(e–g) or S. flexneri (h, wild-type or DT3SS) for 4 h.
Graphs show mean and s.d. or 5–95 percentile
(Box plots) of technical triplicates. Data are
representative of 2 (g, h), 3 (a–d) and 4
(e, f) independent experiments. *P, 0.05,
**P, 0.01 (two-tailed t-test).
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METHODS SUMMARY
BMDMswere cultured and seeded for infections as described previously4. Priming
wasdoneovernightwithPAM3CSK4(1mgml21), LPSO111:B4 (0.1mgml21),murine
IFN-b or murine IFN-c (1 unit per ml). S. typhimurium, S. flexneri, V. cholerae,
E. cloacae,C.koseriandB. thailandensisweregrownovernight inLBorTSBmediumat
37 uC with aeration. Bacteria were diluted in fresh pre-warmed macrophage medium
and added to the macrophages at a multiplicity of infection (m.o.i.) of 100:1 for
measurements of caspase-11 and caspase-1 activity or 10:1 for all other assays. For
assaying NLRC4 activation, Salmonella were subcultured for 4 h to induce SPI-1
T3SS expression before infection (m.o.i. 20:1). S. flexneriwere subcultured for 3 h
to induceT3SS expression before infection (m.o.i. 30:1).When required, apocynin,
L-NG-nitroarginine methyl ester (L-NAME), 3-methyladenine or vehicle controls
were added 30min before infection. Plates were centrifuged for 15min at 500g to
synchronize the infectionandplaced at 37 uCfor 1 h.Next, 100mgml21 gentamycin
was added to kill extracellular bacteria. After 1 h incubation, the cells were washed
once with DMEM and given fresh macrophage medium containing 10mgml21
gentamicin for the remainder of the infection. Transfection with poly(dA:dT) or
MSU, alum or nigericin treatment was done as described previously2 or as indi-
cated.All animal experimentswere approved and performed according to local guide-
lines. Female BALB/c mice (10–14weeks old) were infected intravenously with
Salmonella (1,000 c.f.u.) and euthanized 4–5 days later. For antibody injections,
mice received on day 3 two intraperitoneal injections of 200ml PBS containing
0.2mg anti-IFN-c monoclonal or 0.2mg rat IgG1, k isotype control antibody.
Online Content Any additional Methods, ExtendedData display items and Source
Data are available in the online version of the paper; references unique to these
sections appear only in the online paper.
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METHODS
Bacterial strains and plasmids. Salmonella enterica serovar Typhimurium
(S. typhimurium) SL1344 and congenic mutants were published before12. Other
bacterial strains used were Shigella flexneri, Vibrio cholerae, Enterobacter cloacae,
Citrobacter koseri and Burkholderia thailandensis ATCC700388.
Mice. Gbpchr3 KO, Gbp22/2, Atg5fl/fl-Lyz-Cre, Cybb2/2 (gp91phox), Casp12/2/
Casp112/2 (a.k.a caspase-1 knockout), Casp112/2 and Casp12/2 (Casp12/2/Casp11tg)
mice have been previously described1,11,14,24,25. Mice were bred in the animal facil-
itiesof theUniversityofBasel,Genentech Inc.,Heinrich-Heine-UniversityDuesseldorf
or theUniversity of Osaka. Generation ofmice withGbp5KOalleles by zinc finger
nuclease (ZFN) technology: A ZFN pair was obtained from Sigma-Aldrich (SAGE
Labs). The ZFN pair recognizes a sequence in mouse Gbp5 exon 2 (cut site is
underlined): 59-TGCCATCACACAGCCAGTGGTGGTGGTAGCCATTGTGG
GT-39. ZFN mRNA and a donor plasmid harbouring a 10-bp deletion in Gbp5
exon 2was co-microinjected intoC57BL/6N zygotes using established procedures.
One male founder carrying the 10-bp deletion was obtained by homologous
recombination (10-bp deletion is underlined): 59-TGCCATCACACAGCCAGTG
GTGGTGGTAGCCATTGTGGGT-3.This founderwasbredwithC57BL/6Nfemales
togenerateheterozygousprogeny for subsequent intercrossing.Two founders (amale
and a female) carrying identical 1-bp deletionswere obtained bynon-homologous
end-joining (deleted bp is underlined): 59-TGCCATCACACAGCCAGTGGTGG
TGGTAGCCATTGTGGGT-3. These two founders were intercrossed to directly
generate homozygous progeny. Both the 10-bp (designated KO line 1) and 1 bp
(designated KO line 2) deletions lead to frameshifts and premature stop codons in
Gbp5 exon 2.
Animal infection.All animal experimentswere approved (license 2239,Kantonales
Veterina¨ramt Basel-Stadt) and performed according to local guidelines (Tierschutz-
Verordnung, Basel-Stadt) and the Swiss animal protection law (Tierschutz-Gesetz).
Female BALB/cmice (10–14weeks old) were infected intravenously withmCherry-
positive Salmonella (1,000 c.f.u.) and euthanized 4–5 days later. For antibody injec-
tions, mice (n5 3 per group) received on day 3 two intraperitoneal injections of
200ml PBS containing 0.2mg anti-IFN-c monoclonal antibody (Clone XMG1.2,
BioLegend) or 0.2mg rat IgG1, k isotype control antibody (clone RTK2071, Bio-
Legend). No randomization or blinding was performed.
Cell culture and infections. BMDMs were differentiated in DMEM (Invitrogen)
with 10% v/v FCS (Thermo Fisher Scientific), 10%MCSF (L929 cell supernatant),
10mMHEPES (Invitrogen), and nonessential amino acids (Invitrogen). 1 day before
infection, macrophages were seeded into 6-, 24-, or 96-well plates at a density
of 1.253 106, 2.53 105, or 53 104 per well. If required macrophages were pre-
stimulated with PAM3CSK4, LPS O111:B4 (InvivoGen), mIFN-b or mIFN-c
(eBioscience). For infectionswith S. typhimurium,V. cholerae,E. cloacae,C. koseri
and B. thailandensis, bacteria were grown overnight in LB or TSB at 37 uC with
aeration. The bacteria were diluted in fresh pre-warmedmacrophagemediumand
added to themacrophages at anmultiplicity of infection (m.o.i.) of 100:1 formea-
surements of caspase-11 and caspase-1 activity or 10:1 for all other assays. For
assaying Salmonella-induced NLRC4 activation, Salmonellawere subcultured for
4 h before infection to induce SPI-1 T3SS and flagellin expression. S. flexneriwere
cultured overnight in TSB medium and subcultured for 3 h before infection to
induceT3SS expression. IFN-c-primedBMDMs (to induceGBP expression)were
infectedwithm.o.i. of 30:1 with S. flexneri for FACS analysis.When required, che-
mical reagents, Apocynin (Sigma Aldrich, 100mM), L-NG-nitroarginine methyl
ester (L-NAME; Sigma Aldrich, 100mM) and 3-methyladenine (Sigma Aldrich,
5mM)were added 30minbefore infection. Theplateswere centrifuged for 15min
at 500 g to ensure comparable adhesion of the bacteria to the cells and placed at
37 uC for 60min. Next, 100mgml21 gentamycin (Invitrogen) was added to kill
extracellular bacteria. After a 60-min incubation, the cells were washed once with
DMEM and given fresh macrophage medium containing 10mgml21 gentamicin
for the remainder of the infection. For infections with killed bacteria, Salmonella
were grown as above. Shortly before the infection, bacteria were left untreated or
incubated for 30min at 95 uC, in 4% paraformaldehyde or in 70% ethanol. Fol-
lowing the treatment, bacteria were washed with PBS and prepared for infections
as outlined above. The effectiveness of the killing procedures was verified by plat-
ing serial dilutions. Transfection with poly(dA:dT) or treatment with MSU, alum
or nigericin was done as described previously2 or as indicated.
siRNA knockdown.Gene knockdown was done using GenMute (SignaGen) and
siRNApools (siGenome,Dharmacon). Briefly, wild-type BMDMswere seeded into
24-, or 96-well plates at a density of 1.53 105 or 33 104 per well. siRNA complexes
were prepared at 25nM siRNA in 13 GenMute Buffer according to the manufac-
turer’s instructions for forward knockdowns. siRNA complexes were mixed with
BMDM medium and added onto the cells. BMDMs were infected with S. typhi-
murium at an m.o.i. of 100:1 after 56 h of knockdown and analysed for inflamma-
some activation as outlined below. siRNA pools included: Casp11 (that is, Casp4)
(M-042432-01),Gbp1 (M-040198-01),Gbp2 (M-040199-00),Gbp3 (M-063076-01),
Gbp4 (M-047506-01), Gbp5 (M-054703-01), Gbp6 (M-041286-01), Gbp7 (M-
061204-01), Gbp8 (M-059726-01), Gbp9 (M-052281-01), Gbp10 (M-073912-00),
Gbp11 (M-079932-00) andNT(non-targeting)pool2 (D-001206-14). SeeSupplemen-
tary information for sequences.
LPS transfection.Macrophages were seeded as described above. Cells were pre-
stimulated with 10 ugml21 of PAM3CSK4 for 4 h in Opti-MEM and transfected
for 16 h with ultrapure LPS E. coliO111:B4, ultrapure LPS E. coli K12 or ultrapure
LPS Salmonellaminnesota (InvivoGen) in complexwith FuGeneHD (Promega) as
described previously2.
CytokineandLDHreleasemeasurement. IL-1band tumournecrosis factor (TNF)-a
was measured by ELISA (eBioscience). LDH was measured using LDH Cytotox-
icity Detection Kit (Clontech). To normalize for spontaneous lysis, the percentage
of LDH release was calculated as follows: (LDH infected2LDHuninfected)/(LDH
total lysis2LDH uninfected)*100.
Western blotting.Western blottingwas done as described before4. Antibodies used
were rat anti-mouse caspase-1 antibody (1:1,000; 4B4;Genentech), rat anti-mouse
caspase-11 (1:500; 17D9; Sigma), rabbit anti-IL-1a (1:1,000; ab109555; Abcam),
rabbit anti-IL-18 (1:500; 5180R; Biovision), goat anti-mouse IL-1b antibody (1:500;
AF-401-NA; R&D Systems) and rabbit anti-GBP2 and rabbit anti-GBP5 (1:1,000;
11854-1-AP/13220-1-AP; Proteintech). Cell lysates were probed with anti-b-actin
antibody (Sigma) at 1:2,000.
Statistical analysis. Statistical data analysis was done using Prism 5.0a (GraphPad
Software, Inc.). To evaluate the differences between two groups (cell death, cyto-
kine release, FACS, CFU and immunofluorescence-based counts) the two-tailed
t-test was used. In figures NS indicates ‘not significant’, P values are given in figure
legends.
Immunofluorescence.Macrophages were seeded on glass coverslips and infected
as described above. At the desired time points cells were washed 33with PBS and
fixed with 4% paraformaldehyde for 15min at 37 uC. Following fixation coverslips
were washed and the fixative was quenched with 0.1M glycine for 10min at room
temperature.Coverslipswere stainedwithprimaryantibodies at 4 uCfor16h,washed
43 with PBS, incubated for 1 h with appropriate secondary antibodies at room
temperature (1:500, AlexaFluor, Invitrogen), washed 43 with PBS and mounted
on glass slides with Vectashield containing 49,6-diamidino-2-phenylindole (DAPI)
(Vector Labs). Antibodies usedwere rabbit anti-LC3 (1:1,000; NB600-1384, Novus),
mouse anti-LC3 (1:100, 2G6, NanoTools), guinea-pig anti-p62 (1:100, GP62-C,
Progen), goat anti-Salmonella (1:500, CSA-1 andCSA-1-FITC,KPL),mouse anti-
galectin-8 (1:1,000, G5671, Sigma), goat anti-galectin-8 (1:100, AF1305, R&D),
rabbit anti-Optineurin (1:100, ab23666, Abcam), rabbit anti-NDP52 (1:100, D01,
Abnova), anti-PDI (1:100, ADI-SPA-890, Enzo Lifesciences), anti-Calnexin (1:100,
ADI-SPA-860-D, Enzo Lifesciences), goat anti-GBP1-5 (1:100, sc-166960, Santa
Cruz Biotech), rabbit anti-GBP2 and rabbit anti-GBP5 (1:100; 11854-1-AP/13220-
1-AP; Proteintech). Coverslipswere imaged on aZeiss LSM700 or a Leica SP8 at363
magnification.Colocalization studieswere performedas blinded experiments,with in
general a minimum count of 100 bacteria per coverslip and performed in triplicate.
Immunofluorescencebased counts of live (mCherry1/FITC1) anddead (mCherry2/
FITC1) bacteria were done as blinded experiment on z stacks taken from 15 ran-
dom fields in three biological replicates, with a total of approximately 10,000 bac-
teria counted.
Immunohistochemistry. Cryosections were blocked in 1% blocking reagent (Invi-
trogen) and2%mouse serum(Invitrogen) inTBST(0.05%Tween in13TBSpH7.4),
and stained with primary and secondary antibodies (goat anti-CSA1; 1:500; 01-
91-99-MG; KPL and anti-GBP2; 1:100; 11854-1-AP; Proteintech). Secondary
antibodies included Santa Cruz Biotech sc-362245 and Molecular Probes A21206,
A21445 and A21469.
ROS assay.Measurement of oxygen-dependent respiratory burst of BMDMs was
performed by chemiluminescence in the presence of 5-amino-2,3-dihydro-1,4-
phtalazinedione (luminol, Sigma Aldrich, 66mM) using a thermostatically (37 uC)
controlled luminometer. Both oxygen and nitrogen species were detected (O2
N2,
ONOO2, OHN). Chemiluminescence generation was monitored every minute for
1 h after IFN-c (100Uml21) and/or Salmonella challenge and expressed as counts
per minute.
NO assay. Nitrite production was measured by the Griess assay as previously
described26. Briefly, in 96-well plates, BMDMs were infected as described above
in presence or absence of IFN-cor IL-1b for 16h. Supernatantsweremixed1:1with
2.5% phosphoric acid solution containing 1% sulfanilamide and 0.1% naphthyle-
nediamine. After 30min incubation at room temperature, the nitrite concentration
was determined by measuring absorbance at 550nm. Sodium nitrite (Sigma) was
used as a standard to determine nitrite concentrations in the cell-free medium.
Digitonin assay. For flow-cytometry-based quantification of cytoplasmic and
vacuolar bacteria, macrophages were infected with mCherry1 S. typhimurium or
mCherry1 S. flexneri as described above.At the desired timepoint, cellswerewashed
33 with KHM buffer (110mM potassium acetate, 20mM HEPES, 2mMMgCl2,
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pH7.3) and incubated for 1min inKHMbufferwith150mgml21 digitonin (Sigma).
Cells were immediately washed 23with KHM buffer and then stained for 12min
with anti-Salmonella-FITC (1:500, CSA-1, KPL) or anti-Shigella (1:100, BP1064,
Acris) inKHMbufferwith 2%BSA. Secondary antibodies used for S. flexneri stain-
ing were: anti-Rabbit-488 (1:500, Invitrogen). Cells were washed 33with PBS and
lysed in PBS with 0.1% Triton-X (Sigma) and analysed on a FACS-Canto-II. Con-
trols were included in every assay and are described in (Extended Data Fig. 9).
Live/dead analysis by FACS. Infection of macrophages was performed using
mCherry1 bacteria as described above. At 16 h post-infection cells were washed
and lysedwithPBSsolution containing0.1%TritonX-100 (SigmaAldrich) to release
intracellular bacteria. Salmonellawere counterstained using an anti-Salmonella anti-
body (CSA-1, KPL) and analysed using a FACSCanto-II for fluorescence intensities
in FL-1 and FL-2 channels. Data were analysed with FlowJo 10.0.6 software. The
gate was set for the bacterial population based on the FSC/SSC and the anti-
Salmonella staining (CSA-1-FITC,KPL). Controls included livemCherry-expressing
andmCherry-negative Salmonella stainedwith anti-Salmonella antibodies (CSA-1,
KPL).
24. Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1
adaptors ASC and Ipaf. Nature 430, 213–218 (2004).
25. Zhao, Z. et al.Autophagosome-independent essential function for the autophagy
protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4,
458–469 (2008).
26. Lima-Junior, D. S. et al. Inflammasome-derived IL-1b production induces nitric
oxide-mediated resistance to Leishmania. Nature Med. 19, 909–915 (2013).
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Extended Data Figure 1 | Type-I-interferon signalling is required to induce
caspase-11-dependent cell death in response to bacterial infection, but
not in response to LPS transfection. a, LDH release from unprimed
BMDMs infected for 16 h with wild-type (WT) S. typhimurium or DSPI-2
S. typhimurium grown to stationary phase. b, LDH release from primed
BMDMs transfected with LPS O111:B4. Graphs show the mean and s.d. of
quadruplicate wells and are representative of three independent experiments.
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Extended Data Figure 2 | BMDMs from Gbpchr3 KO mice have normal
responses to priming stimuli, but fail to activate the non-canonical
inflammasome during bacterial infections. a, Schematic representation of
the GBP locus on murine chromosome 3. The extent of the deletion in Gbpchr3
KO mice is indicated. b–d, Induction of pro-caspase-11, GBP2 and GBP5
expression in lysates of wild-type and Gbpchr3 KO BMDMs stimulated for 16 h
with the indicated amounts of murine IFN-b, murine IFN-c or LPS O111:B4.
e, TNF-a release fromBMDMs stimulated for 16 hwithLPSO111:B4. f, g, LDH
release and IL-1b secretion from wild-type and Gbpchr3 KO BMDMs infected
for 16 h with wild-type (WT) S. typhimurium, DSPI-2 S. typhimurium,
V. cholerae, E. cloacae orC. koseri grown to stationary phase. Cells were primed
overnight with LPS (f) or poly(I:C) (g). *Indicates background band. Graphs
show the mean and s.d. of quadruplicate wells and data are representative of
two independent experiments. **P, 0.01, NS, not significant (two-tailed
t-test).
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Extended Data Figure 3 | GBPs assist the detection of bacteria that escape
into the cytosol only in primed macrophages. a–c, LDH release, IL-1b
secretion and immunoblots for processed caspase-1 and caspase-11 released
from unprimed BMDMs infected for 8–16 h with DsifA S. typhimurium or
B. thailandensis grown to stationary phase. d, LDH release and IL-1b secretion
from unprimed or IFN-c-primed BMDMs infected for 16 h with DsifA
S. typhimurium grown to stationary phase. Ext, extract; SN, supernatant.
Graphs show the mean and s.d. of quadruplicate wells and data are
representative of two independent experiments. *P, 0.05; **P, 0.01; NS, not
significant (two-tailed t-test).
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Extended Data Figure 4 | Murine GBP2 controls non-canonical
inflammasome activation during Salmonella infection, but is dispensable
for direct LPS sensing and canonical inflammasomes. a, Schematic drawing
of the inflammasome pathways activated by flagellin-deficient Salmonella.
b–d, LDH release, IL-1b secretion and immunoblots for processed caspase-1
and processed IL-1b released from unprimed BMDMs infected for 17 h with
Dflag S. typhimurium grown to stationary phase. BMDMswere treated with the
indicated siRNA for 56 h before infection. e, Immunoblots for processed
caspase-1, IL-18 and caspase-11 released from unprimed BMDMs infected for
16 h with DSPI-2 S. typhimurium, E. cloacae or C. koseri grown to stationary
phase. f, g, LDH release and IL-1b secretion from primed wild-type and
Gbp22/2 BMDMs transfected with the indicated types of LPS for 16 h, treated
with nigericin for 1 h, infected with SPI-1 T3SS expressing logarithmic phase
wild-type S. typhimurium for 1 h, or transfected with poly(dA:dT) for 6 h.
Cell were primed with PAM3CSK4 in f or LPS g. Graphs show the mean and
s.d. of quadruplicate wells and data are representative of two (e) and three
(b–d, f, g) independent experiments. NT, non-targeting siRNA; GM,GenMute
transfection reagent; NS, not significant (two-tailed t-test).
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Extended Data Figure 5 | Normal activation of non-canonical and
canonical inflammasomes in Gbp52/2 BMDMs. a, Expression of GBP5
in wild-type and two lines of Gbp52/2 BMDMs (1 and 2). *Indicates a
cross-reactive band. b–e, LDH release and IL-1b secretion from BMDMs
infected for 16 h with wild-type (WT) S. typhimurium,DSPI-2 S. typhimurium,
V. cholerae, E. cloacae or C. koseri grown to stationary phase (b), transfected
with the indicated LPS for 16 h (c) infected for 1 h with SPI-1 T3SS expressing
logarithmic phase wild-type S. typhimurium (d), or treated with 5mMATP or
20mM nigericin for 4 h (e). Cells were left unprimed (b) or primed with
PAM3CSK4 in (c) or LPS (d, e). Graphs show the mean and s.d. of triplicate or
quadruplicate wells and data are representative of three independent
experiments.
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Extended Data Figure 6 | GBPs control bacterial replication. c.f.u.s at 16 h
post-infection inwild-type andGbpchr3KOBMDMs infectedwith the indicated
bacterial strains. Experiments are representative of two independent
experiments.
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Extended Data Figure 7 | Inhibition of ROS and NO production does not
affect non-canonical inflammasome activation. a, b, ROS levels, LDH release
and IL-1b secretion in unprimed BMDMs left uninfected or infected for 16 h
with wild-type S. typhimurium grown to stationary phase. c–e, LDH release,
IL-1b secretion, ROS levels and immunoblots for processed caspase-1 and
caspase-11 released from unprimed BMDMs infected for 16 h with wild-type
(WT) S. typhimurium or E. cloacae grown to stationary phase in the presence of
the ROS inhibitor (apocynin) or a vehicle control (DMSO). f, g, LDH
release, IL-1b secretion and immunoblots for processed caspase-1 and
caspase-11 released from unprimed BMDMs infected for 16 h with wild-type
S. typhimurium or E. cloacae grown to stationary phase in the presence of the
iNOS inhibitor (L-NAME) or a vehicle control (DMSO). h, NO release from
unprimed or IFN-c-primed BMDMs infected for 16 h with S. typhimurium in
presence of the iNOS inhibitor (L-NAME) or a vehicle control (DMSO). Ext,
extract; SN, supernatant. Graphs show themean and s.d. of quadruplicate wells
and data are representative of two (a–c, e–g) and three (d, h) independent
experiments. NS, not significant (two-tailed t-test).
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Extended Data Figure 8 | Colocalization of GBPs and autophagy proteins
on intracellular bacteria. a, Colocalization of LC3 with GBPs in unprimed
wild-type BMDMs infected with E. cloacae or C. koseri for 4 h and stained
for LC3, GBP2 and DNA. b, Colocalization of galectin-8 and NDP52 in
unprimed wild-type BMDMs infected with wild-type S. typhimurium for 4 h
and stained for galectin-8, NDP52 and DNA. c, Colocalization of p62 and LC3
in unprimed wild-type BMDMs infected with wild-type S. typhimurium for
4 h and stained for LC3, p62 and DNA. d, Quantification of p62 and LC3
co-staining in wild-type and Gbpchr3 KO BMDMs at 4 h post-infection with
Salmonella. Arrowheads indicate region shown in insets. Scale bars, 1mm (a)
and 10mm(b, c). Graph shows themean and s.d. of triplicate counts and images
and graph are representative of at least two independent experiments. NS, not
significant (two-tailed t-test).
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Extended Data Figure 9 | Digitonin-based quantification of cytoplasmic
bacteria. a, Immunostaining for calnexin and PDI (protein disulphide
isomerase) in wild-type BMDMs left untreated or permeabilized with digitonin
or saponin. b, Differentially permeabilized macrophages stained for cytosolic
and vacuolar Salmonella at 4 h post-infection. c, Schematic representation of
FACS-based analysis of cytosolic and vacuolar bacterial populations of
Salmonella. Scale bars, 10mm.
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Extended Data Figure 10 | Model for the role of GBPs and autophagy in
caspase-11 activation. The pathogen-containing vacuole of vacuolar bacterial
pathogens is recognized by interferon-induced GBPs in an unknown manner.
GBPs promote the lysis of the PCV either directly or indirectly, resulting in
the release of the bacteria into the cytosol and activation of caspase-11 by
bacterial LPS. b-galactosides of the lysed vacuole serve as danger signals upon
exposure to the cytosol and are recognized by galectin-8 leading to the
recruitment of the autophagy machinery. p62 participates in this process by
recognizing ubiquitin-chains on the vacuole or the bacterium. Uptake of the
bacterium and the lysed vacuole into autophagosomes reduces caspase-11
activation by removing the source of LPS from the cytosol.
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Dharmacon Dharmacon 
Pool Catalog 
Number 
Duplex Catalog 
Number 
Gene Symbol Gene Accession GINumber Sequence 
M-042432-01 D-042432-01 Casp4 NM_007609 157951737 GUGCAACAAUCAUUUGAAA
M-042432-01 D-042432-02 Casp4 NM_007609 157951737 GCUAAUGUCUCAUGGCACA 
M-042432-01 D-042432-03 Casp4 NM_007609 157951737 GAUGUGCUACAGUAUGAUA 
M-042432-01 D-042432-04 Casp4 NM_007609 157951737 CGAAAGGCUCUUAUCAUAU 
M-040198-01 D-040198-01 GBP1 NM_010259 134031981 GCAACUACGUCAAGAGAUA 
M-040198-01 D-040198-02 GBP1 NM_010259 134031981 GGAAAGACUUCUCAAGCAA 
M-040198-01 D-040198-03 GBP1 NM_010259 134031981 GAUCAUGCACCAUACUUUA 
M-040198-01 D-040198-04 GBP1 NM_010259 134031981 CAACUCAGCUAACUUUGUG 
M-040199-00 D-040199-01 GBP2 NM_010260 6753949 UGAAGAAGCUGACUGAGAA 
M-040199-00 D-040199-02 GBP2 NM_010260 6753949 GAAGUGCACUAUACUCUGA 
M-040199-00 D-040199-03 GBP2 NM_010260 6753949 GGAGCUGUGUGGUGAAUUU 
M-040199-00 D-040199-04 GBP2 NM_010260 6753949 GGAGCUAACUGAUCUUAUC 
M-063076-01 D-063076-01 Gbp3 NM_018734 134053870 GAACGAAGCAGCAUCUAUU
M-063076-01 D-063076-02 Gbp3 NM_018734 134053870 GGACUUUGGUGCAGACCUA 
M-063076-01 D-063076-03 Gbp3 NM_018734 134053870 GGCCAUUGUUGGUUUAUAU 
M-063076-01 D-063076-04 Gbp3 NM_018734 134053870 CACAAGCGACAAACGUUUA 
M-047506-01 D-047506-01 Gbp4 NM_008620 126157520 GGACAUAACAUCAAGGAAA 
M-047506-01 D-047506-02 Gbp4 NM_008620 126157520 CCAAUUGGAUCCUACGUUU 
M-047506-01 D-047506-03 Gbp4 NM_008620 126157520 GAUAUAAGACACAAGCUGA 
M-047506-01 D-047506-04 Gbp4 NM_008620 126157520 GGAAUUGCGUCGAGAGAUC 
M-054703-01 D-054703-01 GBP5 NM_153564 91064875 CGCAGGAGUUCUAUCAUAA 
M-054703-01 D-054703-02 GBP5 NM_153564 91064875 UGACUGUGUUAUAAGCUAA 
M-054703-01 D-054703-03 GBP5 NM_153564 91064875 ACUCAGAUCUUUGCACUAG 
M-054703-01 D-054703-04 GBP5 NM_153564 91064875 GCGAGAGGCCAUAGAAAUC 
M-041286-01 D-041286-02 Mpa2l NM_194336 170650636 AAGAAACACUGAUCGAAUU
M-041286-01 D-041286-04 Mpa2l NM_194336 170650636 GGGACAGAAUCACGGCUUU 
M-041286-01 D-041286-05 Mpa2l NM_194336 170650636 GGAAUUAAUAGGAGAGAAC 
M-041286-01 D-041286-06 Mpa2l NM_194336 170650636 GCACAAUCAAGUCAGGUUA 
M-061204-01 D-061204-01 Gbp6 NM_001083312 134032013 AAGAAUAGCUCAUUGGGUG 
M-061204-01 D-061204-02 Gbp6 NM_001083312 134032013 CGACCUACGUGGAUGCUAU 
M-061204-01 D-061204-03 Gbp6 NM_001083312 134032013 GGACUAUACCGUACGGGAA 
M-061204-01 D-061204-04 Gbp6 NM_001083312 134032013 GACGUGCCGUGUUUAGAGA 
M-059726-01 D-059726-01 5830443L24RIK NM_029509 115292436 CACCAAAUCCUGAUGGAAU 
M-059726-01 D-059726-03 5830443L24RIK NM_029509 115292436 GUGACAACCUAUGUAGAUG 
M-059726-01 D-059726-17 5830443L24RIK NM_029509 115292436 AUUAAUAGGUGAGGCGAAA 
M-059726-01 D-059726-18 5830443L24RIK NM_029509 115292436 ACGGAGAGAUACAGCAACU 
M-052281-01 D-052281-01 BC057170 NM_172777 118129953 UAGAGAGACUGGAACAUAA
M-052281-01 D-052281-02 BC057170 NM_172777 118129953 GAGGAAGGAUUUACGAACA 
M-052281-01 D-052281-03 BC057170 NM_172777 118129953 GAUCUUCGCCCUAAGUGUG 
M-052281-01 D-052281-04 BC057170 NM_172777 118129953 AAACAUUGGUCCCAUUCUG 
M-073912-00 D-073912-09 Gbp10 NM_001039646 116812913 CCAUAUGAGUAAAGACACA 
M-073912-00 D-073912-10 Gbp10 NM_001039646 116812913 GGAAUUAAUAGGAGAGAAC 
M-073912-00 D-073912-11 Gbp10 NM_001039646 116812913 GCUGAUCCCAGGUGACAAA 
M-073912-00 D-073912-12 Gbp10 NM_001039646 116812913 AGAAACACUGAUCGAAUUA 
M-079932-00 D-079932-13 EG634650 NM_001039647 88900482 UGUAAGAGACCUUGCUUUA 
M-079932-00 D-079932-14 EG634650 NM_001039647 88900482 GGAAUUAAUAAGUGAGAAG 
M-079932-00 D-079932-15 EG634650 NM_001039647 88900482 GAAGAGAGAUCUAUCGACU 
M-079932-00 D-079932-16 EG634650 NM_001039647 88900482 GCUAUAAGAAGAAAGCUGA 
Supplementary information 1: Sequences of siRNA duplexes 
WWW.NATURE.COM/NATURE | 1
SUPPLEMENTARY INFORMATION
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6.2 Research article IV
Guanylate-binding proteins promote activation of
the AIM2 inflammasome during infection with Fran-
cisella novicida
E. Meunier*, P. Wallet*, R. F. Dreier, S. Costanzo, L. Anton, S. Ru¨hl, S. Dussurgey, M. S. Dick,
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The innate immune system detects invading pathogens through 
membrane-bound and cytosolic pattern-recognition receptors, 
which recognize microbe- and damage-associated molecular pat-
terns and induce conserved signaling pathways. Nucleic acids and 
their derivatives are detected by RIG-I-like receptors, cGAS, DAI and 
RNA polymerases, which results in the induction of type I interferons 
via the signaling molecule STING and the kinase TBK1 (refs. 1–3). 
Cytosolic microbial and host DNA also induces inflammasome forma-
tion through AIM2, a member of the PYHIN family of receptors4–7. 
AIM2 binds double-stranded DNA through its HIN-200 domain8 
and recruits the inflammasome adaptor ASC. ASC rapidly oligomer-
izes to form a macromolecular inflammasome complex known as an 
‘ASC speck’, which activates caspase-1. Active caspase-1 promotes 
the maturation and release of the pro-inflammatory cytokines 
interleukin 1B (IL-1B) and IL-18. In addition, it induces pyroptosis, 
a lytic form of cell death that restricts pathogen replication. The 
AIM2 inflammasome mediates the recognition of DNA viruses as 
well as that of various Gram-negative and Gram-positive cytosolic 
bacteria, such as Listeria monocytogenes, Legionella pneumophila, 
Mycobacterium species and Francisella tularensis subspecies novicida 
(F. novicida)8–14. Notably, several studies have shown that activation 
of AIM2 by these bacteria requires bacteriolysis and the subse-
quent release of bacterial chromosomal DNA into the cytosol10,12,15. 
However, whether the bacteriolysis is accidental or is an active, 
host-directed mechanism has remained unclear.
The activation of AIM2 via the transfection of synthetic DNA 
or during infection with a DNA virus is independent of signaling 
via Toll-like receptors or interferons9,13,16. In contrast, the 
activation of AIM2 during infection with F. novicida requires the 
production of type I interferons, which are induced as a result 
of the recognition of an as-yet-undefined F. novicida–derived 
nucleic acid ligand in the cytosol9,10,17–20. Consistent with that, 
the activation of AIM2 inflammasomes in F. novicida–infected 
cells requires signaling through STING and the transcription 
factor IRF3 (refs. 9,10,17). It has been speculated that interferon 
signaling is necessary to increase cellular AIM2 for the detection 
of F. novicida DNA9, yet interferon-mediated induction of AIM2 is 
contested, and even small amounts of transfected DNA efficiently 
trigger activation of AIM2 in an interferon-independent manner9. 
Therefore, it is likely that one or several interferon-inducible 
factor(s) is (are) required for efficient activation of AIM2 during 
bacterial infection.
Type I and type II interferons are potent cytokines that exert 
anti-microbial effects through the induction of a broad transcrip-
tional program involving ~2,000 genes, the so-called ‘interferon-
stimulated genes’ (ISGs), many of which remain uncharacterized. 
1Focal Area Infection Biology, Biozentrum, University of Basel, Basel, Switzerland. 2Centre International de Recherche en Infectiologie, Inserm U1111, CNRS UMR 
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Guanylate-binding proteins promote activation 
of the AIM2 inflammasome during infection with 
Francisella novicida
Etienne Meunier1,6, Pierre Wallet2,6, Roland F Dreier1, Stéphanie Costanzo2, Leonie Anton1, Sebastian Rühl1, 
Sébastien Dussurgey3, Mathias S Dick1, Anne Kistner1, Mélanie Rigard2, Daniel Degrandi4, Klaus Pfeffer4, 
Masahiro Yamamoto5, Thomas Henry2 & Petr Broz1
The AIM2 inflammasome detects double-stranded DNA in the cytosol and induces caspase-1-dependent pyroptosis as well as 
release of the inflammatory cytokines interleukin 1b (IL-1b) and IL-18. AIM2 is critical for host defense against DNA viruses  
and bacteria that replicate in the cytosol, such as Francisella tularensis subspecies novicida (F. novicida). The activation of 
AIM2 by F. novicida requires bacteriolysis, yet whether this process is accidental or is a host-driven immunological mechanism 
has remained unclear. By screening nearly 500 interferon-stimulated genes (ISGs) through the use of small interfering RNA 
(siRNA), we identified guanylate-binding proteins GBP2 and GBP5 as key activators of AIM2 during infection with F. novicida. 
We confirmed their prominent role in vitro and in a mouse model of tularemia. Mechanistically, these two GBPs targeted cytosolic 
F. novicida and promoted bacteriolysis. Thus, in addition to their role in host defense against vacuolar pathogens, GBPs also 
facilitate the presentation of ligands by directly attacking cytosolic bacteria.
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Prominent among the products of these ISGs are several families of 
interferon-inducible GTPases, such as the 47-kilodalton immunity- 
related GTPases and the 65- to 73-kilodalton guanylate-binding 
proteins (GBPs)21,22. GBPs are conserved among vertebrates, with 
11 GBPs in mice and 7 in humans, and exert anti-microbial effects 
on intracellular bacteria and protozoa23. GBP1 and GBP7 restrict 
Mycobacterium bovis bacillus Calmette-Guérin and L. monocytogenes 
by recruiting anti-microbial effectors to the pathogen-containing vac-
uole (PCV)24. Several GBPs are recruited onto the Toxoplasma para-
sitophorous vacuole25, and most are also required for restricting the 
replication of Toxoplasma gondii23,26–28. In addition, GBPs encoded 
by genes on mouse chromosome 3 promote recognition of the vacu-
olar, Gram-negative bacterium Salmonella typhimurium by the innate 
immune system by destabilizing its PCV, which leads to egress of the 
bacteria into the cytosol and subsequent detection of its lipopolysac-
charide (LPS) by the caspase-11 inflammasome29. In this study we 
found that GBPs encoded by genes on mouse chromosome 3 were a 
key factor for the activation of AIM2 during infection with F. novic-
ida. In particular, GBP2 and GBP5 controlled the activation of AIM2 
by targeting cytosolic F. novicida and inducing lysis of these bacte-
ria by an as-yet-uncharacterized mechanism. We demonstrated that 
GBP-deficient mice were unable to control infection with F. novicida 
in vivo. Together our data reveal a function for GBPs during micro-
bial infection, in that GBPs promoted bacteriolysis in the cytosol 
and the exposure of bacterial DNA to cytosolic sensors of the innate 
immune system.
RESULTS
AIM2 activation during F. novicida infection requires interferons
F. novicida is a facultative intracellular Gram-negative bacterium that 
avoids phagosomal degradation in phagocytes by escaping into the 
cytosol, a process that requires the Francisella pathogenicity island 
(FPI). After escaping from the phagosome, F. novicida replicates in 
the cytosol but also triggers AIM2-dependent activation of caspase-1 
(refs. 10,13). Infection of mouse bone marrow–derived macrophages 
(BMDMs) with wild-type F. novicida resulted in cell death (pyrop-
tosis; measured by the release of lactate dehydrogenase (LDH)) and 
the release of IL-1B dependent on AIM2, ASC and caspase-1, while 
a mutant lacking the FPI ($FPI) did not activate the inflammasome 
(Fig. 1a). STING is linked to the activation of AIM2 during infec-
tion with F. novicida10,12. Macrophages deficient in STING (via the 
‘goldenticket’ (Gt) N-ethyl-N-nitrosourea–induced nonfunctional 
mutation of alleles encoding Tmem173 (called ‘StingGt/Gt’ here)) had 
considerable attenuation of their ability to induce expression of type I 
interferons and activation of the AIM2 inflammasome upon infection 
with F. novicida5 (Fig. 1b and Supplementary Fig. 1a). Consistent 
with a role for type I interferons in activation of the AIM2 inflamma-
some17,19, macrophages from mice deficient in Ifnar1, which encodes 
the receptor for interferon-A (IFN-A) and IFN-B (IFNAR1), or Stat1, 
which encodes the transcription factor STAT1, displayed significantly 
less pyroptosis and release of IL-1B when infected with F. novicida 
than did their wild-type counterparts (Fig. 1c). To further confirm 
that activation of AIM2 during infection with F. novicida depended 
on signaling via type I interferons, we assessed whether exogenous 
interferons were able to restore inflammasome activation in STING-
deficient BMDMs. As expected, IFN-B restored cell death and the 
release of cytokines in StingGt/Gt BMDMs (Fig. 1d). The addition of 
IFN-G restored cell death and the release of cytokines in both StingGt/Gt 
BMDMs and Ifnar1−/− BMDMs (Fig. 1d), which indicated a require-
ment for a general interferon signature.
The induction of Aim2 mRNA could explain the considerable 
dependence on type I interferons and signaling via STAT1 during 
infection with F. novicida10. However, activation of the AIM2 inflam-
masome by transfection of DNA or infection with DNA viruses is 
independent of interferon signaling9,13,16. In accordance with those 
reports, induction of cell death by transfection of the synthetic 
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Figure 1 Products of ISGs are required for AIM2 activation during infection with F. novicida.  
(a–c) Release of LDH (assessing cell death) and IL-1B from unprimed wild-type (WT),  
Casp1−/−Casp11−/−, Asc−/− and Aim2−/− BMDMs (a), wild-type and StingGt/Gt BMDMs (b),  
or wild-type, Ifnar1−/− and Stat1−/− BMDMs (c) 8 h after infection with wild-type F. novicida  
strain U112 (FN WT) (a–c) or the $FPI F. novicida mutant (FN $FPI) (a). ND, not detectable.  
(d) Release of LDH and IL-1B from untreated (UT) or IFN-B- or IFN-G-primed wild-type, StingGt/Gt  
and Ifnar1−/− BMDMs 8 h after infection with wild-type F. novicida U112. (e) Release of LDH from  
wild-type, StingGt/Gt, Stat1−/− and Aim2−/− BMDMs transfected with increasing concentrations of poly(dA:dT) (horizontal axis). (f) Incorporation of 
propidium iodide (PI) (assessing cell death) and release of IL-1B by wild-type BMDMs primed with Pam3CSK4 and then transfected with increasing 
concentrations (wedges) of purified F. novicida (FN) genomic DNA or poly(dA:dT) (0, 20, 100, 250, 500 and 1000 ng/ml), assessed 1 h after 
transfection. *P < 0.01 and **P < 0.001 (two-tailed unpaired t-test). Data are representative of three (a,c,e) or two (b,d,f) independent experiments 
(mean and s.d. of quadruplicate wells).
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B-form double-stranded DNA poly(dA:dT) at a concentration of 
1 Mg/ml required AIM2 but was completely independent of STING 
and STAT1 (Fig. 1e). The transfection of large amounts of DNA 
might overload the system and render it independent of interferon 
signaling. To rule out this possibility, we ‘titrated down’ the amount 
of transfected DNA. The activation of AIM2 remained interferon 
independent even upon the transfection of small quantities of DNA 
(Fig. 1e). These results indicated that basal AIM2 was sufficient 
to initiate inflammasome activation9,13. Indeed, we observed only 
weak induction of Aim2 mRNA following infection with F. novicida 
(Supplementary Fig. 1b).
Finally, we confirmed that F. novicida genomic DNA was as stimu-
latory as synthetic DNA by transfecting increasing amounts of each 
into macrophages that had been primed with the synthetic lipopeptide 
Pam3CSK4 to induce expression of pro-IL-1B. Both types of DNA 
triggered similar cell death and release of IL-1B (Fig. 1f), which excluded 
the possibility that F. novicida DNA had properties that allowed it to 
evade recognition by AIM2. Together these results indicated that one 
(or several) IFN-B- or IFN-G-inducible gene(s) was (were) needed 
to activate AIM2 specifically during bacterial infection.
Identification of the GBP family by genetic screening
To identify ISGs encoding products involved in F. novicida–mediated 
activation of the AIM2 inflammasome, we screened BMDMs by 
RNA-mediated interference with small interfering RNA (siRNA). 
We selected 443 genes with at least twofold higher expression in 
F. novicida–infected wild-type macrophages than in F. novicida– 
infected Ifnar1−/− macrophages17 and selected 40 additional genes 
on the basis of published reports9,10,17,18 (data not shown and 
Supplementary Table 1). At 48 h after transfection of siRNA specific 
for those genes, we infected macrophages with F. novicida and moni-
tored inflammasome activation by measuring the release of IL-1B 
and incorporation of propidium iodide (as a measure of cell death). 
Knockdown of most of the 483 genes did not substantially affect the 
release of IL-1B or cell death (Fig. 2a). In contrast, knockdown of Gbp2 
or Gbp5 resulted in much less F. novicida–mediated release of IL-1B 
and macrophage death than that of cells treated with nontargeting 
siRNA, while knockdown of other GBP-encoding genes showed no 
comparable effect (Fig. 2a). Gbp2 and Gbp5 had the highest expres-
sion among the GBP-encoding genes in macrophages and were sub-
stantially and specifically induced upon infection with wild-type 
F. novicida in a STING- and IFNAR-dependent manner but independ-
ently of Toll-like receptor 2 and MyD88 (Fig. 2b and Supplementary 
Fig. 1c–e). We confirmed by RT-PCR the efficiency of siRNA- 
mediated knockdown of GBP-encoding genes expressed during 
infection with F. novicida (Supplementary Fig. 2a). We next 
confirmed the screening results by knocking down all 11 mouse 
GBP-encoding genes individually and measuring cell death and IL-1B 
release (Fig. 2c). Knockdown of Gbp2 and Gbp5 specifically decreased 
the F. novicida–mediated release of IL-1B and cell death, as assessed 
by two different techniques (Fig. 2c and Supplementary Fig. 2b). 
In conclusion, our screening approach identified GBP2 and GBP5 
as two possible ISG products that controlled the activation of AIM2 
during infection with F. novicida.
AIM2 activation requires GBP-encoding genes on chromosome 3
To confirm our screening data, we obtained macrophages from 
wild-type mice, mice deficient in both caspase-1 and caspase-11 
(Casp1−/−Casp4−/−; called ‘Casp1−/−Casp11−/−’ here) or mice that lack 
the locus on chromosome 3 encoding GBP1, GBP2, GBP3, GBP5 
and GBP7 (called ‘Gbpchr3’ here)23 and infected naive or primed 
macrophages with F. novicida. Consistent with defective activation 
of the AIM2 inflammasome, Gbpchr3-deficient BMDMs displayed a 
significant reduction in cell death and cytokine release and had a 
diminished abundance of processed caspase-1 p20 compared with 
that of their wild-type counterparts, even though their expression of 
pro-caspase-1, ASC and AIM2 protein was similar to that of wild-type 
cells (Fig. 3a,b and Supplementary Fig. 3a). Measuring the incorpo-
ration of propidium iodide in real time following infection showed 
that Gbpchr3-deficient BMDMs died with delayed kinetics compared 
with that of wild-type cells and similar to that of Ifnar1−/− BMDMs 
(Supplementary Fig. 3b). To determine if GBPs encoded by genes on 
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Figure 2 Screening by RNA-mediated interference identifies members of the GBP family as activators of AIM2. (a) Screening results for wild-type 
BMDMs treated with siRNA targeting various genes (red, genes encoding members of the GBP family; black arrows, Gbp2 and Gbp5), presented as 
incorporation of propidium iodide and release of IL-1B, normalized to the average values obtained with all siRNA (set as 100%) and to the values 
obtained with Aim2-specific siRNA (set as 0%). (b) Expression of mRNA from various GBP-encoding genes (top) in wild-type BMDMs left uninfected (−)  
or infected (+) with wild-type F. novicida strain U112 or the $FPI mutant, assessed 8 h after infection. (c) Release of LDH and IL-1B from unprimed 
wild-type BMDMs pretreated with nontargeting control siRNA (NT) or with siRNA targeting genes encoding various GBPs (horizontal axis) 48 h before 
infection with wild-type F. novicida strain U112, assessed 8 h after infection. *P < 0.05, **P < 0.01 and ***P < 0.001 (two-tailed unpaired t-test). 
Data are representative of one experiment (a) or two (b) or three (c, LDH) independent experiments or are pooled from six independent experiments  
(c, IL-1B) (mean and s.d. of quadruplicate wells in b,c).
np
g
© 
20
15
 N
at
ur
e A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
Appendix
173
NATURE IMMUNOLOGY VOLUME 16 NUMBER 5 MAY 2015 479
A RT I C L E S
chromosome 3 were directly involved in the activation of AIM2, we 
engaged AIM2 by transfecting synthetic DNA into unprimed wild-
type and Gbpchr3-deficient macrophages. Cytosolic DNA triggered 
LDH release to a similar extent in both groups of cells, even when 
the amount of transfected DNA was ‘titrated down’ (Fig. 3c). Wild-
type, Gbpchr3-deficient and Ifnar1−/− cells also responded similarly 
to the transfection of purified F. novicida genomic DNA (Fig. 3d). 
Thus, GBPs were not required in the context of DNA transfection, 
which suggested that they functioned upstream of AIM2-mediated 
DNA detection.
GBP2 and GBP5 direct parallel pathways of AIM2 activation
Since our screening data suggested that mainly GBP2 and GBP5 were 
required for the activation of AIM2 (Fig. 2a), we infected BMDMs 
from wild-type, Casp1−/−Casp11−/−, Gbpchr3-deficient, Gbp2−/− or 
Gbp5−/− mice with F. novicida and measured activation of the AIM2 
inflammasome. Gbp2−/− BMDMs displayed less death and cytokine 
release than did wild-type BMDMs (Fig. 4a,b). Similarly, Gbp5−/− 
BMDMs also displayed attenuated inflammasome activation when 
infected with F. novicida relative to that of their wild-type counterparts 
(Fig. 4a,b). Deficiency in Gbp2 or Gbp5 did not affect cell death in 
response to DNA transfection, even when we used very small amounts 
of DNA (Fig. 4c). To determine if expression of GBP2 or GBP5 could 
restore activation of the AIM2 inflammasome in Ifnar1−/− cells, we 
retrovirally transduced macrophages with constructs expressing GBP2 
or GBP5 or with an empty vector (control) and infected them with 
F. novicida. Such ectopic expression was not able to complement the 
deficiency in inflammasome activation (Supplementary Fig. 4a–c), 
which suggested that other products of ISGs might be required for 
the function of GBP2 and GBP5, in line with data showing that 
GBPs are active and correctly targeted only in the context of the 
interferon response25.
Single deficiency in Gbp2 or Gbp5 did not reduce the activation of 
AIM2 during infection with F. novicida as much as Gbpchr3 deficiency 
did (Fig. 4a,b), which suggested that GBP2 and GBP5 promoted acti-
vation of AIM2 through independent pathways. To investigate whether 
GBP2 and GBP5 acted sequentially or in parallel, we knocked down 
Gbp2 expression in wild-type, Gbp2−/− and Gbp5−/− BMDMs (control 
Figure 3 Macrophages from Gbpchr3-deficient 
mice have deficient activation of AIM2 in 
response to F. novicida. (a) Release of LDH and 
IL-1B from naive or IFN-G-primed wild-type,  
Gbpchr3-deficient (Gbpchr3-KO) and  
Casp1−/−Casp11−/− BMDMs 8 h after infection 
with wild-type F. novicida strain U112.  
(b) Immunoblot analysis of cleaved caspase-1  
(p20) and IL-18 (p19) in culture supernatants  
(Sup), and of GBP2, GBP5, pro-caspase-1  
(Pro-Casp1), pro-IL-18, pro-IL-1B, ASC and  
B-actin (loading control) in extracts (Extract),  
of wild-type and Gbpchr3-deficient BMDMs  
primed with LPS, IFN-B or IFN-G (below blots)  
and then infected with wild-type F. novicida  
strain U112, assessed 8 h after infection.  
(c) Release of LDH from wild-type and Gbpchr3-
deficient BMDMs 8 h after transfection of 
increasing concentrations (wedges) of poly(dA:dT) or poly(dG:dC) (0.25, 0.5 or 1 Mg/ml). (d) Release of LDH from wild-type, Gbpchr3-KO and Ifnar1−/− 
BMDMs 8 h after transfection of increasing concentrations (wedges) of F. novicida genomic DNA (0.1, 0.25, 0.5 or 1 Mg/ml). *P < 0.001 (two-tailed 
unpaired t-test). Data are representative of six (a) three (b,c) or two (d) independent experiments (mean and s.d. of quadruplicate wells in a,c,d).
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Figure 4 GBP2 and GBP5 independently control activation of AIM2  
during infection with F. novicida. (a,b) Release of LDH (a) and  
IL-1B (b) from naive or IFN-G-primed wild-type, Casp1−/−Casp11−/−,  
Gbp2−/−, Gbp5−/− and Gbpchr3-deficient BMDMs 6 h after infection  
with wild-type F. novicida strain U112. (c) Release of LDH from  
naive wild-type, Gbpchr3-deficient, Gbp2−/− and Gbp5−/− BMDMs  
transfected with increasing concentrations (wedges) of poly(dA:dT)  
(0.1, 0.25, 0.5 or 1 Mg/ml). (d) Release of LDH and IL-1B from  
naive wild-type, Gbp2−/− and Gbp5−/− BMDMs treated with  
nontargeting control siRNA or siRNA specific for the gene encoding GBP2 or GBP5 (horizontal axis), then, 22 h later, infected with wild-type F. novicida 
U112, assessed 8 h after infection. *P < 0.05, **P < 0.01 and ***P < 0.001 (two-tailed unpaired t-test). Data are representative of four (a,b), three (c) 
or two (d) independent experiments (mean and s.d. of quadruplicate wells).
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of siRNA knockdown efficacy, Supplementary Fig. 4d) and measured 
inflammasome activation after infection with F. novicida. Knockdown 
of Gbp2 reduced cell death and release of IL-1B in wild-type 
BMDMs but not in Gbp2-deficient BMDMs (Fig. 4d). Treatment 
with Gbp2-specific siRNA also significantly reduced inflammasome 
activation in Gbp5−/− BMDMs (Fig. 4d), which demonstrated that 
in Gbp5-deficient cells, GBP2 was still active and was able to pro-
mote activation of AIM2. Consistent with that, knockdown of Gbp5 
reduced activation of the inflammasome in both wild-type BMDMs 
and Gbp2−/− BMDMs (Fig. 4d). In conclusion, our data suggested 
that the interferon-inducible GTPases GBP2 and GBP5 controlled 
non-redundant, parallel pathways that promoted activation of AIM2 
during infection with F. novicida.
Escape of F. novicida from phagosomes is GBP independent
Since cytosolic localization of F. novicida is required for the activa-
tion of AIM2 and since GBPs promote the destabilization of phago-
somes and/or pathogen-containing vacuoles of protozoan parasites or 
bacteria23,27,29, we speculated that GBPs might facilitate the escape of 
F. novicida from phagosomes. We used a phagosome-protection 
assay29,30 based on selective permeabilization of the plasma membrane 
with digitonin to assay the escape of F. novicida from phagosomes. As 
reported before30, we observed that 90–95% of wild-type F. novicida  
escaped from phagosomes within a few hours of infection, but this 
frequency was similar for wild-type BMDMs and Gbpchr3-deficient 
BMDMs at various time points after infection (Fig. 5a). In contrast, 
$FPI F. novicida remained in the phagosome (data not shown).
F. novicida is naturally resistant to B-lactam antibiotics and secrete 
the B-lactamase FTN_1072. Taking advantage of this, we developed 
an alternative assay to detect cytosolic bacteria based on cleavage of 
the FRET (Förster resonance energy transfer) reporter probe CCF4 by 
FTN_1072, which leads to a loss of FRET activity31,32 (Supplementary 
Fig. 5). We preloaded wild-type, Gbp2−/− and Gbpchr3-deficient 
BMDMs with CCF4-AM, the membrane-permeable form of the 
reporter, and subsequently infected the cells with wild-type F. novicida, 
an FTN_1072-deficient strain (the B-lactamase mutant $bla) or the 
$FPI mutant. We observed no difference among wild-type, Gbp2−/− or 
Gbpchr3-deficient BMDMs in terms of FRET activity after infection with 
wild-type F. novicida (Fig. 5b and Supplementary Fig. 5). The $FPI 
and $bla mutant strains did not produce any significant FRET signals, 
similar to the signaling of uninfected macrophages (Supplementary 
Fig. 5). Thus, we concluded that GBPs did not control the activation of 
AIM2 by promoting the escape of F. novicida from phagosomes but that 
they were active after F. novicida reached the cytosol. This was consist-
ent with our data showing that in unprimed cells, F. novicida–induced 
expression of GBP-encoding mRNA was dependent on the FPI and on 
the escape from phagosomes (Fig. 2b) and that cytosolic recognition 
was required for interferon induction (Supplementary Fig. 1a).
GBPs promote cytosolic lysis of F. novicida
To identify the mechanism by which GBPs controlled the activation of 
AIM2 during infection with F. novicida, we investigated the subcellular 
localization of GBPs in infected cells. GBPs are known to co-localize 
with vacuolar pathogens such as S. typhimurium, M. bovis bacillus 
Calmette-Guérin and T. gondii, consistent with the ability of GBPs 
to recruit anti-microbial effector mechanisms to the pathogen and 
to destabilize PCVs24,27,29. We observed that both GBP2 and GBP5 
were targeted to intracellular F. novicida (Fig. 6a). Closer examination 
of GBP-positive F. novicida revealed that GBPs localized to different 
spots close to or onto the surface of the bacterium (data not shown). 
However, it was unclear if GBPs targeted the bacterium directly or 
targeted remnants of the host membrane (i.e., lysed phagosomes) or 
another closely associated membrane compartment.
Since the irregular shape of GBP-positive bacteria suggested 
that they were lysed, we next determined if wild-type and Gbpchr3-
deficient cells differed in the abundance of lysed intracellular 
F. novicida. Viable and lysed intracellular bacteria can be quantified 
on the basis of propidium iodide staining, since intact bacteria remain 
protected from the influx of propidium iodide33 (Fig. 6b). We tested 
the assay by quantifying lysed bacteria in wild-type BMDMs infected 
with wild-type F. novicida or an F. novicida mutant in which the 
gene encoding the outer membrane protein FopA is deleted ($fopA) 
and thus it has lower membrane stability that results in increased 
intracellular lysis and hyperactivation of the AIM2 inflammasome15. 
We detected significantly larger amounts of propidium iodide– 
positive $fopA F. novicida than wild-type F. novicida (Fig. 6c), which 
confirmed the validity of our assay. We next compared the frequency 
of lysed bacteria in wild-type and Gbpchr3-deficient macrophages. 
The Gbpchr3-deficient BMDMs had a significantly lower frequency 
of lysed bacteria (positive for staining with antibodies to F. novicida 
and propidium iodide) (23% on average) than the wild-type BMDMs 
had (40% on average) (Fig. 6c).
The macromolecular inflammasome complex known as the ‘ASC 
speck’ assembles on genomic DNA released from lysed cytosolic 
F. novicida10. Immunofluorescence analysis revealed mostly irreg-
ularly shaped F. novicida in the vicinity of ASC specks (Fig. 6d). 
These bacteria released DNA and were often also positive for GBP 
staining (Fig. 6d and Supplementary Fig. 6). Consistent with that, 
the number of ASC speck-containing cells was significantly lower 
in GBP-deficient (Gbp2−/−, Gbp5−/− or Gbpchr3-deficient) BMDMs 
than in wild-type BMDMs (Fig. 6e). In conclusion, these findings 
indicated that GBPs associated with cytosolic F. novicida and, by an 
as-yet-undefined mechanism, induced lysis of the bacterium, which 
resulted in DNA release and detection by the cytosolic DNA sensor 
AIM2, followed by oligomerization of ASC.
GBPs control F. novicida replication
Inflammasome-induced cell death (pyroptosis) restricts intra-
cellular bacteria by removing their replicative niche and reexposing 
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Figure 5 The escape of F. novicida from phagosomes is GBP  
independent. (a) Frequency of cytosolic F. novicida (FN) among total 
bacteria at 3 h and 6 h after infection of wild-type and Gbpchr3-deficient 
BMDMs with wild-type F. novicida strain U112, assessed by phagosome-
protection assay. (b) Quantification of cells with ruptured phagosomes  
at 16 h after infection of wild-type, Gbp2−/− and Gbpchr3-deficient 
BMDMs with wild-type F. novicida U112, the B-lactamase-deficient 
mutant $bla or the $FPI mutant or in uninfected cells (UI), assessed 
with the B-lactamase-cleavable FRET probe CCF4 and presented relative 
to that of wild-type cells infected with wild-type F. novicida. NS, not 
significant (two-tailed unpaired t-test). Data are pooled from four 
independent experiments with 300 bacteria counted in each (a; mean  
and s.d.) or three independent experiments with 1.5 × 105 cells counted 
three times in each (b; mean and s.d.).
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them to extracellular immunological mechanisms34. Cell-autonomous 
immunity, on the other hand, relies on cell-intrinsic mechanisms 
to restrict bacterial growth without the need for killing the host 
cell21. To determine whether GBPs restricted F. novicida growth 
through cell-autonomous mechanisms or inflammasome-dependent 
mechanisms, we infected wild-type, Aim2−/−, Gbpchr3-deficient 
and Ifnar1−/− BMDMs with wild-type F. novicida expressing green 
fluorescent protein (GFP) and used flow cytometry to quantify 
infected cells (more than two bacteria per cell, our specific 
fluorescence-detection threshold) among the live cell population. We 
observed a significantly higher percentage of live infected Aim2−/−, 
Gbpchr3-deficient and Ifnar1−/− BMDMs than live infected wild-
type BMDMs (Fig. 7a). This suggested that deficiency in Ifnar1 or 
Gbpchr3, similar to deficiency in Aim2, resulted in a reduction in 
inflammasome-mediated killing of host cells upon infection.
Cell-autonomous growth restriction is an interferon-induced 
mechanism that is at least partially independent of inflammasome-
mediated cell death35,36. Therefore, we next determined if Gbpchr3-
deficient BMDMs and Ifnar1-deficient BMDMs also had a defect 
in restricting intracellular bacterial replication. We infected mac-
rophages with GFP+ F. novicida and quantified bacteria (per cell) 
by both automated microscopy in flow and microscopy at various 
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of AIM2 by inducing bacteriolysis.  
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(anti-GBP2) and anti-GBP5, and staining with  
the DNA-binding dye DAPI, in IFN-G-primed  
wild-type BMDMs 8 h after infection with  
wild-type F. novicida. (b) Microscopy of lysed 
(propidium iodide–positive) F. novicida in  
IFN-G-primed wild-type BMDMs 8 h after  
infection with wild-type F. novicida.  
(c) Quantification of lysed (propidium iodide–
positive) F. novicida (PI+ FN) in IFN-G-primed 
wild-type and Gbpchr3-deficient BMDMs 8 h  
after infection with wild-type F. novicida  
(FN WT) or the $fopA mutant (FN $fopA).  
(d) Immunostaining of ASC, GBP2 and  
F. novicida in IFN-G-primed wild-type BMDMs 
8 h after infection with wild-type F. novicida. 
(e) Quantification of ASC speck formation in  
IFN-G-primed wild-type, Gbp2−/−, Gbp5−/−  
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marked by arrowheads. Scale bars (a,b,d),  
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unpaired t-test). Data are representative of  
three independent experiments (a,b,d) or are  
pooled from three independent experiments  
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each (mean and s.d.).
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Figure 7 GBPs restrict the intracellular replication 
of F. novicida. (a) Flow cytometry–based 
quantification of infected (GFP+) cells among 
live wild-type, Aim2−/−, Gbpchr3-deficient and 
Ifnar1−/− BMDMs 12 h after infection with GFP-
expressing wild-type F. novicida at a multiplicity  
of infection (MOI) of 1 (top) or 10 (bottom).  
*P < 0.001 (two-tailed unpaired t-test).  
(b) Quantification of bacterial loads in single cells 
among wild-type, Aim2−/−, Gbpchr3-deficient and 
Ifnar1−/− BMDMs 12 h after infection with GFP-
expressing wild-type F. novicida at a multiplicity 
of infection of 10, assessed by high-resolution 
microscopy in flow and presented as a comparison 
of all four genotypes (top left) or a comparison 
of wild-type cells with each other genotype, with 
bacteria-per-cell values grouped by increments of 
10 (horizontal axes). P < 0.0001, wild-type versus 
Aim2−/−, wild-type versus Gbpchr3-deficient, and  
wild-type versus Ifnar1−/− (Kolmogorov-Smirnov 
test with Bonferroni correction). Data are 
representative of three independent experiments 
(a; mean and s.d. of triplicate wells) or are pooled 
from three independent experiments (b).
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time points after infection. Wild-type macrophages efficiently 
controlled intracellular replication, but Aim2−/− BMDMs contained 
large numbers of intracellular F. novicida (30 or more per cell) 
(Fig. 7b and Supplementary Fig. 7a,b), consistent with a loss of 
inflammasome-mediated killing of host cells. Bacterial loads were even 
higher in Gbpchr3-deficient or Ifnar1-deficient BMDMs, with many cells 
containing up to 100 bacteria (Fig. 7b and Supplementary Fig. 7a,b). 
The production of reactive oxygen species and nitric oxide is a potent 
cell-intrinsic anti-microbial mechanism that can also be activated in 
an interferon-dependent manner. GBP7 has been shown to recruit 
subunits of the NADPH oxidase to intracellular L. monocytogenes  
and M. bovis bacillus Calmette-Guérin24, and inducible nitric oxide 
synthase can restrict bacterial growth in a cell-intrinsic manner21. 
However, deficiency in these mechanisms achieved through the use 
of BMDMs deficient in both inducible nitric oxide synthase and 
Nox2 did not significantly alter bacteriolysis and inflammasome 
activation after infection with F. novicida (P = 0.3081, P = 0.2786 and 
P = 0.0529; Supplementary Fig. 8a,b). Overall, these data indicated 
that GBPs encoded by the locus on chromosome 3 participated in 
growth restriction in two ways: directly, by promoting the lysis of 
intracellular bacteria by an as-yet-unknown mechanism; and indi-
rectly, by promoting the inflammasome-mediated killing of host cells, 
thereby removing the intracellular replicative niche of F. novicida.
GBPs control F. novicida replication in vivo
AIM2, ASC and caspase-1 control the replication of F. novicida in vivo 
in mice9,10,37. Since GBPs are required for inflammasome activation 
in vitro, we investigated whether these proteins also have a physiologi-
cal role in host defense. We infected age- and sex-matched wild-type, 
Casp1−/−Casp11−/−, Gbp2−/− and Gbpchr3-deficient mice subcutane-
ously with 5 × 103 colony-forming units of wild-type F. novicida strain 
U112 and measured the bacterial burden in the liver and spleen at 
2 d after infection. As published before37, Casp1−/−Casp11−/− mice 
displayed a significantly higher bacterial burden in the liver and 
spleen than that of wild-type mice (Fig. 8a). Similarly, Gbp2−/− and 
Gbpchr3-deficient mice showed higher bacterial counts than wild-
type mice, similar to or even higher than those of Casp1−/−Casp11−/− 
mice (Fig. 8a). Consistent with diminished inflammasome activa-
tion in vivo, we detected a significantly lower serum concentration 
of IL-18 in Casp1−/−Casp11−/−, Gbp2−/− and Gbpchr3-deficient mice 
than in wild-type mice (Fig. 8b). To further assess the effects of GBP 
deficiency in vivo, we analyzed survival. Within 4 d of infection, all 
Casp1−/−Casp11−/−, Gbp2−/− and Gbpchr3-deficient mice died, while 
most wild-type mice survived until the end of the experiment (day 10) 
(Fig. 8c). These results confirmed the relevance of our in vitro data 
and demonstrated that GBPs encoded by the locus on chromosome 3 
were important for inflammasome activation and host defense against 
F. novicida in vivo.
DISCUSSION
Since the activation of AIM2 during infection with the cytosolic path-
ogen F. novicida required interferon signaling, we investigated the role 
of the products of ISGs in this process. Our results showed that the 
interferon-inducible GTPases GBP2 and GBP5 promoted F. novicida– 
mediated activation of the AIM2 inflammasome but were dispensa-
ble for the activation of AIM2 upon transfection of DNA. Members 
of the GBP family take part in interferon-induced cell-autonomous 
immunity and are known to induce disruption of the PCVs of vacuolar 
bacteria and parasites23,27,29. However, the cytosolic localization of 
F. novicida was similar in wild-type and Gbpchr3-deficient cells, which 
indicated that GBPs must have been involved later during infection, 
after the bacteria had entered the cytosol. This was consistent with 
results showing that the escape from phagosomes is an interferon-
independent process36 and that cytosolic localization of F. novicida 
is a prerequisite for interferon induction17. Since the activation of 
AIM2 during infection with F. novicida or L. monocytogenes is known 
to require cytosolic bacteriolysis12,15, we investigated whether GBPs 
controlled the bacteriolysis and replication of F. novicida in the cytosol. 
Significantly fewer lysed and more overall F. novicida were present in 
cells deficient in GBP-encoding genes or Ifnar1 than in wild-type cells, 
which indicated that GBPs were required for interferon-mediated cell-
autonomous immunity to the pathogen. Furthermore, our results 
demonstrated that in addition to their known function in destabilizing 
PCVs, GBPs can also promote the lysis of cytosolic bacteria.
GBPs are also critical for the cytosolic recognition of LPS and for 
activation of the caspase-11 inflammasome pathway. In this context, 
they act by promoting the release of vacuolar S. typhimurium into the 
cytosol or by promoting activation of caspase-11 during infection with 
L. pneumophila29,38. At present, no model fully explains how GBPs 
restrict pathogen growth during infection with microbes or protozoa 
Figure 8 GBPs control host defense against  
F. novicida in vivo. (a) Bacterial burden  
(as colony-forming units (CFU) of F. novicida 
(FN) per gram tissue) in the liver and spleen  
at day 2 after subcutaneous infection of  
wild-type, Casp1−/−Casp11−/−, Gbp2−/− and 
Gbpchr3-deficient mice with 5 × 103 wild-type  
F. novicida. Each symbol represents an 
individual mouse (n = 8 (wild-type),  
10 (Casp1−/−Casp11−/−), 7 (Gbp2−/−) and  
10 (Gbpchr3-deficient) (spleen), or n = 8  
(wild-type), 13 (Casp1−/−Casp11−/−),  
8 (Gbp2−/−) and 9 (Gbpchr3-deficient) (liver)); 
small horizontal lines indicate the mean.  
*P < 0.05, **P < 0.01 and ***P < 0.001 
(Mann-Whitney test). (b) IL-18 in serum 
obtained from wild-type mice (n = 12),  
Casp1−/−Casp11−/− mice (n = 11), Gbp2−/− mice 
(n = 12) and Gbpchr3-deficient mice (n = 14)  
16 h after subcutaneous infection with 1.5 × 105 wild-type F. novicida. *P < 0.01 and **P < 0.001 (Mann-Whitney test). (c) Survival of wild-type, 
Casp1−/−Casp11−/−, Gbp2−/− and Gbpchr3-deficient mice (n = 10 per genotype) after subcutaneous infection with 5 × 103 wild-type F. novicida.  
P < 0.0001, wild-type versus Casp1−/−Casp11−/− or wild-type versus Gbpchr3-deficient, and P = 0.0005, wild-type versus Gbp2−/− (log-rank (Mantel-Cox)  
test). Data are representative of two independent experiments (a,c) or are pooled from two individual experiments (b; with 10th–90th percentiles).
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and at the same time control inflammasome signaling. It is, however, 
conceivable that the membrane-destabilizing activity of GBPs in com-
bination with their bacteriolytic activity could not only result in the 
entry of bacteria into the cytosol but also release microbe-associated 
molecular patterns (for example, LPS and DNA) directly. Such a model 
might explain their effect on both the caspase-11 pathway38 and the 
AIM2 pathway in response to cytosolic bacteria. Thus, bacteriolysis 
would also release F. novicida LPS into the cytosol. However, since 
F. novicida LPS is tetra-acylated, it does not trigger caspase-11 
activation39. Conversely, we would expect GBPs to lyse cytosolic 
Salmonella or Legionella, which would result in activation of AIM2. 
But in this case, activation of AIM2 is most probably masked by a high 
degree of caspase-11-dependent cell death and cytokine release.
GBP-mediated bacteriolysis might also be expected to release 
DNA and amplify the production of type I interferons via STING. 
Notably, what triggers initial STING signaling and the induction of 
GBP-encoding genes during infection with F. novicida is still unde-
fined, but two possibilities exist. One is the direct activation of STING 
via a secreted bacterial cyclic nucleotide, analogous to infection with 
L. monocytogenes40, and another is activation of the DNA sensor 
cGAS by F. novicida DNA and subsequent production of the cyclic 
dinucleotide cGAMP41,42. Lysis of F. novicida within the phagosome 
followed by translocation of its DNA into the cytosol could trigger 
interferon production9. Alternatively, low levels of F. novicida extra-
cellular DNA could reach the cytosol by sticking to the surface of the 
infecting bacteria, as suggested for infection with M. tuberculosis43. 
Finally, small amounts of spontaneous bacteriolysis might occur in 
the host-cell cytosol. If DNA indeed triggers initial STING-mediated 
production of interferons, it remains to be shown why it is insufficient 
to trigger activation of AIM2. Additional experiments are needed to 
determine the relative DNA-binding affinities of cGAS and AIM2 and 
how their signaling hierarchy is controlled.
Our results have revealed an underappreciated, close connection 
between cell-autonomous immunity and recognition by the innate 
immune system. The attack of GBPs on PCVs or pathogens liberates 
microbe-associated molecular patterns and thus ensures subsequent 
immunological recognition of the pathogen, which explains the role 
of interferon signaling in the detection of bacterial DNA by AIM2 
or LPS from vacuolar bacteria by the caspase-11 pathway9,10,13,44,45. 
Additional questions remain, such as how GBP targeting is regulated 
and how GBPs act mechanistically. Ectopic expression of GBP2 or 
GBP5 did not ‘rescue’ the inflammasome deficiency of Ifnar1−/− cells, 
which suggests that other products of ISGs are necessary for proper 
targeting and activity of GBPs24,25. Indeed, members of the IRGM 
family, a subclass of the immunity-related GTPases, can act as guanine-
 dissociation inhibitors and control the targeting of both immunity-
related GTPases and GBPs to pathogen-containing vacuoles, yet the 
molecular mechanism of this is still unclear46–49. Additional biochemi-
cal studies are needed to define the mechanism of GBP targeting and 
action during bacterial infection and how this promotes the exposure 
of bacterial ligands to cytosolic recognition pathways.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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Bacterial strains and plasmids. F. novicida strain U112 and isogenic $FPI 
mutants have been published10. Where applicable, strains were transformed 
with the plasmid pKK219-GFP (Supplementary Table 2). The B-lactamase 
mutant $bla was generated by PCR-mediated homologous recombination 
with a kanamycin selection cassette through use of the following primers 
(upper case indicates F. novicida sequence; lower case indicates the 
 kanamycin-resistance casette sequence): ForUpstream, GTCGAGTACGCT
AATATAAAAATTCTAAAAA; RevUpstream, gcttatcgataccgtcgacctcGGGA 
TTAATGATAAAGTTGTAACTAATATACGC; ForDownstream, gatatcgat 
cctgcagctatgcCACTTATAAATAAGCGGTACGCCAC; and RevDownstream, 
AAGACGGTGATGTACCATTTGTCTATAG. The kanamycin-resistance 
casette was removed by transformation of the mutant obtained with the ther-
mosensitive plasmid pFFlp (provided by L. Gallagher and C. Manoil) encod-
ing the recombinase Flp. Following loss of the plasmid, genomic deletion was 
verified by sequencing.
Mice. Gbpchr3-deficient, Gbp2−/−, Gbp5−/−, Nos2−/−Cybb−/−, Casp1−/−Casp11−/− 
(‘caspase-1-knockout’), Asc−/−, Aim2−/−, Stat1−/−, Ifnar1−/−, StingGt/Gt, Tlr2−/− 
and Myd88−/− mice have been described3,10,23,27,29,44. Mice were bred in 
the animal facilities of the University of Basel or at the Plateau De Biologie 
Expérimentale De La Souris.
Animal infection. All animal experiments were approved (license 2535, 
Kantonales Veterinäramt Basel-Stadt and ENS_2012_061) and were per-
formed according to local guidelines (Tierschutz-Verordnung, Basel-Stadt and 
CECCAPP, Lyon) and the Swiss animal protection law (Tierschutz-Gesetz). 
Age- and sex-matched mice (8–10 weeks of age) were infected subcutaneously 
with 5 × 103 or 1.5 × 105 colony-forming units of stationary-phase wild-type 
F. novicida strain U112 in 50 Ml PBS. Mice were killed at the appropriate time 
point after infection. No randomization or ‘blinding’ of researchers to sample 
identity was used.
Cell culture and infection. BMDMs were differentiated in DMEM (Invitrogen) 
with 10% vol/vol FCS (Thermo Fisher Scientific), 10% MCSF (supernatants 
of L929 mouse fibroblasts), 10 mM HEPES (Invitrogen) and nonessential 
amino acids (Invitrogen). 1 d before infection, macrophages were seeded into 
6-, 24- or 96-well plates at a density of 1.25 × 106, 2.5 × 105 or 5 × 104 cells 
per well. Where required, macrophages were pre-stimulated with Pam3CSK4 
(tripalmitoyl cysteinyl seryl tetralysine), LPS (from Escherichia coli strain 
O111:B4 (InvivoGen)), mouse IFN-B or mouse IFN-G  (eBioscience). For infec-
tion with F. novicida, bacteria were grown overnight at 37 °C with aeration in 
brain-heart–infusion medium or tryptic soy broth. The bacteria were added to 
the macrophages at a multiplicity of infection of 100 or the appropriate value. 
The plates were centrifuged for 15 min at 500g to ensure similar adhesion of 
the bacteria to the cells and were incubated for 120 min at 37 °C. Next, cells 
were washed and fresh medium with 10 Mg/ml gentamycin (Invitrogen) was 
added to kill extracellular bacteria, then plates were incubated for the desired 
length of time. Transfection with poly(dA:dT) or poly(dG:dC) was done as 
described29 or as indicated in the figures and legends (Figs. 1 and 3).
siRNA-mediated knockdown. Genes were knocked down with GenMute 
(SignaGen Laboratories) and siRNA pools (siGenome; Dharmacon). Wild-
type BMDMs were seeded into 24- or 96-well plates at a density of 1.5 × 105 
or 3 × 104 cells per well. siRNA complexes were prepared at a concentration 
of 25 nM siRNA in GenMute Buffer according to the manufacturer’s instruc-
tions for forward knockdown (SignaGen laboratories). siRNA complexes were 
mixed with BMDM medium (described above) and were added onto the cells. 
After 22–48 h of gene knockdown, BMDMs were infected with F. novicida at a 
multiplicity of infection of 100:1 and were analyzed for inflammasome activa-
tion as outlined below. siRNA pools targeted the following genes (numbers 
in parentheses indicate Dharmacon reference): Aim2 (M-044968-01), Casp11 
(that is, Casp4) (M-042432-01), Gbp1 (M-040198-01), Gbp2 (M-040199-00), 
Gbp3 (M-063076-01), Gbp4 (M-047506-01), Gbp5 (M-054703-01), Gbp6 
(M-041286-01), Gbp7 (M- 061204-01), Gbp8 (M-059726-01), Gbp9 
(M-052281-01), Gbp10 (M-073912-00), Gbp11 (M-079932-00) and NT (non-
targeting) pool 2 (D-001206-14).
siRNA screening. Knockdown of the 483 selected genes was performed as 
described above in the 36 central wells of 96-well plates; this included the 
nontargeting control siRNA and siRNA specific for Asc and Aim2 on each 
plate. Macrophages were infected with F. novicida at a multiplicity of infection 
of 100:1 and, following a wash at 1 h after infection, cells were incubated with 
medium supplemented with propidium iodide at 5 Mg/ml. At 6 h after infec-
tion, the fluorescence of propidium iodide was determined on a plate reader 
(Tecan) and supernatants were collected for analysis of the release of IL-1B 
by enzyme-linked immunosorbent assay (DuoSet; R&D Systems). The fluo-
rescence of propidium iodide and concentration of IL-1B in cells transfected 
with each siRNA were normalized to the average value of the full plate set, set 
as 100, and to the value obtained with Aim2-specific siRNA, set as 0, with the 
following calculation (for gene ‘X’): normalized value obtained with X-specific 
siRNA = (value obtained with X-specific siRNAx − value obtained with 
Aim2-specific siRNA) / (average value obtained with siRNA − value obtained 
with Aim2-specific siRNA). All the siRNA presenting variation of more 
than 50% in either one of the two parameters have been retested two or three 
times. Average normalized values are presented in the display items.
Ectopic expression of GBP2 and GBP5. Mouse Gbp2 and Gbp5 were cloned 
into the lentiviral plasmid TRIP iziE-SSFV-GFP with the following prim-
ers and restriction enzymes (upper case indicates gene sequence; lower case 
indicates restriction site (underlined) and four bases flanking in the 5` direc-
tion): For_mGBP2_AvrII, attacctaggGACATGGCCTCAGAGATCCACATG; 
Rev_mGBP2_EcoRV, aatagataTCAGAGTATAGTGCACTTCCCAGACG; 
For_mGBP5_AvrII, aaatcctagGACATGGCCCCAGAGATTCACATG; and 
Rev_mGBP5_HpaI, atttgttaacTTAGCTTATAACACAGTCATGATGATGT 
CTAC. The production of lentiviruses in 293T human embryonic kidney cells 
and the transduction of primary BMDMs were performed by standard meth-
ods. IFNAR1-deficient macrophages were transduced after 8 d of differentia-
tion by spin-inoculation (1,500g for 2 h at room temperature). Transduced 
macrophages were infected 48 h later. Transduction frequency was determined 
by flow cytometry based on GFP expression. Specific ectopic expression was 
checked by quantitative RT-PCR.
Cytokine and LDH release measurement. IL-1B, IL-18 and tumor-necrosis 
factor were measured by enzyme-linked immunosorbent assay (eBioscience). 
LDH was measured with an LDH Cytotoxicity Detection Kit (Clontech). To 
normalize for spontaneous lysis, the percentage of LDH release was calcu-
lated as follows: (LDH infected − LDH uninfected) / (LDH total lysis − LDH 
uninfected) × 100.
Immunoblot analysis. Immunoblot analysis was done as described29. 
Antibodies used were rat anti–mouse caspase-1 (1:1,000 dilution; 4B4; 
Genentech), rabbit anti-IL-1A (1:1,000 dilution; ab109555; Abcam), rabbit 
anti-IL-18 (1:500 dilution; 5180R; Biovision), goat anti–mouse IL-1B (1:500 
dilution; AF-401-NA; R&D Systems), rabbit anti-GBP2 (1:1,000 dilution; 
11854-1-AP; Proteintech) and rabbit anti-GBP5 (1:1,000 dilution; 13220-1-AP; 
Proteintech). Cell lysates were probed with monoclonal anti-B-actin (1:2,000 
dilution; AC-15; A1978; Sigma). Secondary antibodies were as follows (all 
conjugated to horseradish peroxidase and all at a dilution of 1:3,000): goat anti-
rat (NA935V; GE Healthcare), goat anti-rabbit (G21234; Invitrogen), rabbit 
anti-goat (811620; Invitrogen) and rabbit anti-mouse (816720; Invitrogen).
Real-time PCR. Primers used for mRNA quantification are in Supplementary 
Table 3. Experiments were performed with an iCycler (Bio-Rad) and SYBR 
green (Applied Biosystems) with standard protocols.
Statistical analysis. Prism 5.0a software (GraphPad Software) was used for 
statistical analysis of data. For evaluation of the differences between two 
groups (cell death, cytokine release, flow cytometry, colony-forming units 
and immunofluorescence-based counts), a two-tailed t-test was used. The 
Kolmogorov-Smirnov test was used for comparison of the cell distribu-
tion as determined by ImageStream microscopy in flow. P values were 
adjusted for multiple comparisons with the Bonferroni correction approach. 
Animal experiments were evaluated with the Mann-Whitney or log-rank 
Cox-Mantel test.
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Immunofluorescence. Macrophages were seeded on glass coverslips and were 
infected as described above. At the desired time points, cells were washed 
three times with PBS and were fixed for 15 min at 37 °C with 4% parafor-
maldehyde. Following fixation, coverslips were washed, and the fixative was 
quenched for 10 min at room temperature with 0.1 M glycine. Coverslips were 
stained for 16 h at 4 °C with primary antibodies (identified below), then were 
washed with PBS and then incubated for 1 h at room temperature with the 
appropriate Alexa Fluor–conjugated secondary antibodies (identified below) 
(1:500 dilution; Invitrogen), then were washed with PBS and mounted on 
glass slides with Vectashield containing DAPI (6-diamidino-2-phenylindole; 
Vector Labs). Antibodies used were chicken anti–F. novicida (1:1,000 dilution; 
a gift from D. Monack), rat anti-ASC (1:1,000 dilution; Genentech), rabbit 
anti-GBP2 (1:100 dilution; 11854-1-AP; Proteintech) and rabbit anti-GBP5 
(1:100 dilution; 13220-1-AP; Proteintech). Secondary antibodies used were 
as folllows (all at a dilution of 1:500 and all from Life Technologies): goat anti-
rat coupled to Alexa Fluor 488 (A11006), Alexa Fluor 568 (A11077) or Alexa 
Fluor 633 (A21094); goat anti-rabbit coupled to Alexa Fluor 488 (A11008) or 
Alexa Fluor 568 (A10042); and goat anti-chicken coupled to Alexa Fluor 488 
(A11032), Alexa Fluor 568 (A11047) or Alexa Fluor 633 (A21103). Coverslips 
were imaged on a Zeiss LSM700 or a Leica SP8 at a magnification of ×63 and 
vacuolar versus cytosolic bacteria, total intracellular bacteria or ASC specks 
were quantified as described in the figure legends.
Phagosome protection assay. For quantification of cytoplasmic and vacuolar 
bacteria, macrophages were infected with GFP+ F. novicida as described 
above. At the desired time point, cells were washed with KHM buffer (110 mM 
potassium acetate, 20 mM HEPES and 2 mM MgCl2, pH 7.3), followed 
by incubation for 1 min in KHM buffer with 50 Mg/ml digitonin (Sigma). 
Cells were immediately washed three times with KHM buffer and then were 
stained for 12 min with Texas Red–coupled chicken antibody to F. novicida 
(identified above) in KHM buffer with 2% BSA. Cells were washed with PBS, 
then were fixed and analyzed by microscopy. Controls were included in every 
assay as described29.
Intracellular viability measurement. For measurement of the intracellu-
lar lysis of F. novicida, we adapted a published propidium iodide–staining 
method33. Infected BMDMs were incubated for 12 min at 37 °C with Alexa 
Fluor 488–conjugated mouse antibody to F. novicida (identified above) and 
2.6 MM propidium iodide (Sigma) in KHM buffer (described above) for label-
ing of accessible cytosolic bacteria and compromised bacteria, respectively, 
in permeabilized cells. Cells were fixed and imaged as described above.
CCF4 measurements. Quantification of escape from vacuoles with the 
B-lactamase–CCF4 assay was performed following manufacturer’s instructions 
(Life Technologies). Macrophages seeded onto non-treated plates were 
infected for 1 h as described above, washed and then incubated for 1 h at 
room temperature in CCF4 in the presence of 2.5 mM probenicid (Sigma). 
Live (propidium iodide–negative) cells were used for quantification of cells 
containing cytosolic F. novicida, with excitation at 405 nm and detection at 
450 nm (cleaved CCF4) or 510 nm (intact CCF4).
Flow cytometry. For assessment of bacterial replication by flow cytometry, 
macrophages seeded onto untreated plates were infected as described above 
with GFP-expressing F. novicida strains. At 8 h after infection, cells were 
lifted with trypsin and were immediately analyzed by flow cytometry on a 
FACSCanto II cytometer (BD Biosciences). Dead cells were excluded on the 
basis of staining with propidium iodide.
ImageStream flow cytometry. Macrophages infected with GFP-expressing 
bacteria were fixed in 4% PFA and were analyzed on an ImageStream X Mark II 
(Amnis; EMD-Millipore) with Inspire software, with the extended depth- 
of-field function activated to increase the accuracy of spot counts. Images of 
single cells were analyzed with Ideas software (Amnis; EMD-Millipore) with 
the following steps (each step being confirmed by visualization of at least 20 
single cells). Doublets and debris were excluded by morphological param-
eters (aspect ratio and area in the brightfield channel). Defocused images 
were eliminated by the Gradient RMS function of the brightfield function. 
For spot counts and definition of the mean fluorescence of single bacterium, 
the specific GFP fluorescence signal was defined by application of a mask 
combining an intensity threshold and a spot to cell background ratio (peak) 
function. Automatic spot counts were performed with the mask described 
above. Cells containing a single spot (either a single bacterium or a tight cluster 
of several bacteria) were gated. The area of the specific signal was analyzed in 
single cells on the gated population. For the exclusion of bacterial clusters and 
quantification of the fluorescence of single bacterium, the mean fluorescence 
intensity was calculated on the GFP+ signal covering an area of 1 o 0.5 Mm2 
in 1,599 cells.
Bacteria in single cells were quantified by the automatic spot count 
function or their numbers were calculated based on the fluorescence of single 
bacterium. The quantification was identical for cells containing fewer than 
seven bacteria (R2 > 0.99). For higher intracellular burden, the spot-count 
function largely underestimated the number of bacteria per cell due to 
the difficulty to discriminate bacterial cluster. We thus relied on the specific 
fluorescence of the bacteria within the cells as defined by the mask described 
above and the calculated fluorescence value of single intracellular bacterium 
to quantify bacteria per cell. The mask was applied to at least 10,000 images of 
single cells per sample to extract the specific fluorescence of the intracellular 
bacteria in single cells.np
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Supplementary Figure 1 
Induction of Ifnb, Aim2 or Gbp mRNA in dependence of STING and IFNAR signaling. 
(a) Induction of Ifnb expression from unprimed wild-type (WT), Tlr2–/–, Myd88–/–, Trif–/– and Stinggt/gt bone-marrow derived macrophages 
(BMDMs) following infection with wild-type F. novicida U112 for 6 h. (b–e) Induction of Gbp2, Gbp3, Gbp5 or Aim2 expression from 
unprimed wild-type, Tlr2–/–, Myd88–/–, Ifnar1–/– and Stinggt/gt BMDMs following infection with wild-type F. novicida U112 for 6 h. Graphs 
show mean and s.d. of quadruplicate assays and data are representative of two (b-d) or three (a) independent experiments. 
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Supplementary Figure 2 
Gbp knockdown efficiency and real-time cell death after knock-down of Gbps. 
(a) Induction of the expression of individual Gbps from LPS/IFN-primed wild-type BMDMs treated with Non-Targeting (NT) or the 
indicated gene-specific siRNA for 22 h. Graph shows mean and s.d. of quadruplicate wells. Gbp1, 4, 6/10, 11 were not tested due to 
their low expression (see Fig. 2b). (b) Cell death as measured by propidium iodide (PI) influx in real-time in unprimed wild-type BMDMs 
infected with wild-type F. novicida U112. BMDMs were treated with Non-Targeting (NT) or indicated gene-specific siRNA for 48 h 
before infection. Graphs show mean and s.d. of triplicate assays and data are representative of three• independent experiments. *, 
p<0.05; **, p<0.01; NS, not significant (two-tailed unpaired t-test). 
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Supplementary Figure 3 
Aim2 induction and real-time cell death assay in Gbp-deficient and Ifnar1-deficient cells. 
(a) Induction of Aim2 expression from unprimed wild-type, Gbpchr3-deleted and Ifnar1–/– BMDMs infected with wild-type F. novicida U112 
for 6 h. *, p<0.01; NS, not significant (two-tailed unpaired t-test). (b) Cell death as measured by propidium iodide influx in real-time in 
unprimed wild-type, Gbpchr3-deleted and Ifnar1–/– BMDMs left uninfected (UI) or infected with wild-type F. novicida U112. Graphs show 
mean and s.d. of triplicate assays and data are representative of two (a) and three (b) independent experiments. 
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Supplementary Figure 4 
Ectopic expression of GBPs in Ifnar1–/– cells and efficiency of Gbp2 and Gbp5 knockdown. 
(a–c) Ectopic expression of GBP2 or GBP5 do not complement type-I-IFN receptor deficiency. Ifnar1–/– macrophages were transduced
with lentivirus encoding either GFP only (EV = empty vector) and GFP-GBP2 and GFP-GBP5. 48 h post transduction, macrophages 
were infected with F. novicida at the indicated MOI. IL-1 concentration in the supernatant was determined at 7 h and 10.5 h post
infection (a). Specific ectopic expression was verified by quantifying the Gbp3 (control), Gbp2 and Gbp5 transcript levels. Results are 
expressed as fold induction relative to the transcript level in Ifnar1–/– macrophages transduced with empty vector control (b). Graphs 
show mean and s.d. of triplicate assays. The percentage of transduced cells was determined by flow cytometry based on GFP
expression (c). (d) RT-PCR for Gbp2 and Gbp5 expression from unprimed wild-type, Gbp2–/– and Gbp5–/– BMDMs treated with Non-
Targeting or the indicated gene-specific siRNA for 22 h and infected for 8 h with wild-type F. novicida U112. Graphs show mean and 
s.d. of quadruplicate assays and data are representative of independent two experiments. *, p<0.05; **, p<0.01; NS, not significant
(two-tailed unpaired t-test). ND, not detected. 
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Supplementary Figure 5 
Phagosomal rupture assay using the CCF4/-lactamase system. 
Wild-type, Ifnar1–/– and Gbpchr3-deleted BMDMs were primed for 16 h with IFN- (500 units/ml), infected for 1 h with wild-type F. novicida
(FN) U112, a -lactamase-deficient mutant (bla) or a FPI mutant and loaded with CCF4-AM for 1 h before analysis by flow cytometry. 
Phagosomal rupture is associated with -lactamase (encoded by FTN_1072) release into the cytosol and cleavage of the CCF4
substrate (maximum emission at 520 nm) into a product which emits with a maximum of fluorescence at 447 nm. FACS plots show
pooled data from three independent samples and representative of three independent experiments. Live cells (propidium iodide
negative) are shown. 
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Supplementary Figure 6 
GBPs co-localize with irregularly shaped bacteria next to ASC specks. 
Wild-type BMDMs infected with wild-type F. novicida for 8 h, stained for DNA (DAPI), GBP2, F. novicida and ASC. Scale bars: 10 m. 
Data are representative of three• independent experiments. 
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Supplementary Figure 7 
Analysis of bacterial replication in infected macrophages. 
(a) Quantification of bacterial loads in single cells by high-resolution microscopy in flow over time. Wild-type BMDMs were left 
uninfected or infected with GFP+-wild-type F. novicida or a FPI mutant at an MOI of 10 for 0-12 h, fixed and analyzed by 
ImageStreamTM microscopy in flow. Each bar corresponds to the number of cells with the indicated numbers of bacteria per cell grouped 
by increments of 5... Wild-type UI vs. wild-type MOI 10 3h p>0.9999, wild-type UI vs. wild-type MOI 10 6h p>0.9999, wild-type UI vs. 
wild-type MOI 10 9h p<0.0001, wild-type UI vs. wild-type MOI 10 12h p<0.0001, wild-type MOI 10 12h vs. FPI MOI 10 12h p<0.0001 
Kolmogorov-Smirnov test with Bonferroni correction). (b) Quantification of bacterial loads as determined by microscopy. Wild-type, 
Aim2–/–, Gbpchr3-deleted and Ifnar1–/– BMDMs were infected with GFP+-wild-type F. novicida at an MOI of 10 for 16 h, fixed and analyzed 
by confocal microscopy. Graph show pooled data from 2 independent experiments (n>1000 bacteria counted). *, p<0.05; **, p<0.01;
***, p<0.001 (two-tailed unpaired t-test). 
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Supplementary Figure 8 
Bacteriolysis and cell death during F. novicida infection are independent of ROS or NO production. 
(a) Quantification of lysed (propidium iodide+ F. novicida) in IFN--primed wild-type and Nos2–/–/Cybb–/–BMDMs infected for 8 h with wild-
type F. novicida. Imaging of lysed (propidium iodide+) F. novicida in IFN--primed wild-type and Nos2–/–/Cybb–/–BMDMs infected for 8 h 
with wild-type F. novicida. Arrowheads indicate region in insets. Scale bars 10 m. (b) LDH release from naïve or IFN--primed wild-
type and Nos2–/–/Cybb–/– BMDMs infected for 8 h with wild-type F. novicida U112. Graphs show mean and s.d. of quadruplicate wells 
and data are representative of three• independent experiments. NS, not significant (two-tailed unpaired t-test). 
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Supplementary Table 2 Bacterial strains and plasmid used in this study. 
   Name Parental strain Characteristic 
wild-type  
F. novicida U112 _ _ 
∆FPI 
wild-type  
F. novicida U112 ∆FTN_1309-1325::Kan 
∆bla 
wild-type  
F. novicida U112 ∆FTN_1072 
∆fopA 
wild-type  
F. novicida U112 fopA::T20 
pKK219-GFP  _ 
GFP expressing 
plasmid 
 
Supplementary Table 3 | Primers used for qRT-PCR. Target gene, sequence and 
size of amplicon are indicated. 
Target 
gene Forward primer Reverse primer 
Amplicon 
(bp) 
mGBP1 aataagctggctggaaagca tgtgtgagactgcacagtgg 60 
mGBP2 accagctgcactatgtgacg tcagaagtgacgggttttcc 172 
mGBP3 gtctggagaacgcagtgaca gtgctccatgaagacagcaa 182 
mGBP4 gagcagctcatcaaagacca ttcctcacggaaagtcttttg 72 
mGBP5 ccagagtaaagcggaacaag gtgcaactcttgccttctcc 158 
mGBP6/10 tggagcagctgcattatgtc gcattctgggtttgtcacct 228 
mGBP7 aacagcatgagcaccatcaa gaagtggactttgccctgat 89 
mGBP8 tgctatgacccaaccacaaa ccttggtctgagactgcaca 227 
mGBP9 tgtgcagtctcagaccaagg aagcacacttagggcgaaga 154 
mGBP11 agcaactgagaaggaagctga caaggagagccttttgttcct 99 
mβ-actin gtggatcagcaagcaggagt agggtgtaaaacgcagctca 96 
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